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Abstract 
The production of retroviral vectors for gene therapy applications faces a number of 
challenges. Of primary concern is the low titre of vector stocks produced by packaging cells 
in culture and the inherent instability of retroviral vector activity. 
A systematic investigation of culture parameters that can effect vector titre was conducted. 
Physical and chemical factors including temperature, pH, medium composition, dissolved 
oxygen and serum concentration were all assessed. In addition, a number of studies were 
undertaken to assess the effects of packaging cell growth rate on vector production. 
The use of a packed bed, as a novel system for large-scale vector production, was also 
investigated. Prolonged production of retroviral vector stocks was demonstrated in the 
packed bed system with immobilised packaging cells. Determination of the critical culture 
parameters allowed optimisation of culture conditions, which can be continuously controlled 
in the packed bed system, thereby ensuring optimal vector production throughout the 
production period. Furthermore, vector decay rates can be reduced by the immediate 
collection of vectors into a recovery vessel. 
The studies within this thesis will aid the development of appropriate procedures for the 
large-scale production and handling of retroviral vector stocks for human gene therapy 
applications. 
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Chapter 1: Introduction 
1.1 Gene Therapy 
Gene therapy was originally conceived as a treatment for genetic disorders. In such cases, 
the principle of gene therapy is the introduction of a normal functional copy of a defective or 
missing gene into the genome, in order to restore normal cell function and thereby eliminate 
the disease symptoms. A number of diseases, of known molecular pathology, have been 
targeted for gene therapy research. These include adenosine deaminase deficiency (Blaese et 
aI., 1990), cystic fibrosis (Knowles et aI., 1995), haemophilia A and B (Fallaux and Hoeben, 
1996), insulin-dependent diabetes mellitus (Bailey et aI., 1999), Duchenne muscular 
dystrophy (Parrish et aI., 1999), emphysema and Gaucher's disease (Morgan, 1995). Today, 
the delivery of genes is also under investigation for the treatment of infectious diseases such 
as Acquired Immunodeficiency Syndrome (Todd et aI., 2000), Herpes and Hepatitis 
(Weatherall, 1995). A number of neurological degenerative diseases are also being targeted 
(Parasrampuria, 1998). Other complications such as atherosclerotic plaque formation (Fan et 
aI., 1999) and organ transplant rejection (Moore, 1999) may also benefit from gene therapy. 
Gene therapy has also been recognised as a potential cure or treatment for cancer (Fujiwara 
et aI., 1994). While cancer may be considered a genetic disorder due to the numerous 
mutations in evolving clones of tumours, any attempt to correct these mutations by gene 
therapy would be impossible in most cases, due to the huge range and complexity of 
mutations. Instead, gene therapy has been identified as a potential method for the selective 
killing of cancer cells (Avalosse et aI., 1995; Davis et aI., 1996). 
A number of approaches to kill cancer cells using gene therapy have been identified. For 
example, genes encoding a novel 'pro-drug activating enzyme' can be transferred to tumour 
cells, resulting in the expression of this novel enzyme by these cells (Davis et aI., 1996; 
Green et aI., 1998; Palu et aI, 1999). This enzyme has the ability to convert a non-toxic 'pro-
drug' administered to the patient into a cytotoxic agent, thereby killing any cells producing 
that enzyme (and neighbouring cells). Obviously such an approach would be limited to 
localised tumours and gene transfer would ideally need to be specific to the tumour cells 
only. Such approaches have a great advantage over conventional chemotherapy, in that 
cytotoxicity is more targeted to the tumour cells. 
Alternatively, the transfer of genes encoding immuno-stimulatory proteins (such as various 
cytokines or the co-stimulatory protein B7/CD80) into tumour cells can result in a systemic 
immune response against these tumour cells (Fujiwara et aI., 1994; Davis et aI., 1996; 
Gilligan et aI., 1998). The resultant tumour cell-specific cytotoxic T-cells can identify and 
kill the tumour cells in the body and induce systemic immunity. 
The huge potential for gene therapy to cure a wide range of diseases has lead to high 
expectations and a great increase in research efforts in this area. The first human gene 
therapy protocol was conducted in 1990 by W. French Anderson and showed promising 
results (Blaese et aI., 1995). Over the following four years, more than 100 gene therapy 
protocols were approved for clinical trials (Gordon and Anderson, 1994) and by 1999, 184 
gene therapy clinical trials were ongoing, illustrating the rapid growth of this field. As of 
September 2000, the FDA (Food and Drug Administration) have allowed 386 gene therapy 
INDs (Investigational New Drugs) to proceed to clinical trial (personal communication, Julie 
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Zawisza, Centre for Biologics Evaluation and Research, FDA). Furthennore, with the 
advent of the first draft of the human genome sequence (see Coghlan and Boyce, 2000) and 
the development of advanced technologies for the identification of genes and their function 
(Kost, 1999), the number of candidate diseases for gene therapy is likely to dramatically 
increase. However, to date, evidence of clinical improvement has been proven in only a 
handful of patients undergoing gene therapy (Palu et aI., 1999). This apparently poor 
outcome can be attributed to the number of challenges faced by gene therapy, such as the 
ability to reproducibly transduce a sufficient number of target cells with the therapeutic gene 
and to obtain and sustain sufficient levels of the gene product to alleviate the disease 
symptoms. The efficient transfer of a therapeutic gene into human cells will depend upon 
the technology used for gene delivery. A number of delivery systems have been identified, 
which either involve physical delivery of naked DNA (non-vector delivery), or the use of 
vectors (viral and non-viral). The advantages and disadvantages of each are outlined below. 
1.2.1 Gene Delivery 
1.2.1 Non-Vector Delivery 
Naked DNA can be physically transferred into cells by a number of methods, including 
microinjection (Capecchi, 1980), electroporation (Chu et aI., 1987), calcium phosphate 
precipitation (Loyter et aI, 1982) and microparticle bombardment (Burkholder et aI., 1993). 
Such methods rarely lead to integration of the DNA into the host genome, and hence 
expression is usually only transient (non-integrated DNA is readily degraded). 
Microinjection is not suitable for most gene therapy applications due to the limited number 
of cell nuclei one can directly inject with naked DNA. Conversely, under optimal 
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conditions, electroporation can allow up to 90% of a cell sample to be transfected with 
foreign DNA. Electroporation involves the exposure of cells to a high voltage, thereby 
allowing the passage of DNA inside the cells. However, transfection of these cells is usually 
only transient. While transfection efficiencies may not be as high, an alternative method 
involves the co-precipitation of DNA with calcium phosphate, thereby enabling some of the 
DNA to be taken up into cells by non-specific endocytosis. However, a number of cell types 
appear to resist such transfection. Again, DNA transferred by this method does not usually 
integrate into the host chromosomes, but transiently resides in the nucleus as an episome. 
Finally, cells can be bombarded with microparticles onto which DNA has been precipitated. 
These particles enter the cells and the DNA is gradually released from the particles to allow 
its transient expression (Burkholder et aI., 1993). 
1.2.2 Non-Viral Vectors 
Despite the great number of advantages of viral vectors (discussed below), the development 
of non-viral vectors is still ongoing. The use of non-viral vectors avoids the potential risks 
of viral infections and immune responses, which could result from the use of viral vectors for 
gene delivery. However, whilst non-viral vectors are essentially non-pathogenic, they are 
less effective than viral vectors for gene delivery in vivo (Robbins, 1998). 
Most non-viral vectors involve DNA-conjugates (a complex of positively charged molecules 
with the negatively charged nucleic acids). The~e methods of gene delivery will require 
significant modifications before they are able to reach the current efficiency achievable with 
viral vectors. 
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1.2.3 Viral Vectors 
Currently preferred methods for gene delivery involve the use of viral vectors (Mitani and 
Caskey, 1993; Gordon and Anderson, 1994; Robbins et aI., 1998; Palu et aI., 1999). This is 
because genes are delivered more efficiently by viral vectors, compared to DNA transfection 
(Hwuang and Gilbo, 1984; Kim et aI., 1998). Viruses have evolved to efficiently transfer 
their own genome into a host cell, thereby using the cell's machinery for their own 
reproduction. This unique process has been exploited in the development of viral vectors for 
gene delivery (Morgenstem and Land, 1990; Morgan, 1995; Duisit et aI., 1999; Palu et aI., 
1999; Peng and Russell, 1999). Vectors derived from retroviruses are used in the majority of 
gene therapy clinical trials to date (Gordon and Anderson, 1994; Vos, 1995; Andreadis et aI., 
1999). However, vectors derived from adenovirus, adeno-associated virus and herpesvirus 
are receiving increasingly more attention in the field of gene therapy (Mitani and Caskey 
1993; Vos, 1995; Parasrampuria, 1998). The properties of each of these vectors are 
described in brief, with emphasis on retroviral vectors, for the purposes of this thesis. 
1.2.3.1 Retrovirus Vectors 
Retroviral particles consist of 2 identical copies of single stranded, positive sense RNA 
(typically 7-10 kilo base pairs in length), plus integrase and reverse transcriptase enzymes, 
contained within a protein shell (capsid) which is surrounded by a lipid membrane. This 
outer membrane is studded with glycoprotein projections (envelope proteins). Some classes 
of retrovirus also possess an intermediate layer between the protein shell and viral membrane 
(Nermut and Hockley, 1996). The diameter of a typical retrovirus particle has been reported 
to range from 90 to 140nm. 
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The envelope proteins play a pivotal role in determining the specificity of the retrovirus and 
are responsible for the attachment to and fusion with target cell membranes (allowing 
internalisation of a retroviral particle into the target cell). Alternatively, some retroviruses 
gain entry, after binding to the target cell, by endocytosis. Retroviral RNA is reverse 
transcribed into DNA, through action of the reverse transcriptase enzyme (characteristic of 
retroviruses). The double stranded viral DNA (a precursor to the integrated proviral form) 
passes into the nucleus of the infected cell and is integrated into the host cell genome (via 
integrase action). The retroviral DNA permanently resides within the chromosomes of the 
infected cell, allowing the expression of viral genes and proviral DNA replication along with 
the cell's own DNA. Hence retroviral particles use the host cell's machinery for their own 
replication. Proviral DNA is also passed onto the cell progeny. The production of new 
particles requires the transcription of integrated viral DNA into RNA and the processing of 
retroviral proteins. The core proteins and envelope proteins assemble at the plasma 
membrane of the infected cell, where retroviral RNA is packaged and the particles bud off 
from the cell. Alternatively, some types of retrovirus particles assemble in the host cell 
cytoplasm before moving towards the plasma membrane where they become enveloped and 
bud off from the cell (Nermut and Hockley, 1996). Wild type retrovirus particles are 
constitutively released from an infected cell, usually without any deleterious effects to the 
cell itself. The life cycle of a typical wild-type retrovirus is illustrated in Figure 1.2.3.1. 
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Life cycle ofa typical wild-type retrovirus (approximately lOOnrn diameter): 
Retroviral particles attach to target cell receptors via envelope proteins and become internalised (usually via 
endocytosis). Viral RNA is reverse transcribed into DNA, which enters the nucleus and integrates with the 
target cell genome (to become proviral DNA). The target cell's machinery is used for the transcription of 
proviral DNA and the translation of viral proteins, allowing the packaging of viral RNA and the assembly of 
new retrovirus particles which 'bud off from the target cell membrane. 
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The retroviral genome contains three regions, gag, pol and env, which encode for the capsid 
proteins, the viral enzymes (reverse transcriptase, integrase and protease) and the envelope 
proteins, respectively. The lipids and carbohydrates of the virus particle are derived from the 
host cell plasma membrane (during budding). An important feature of the retroviral genome 
is the long terminal repeats (LTRs) repeated at each end of the genome. These sequences are 
essential for the initiation of viral DNA synthesis, integration of proviral DNA and the 
regulation viral gene transcription (Fritz 1996). In addition, the psi packaging sequence (\jJ) 
is essential for the packaging ofretroviral RNA during the synthesis ofretroviral progeny. 
Three sub-groups of retrovirus exist: oncoretroviruses (e.g. Moloney Murine Leukaemia 
Virus, MoML V), lentiviruses (e.g. Human Immunodeficiency Virus, HIV) and spumaviruses 
(also known as foamy viruses). Retroviruses have been extensively studied for a number of 
years. Prior to the incidence of widespread HIV -induced disease in humans, MoMLV was 
the most commonly studied retrovirus. However, the last two decades has seen a dramatic 
increase in HIV research. Until recently, spumaviruses have received little attention due to 
their lack of significant association with disease (Russell and Miller, 1996). The pre-existing 
wealth of knowledge on the structure and function ofretroviruses has resulted in the majority 
of vectors developed for gene therapy being constructed from these viruses (namely 
MoML Vs). In fact, over 60% of gene therapy clinical trials in 1999 used retroviral vectors 
for gene delivery (Andreadis et aI., 1999). 
The Moloney Murine Leukaemia Virus (MoML V) is considered to have one of the simplest 
genomes of the retroviruses. In contrast, HIV is considered to have one of the most complex 
genomes of most retroviruses. However, while many other genes encoding for non-
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structural proteins exist, the L TRs and gag, pal and env genes still predominate the HIV 
genome. The important features of the MoML V gag, pal and env genes and their encoded 
proteins are described below. 
The majority of structural viral proteins are encoded by the gag gene (group antigen gene). 
A 'gag polyprotein' is expressed and post-transcriptional modification yields four proteins: 
plO (nucleocapsid), p12, pl5 (matrix protein) and p30 (capsid protein). Adjacent to the gag 
gene is the polymerase (pal) gene which encodes the integrase, reverse transcriptase and 
protease enzymes. Finally the envelope (env) gene, adjacent to the pal gene encodes a 
polyprotein which is cleaved by protease enzymes to yield gp70 (surface glycoprotein) and 
pl5E (transmembrane protein). The fact that these protein-coding domains are separate from 
the regulatory elements of the viral genome, makes these viruses amenable to modification 
for gene transfer vectors. 
In order to use retroviruses as gene delivery vehicles, the life cycle of the retrovirus must be 
altered such that these particles will not replicate within the target cell (to avoid spread of the 
virus in vivo). By deleting the viral genes (gag, pal and env) from the retroviral genome and 
replacing them with a therapeutic foreign gene, the modified virus can still enter a target cell 
and insert its genome. However, further particles cannot be produced due to the lack of the 
essential gene functions. Hence the virus is rendered replication incompetent. In addition, a 
selectable marker gene is usually inserted to enable detection of successfully infected target 
cells. The LTRs and psi packaging sequence (\If, essential for encapsidation), are retained in 
such retroviral vectors. The production of such vectors for gene delivery is made possible 
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through the use of so-called packaging/producer cells which contain the viral structural and 
functional genes as separate trans-complementing expression cassettes. (see Section 1.3). 
Modifications to this basic retroviral vector design have been made to improve the 
production in packaging cells. For example, it has been observed that the complete removal 
of the gag, pal and env sequences and insertion of the foreign genes directly adjacent to the 
\If sequence can result in a significantly reduced vector titre released by packaging cells, 
compared to wild-type virus (Armentano et aI., 1987). The inclusion of extra sequences 
from the gag gene adjacent to the \If sequence (so-called \If+ region) was subsequently 
demonstrated to improve vector titre, such that levels were similar to those of wild-type virus 
(Armentano et aI., 1987; Morgenstem and Land, 1990), so long as the \If and gag sequences 
were kept together. Retroviral vectors such as this are continually being modified and 
improved to increase both productivity and safety (see Section 1.3 for safety improvements 
in retroviral vectors). 
Retroviral vectors possess a number of advantages for human gene therapy applications. 
Firstly the gene of interest can be permanently integrated into the host genome, allowing the 
potential for permanent gene expression and hence a 'cure' for genetic disorders. However, 
in reality this has become difficult to achieve, due to the frequent loss of gene expression 
observed in vivo. A number of mechanisms for the reduced transgene expression in vivo 
have been proposed, including the methylation of viral promoters, hence cellular promoters 
have been investigated in an attempt to circumvent this problem (Kurian et aI., 2000). 
Kitamura (1999) has demonstrated that Murine LeukaemiaVirus (MLV) Long Terminal 
Repeats can be 'silenced by TNF-a and TGF-~1 released by activated macrophages. Hence 
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if cells transduced by ML Vs are in the vicinity of activated macrophages, or cytokines 
released by other immune cells, the transgene expression could be silenced. 
The gene transfer by retroviral vectors is however highly efficient and up to 8 kilobases of 
DNA can be inserted. They also have a wide host range, which is an advantage with respect 
to the number of gene therapy applications, but a disadvantage where gene insertion is 
required to be restricted to one cell type. Further disadvantages include the risk of 
insertional mutagenesis or activation of oncogenes as a result of random integration of the 
viral genome into the host cell chromosomes. Random integration can also lead to varying 
levels of therapeutic gene expression, as this is dependent on the site of integration (Gordon 
and Anderson 1994). Furthennore, integrated transgene expression is highly susceptible to 
transcriptional silencing by adjacent heterochromatin. Ongoing research into the use of 
various promoters and enhancers aims to allow better control over the levels of expression of 
retroviral vector delivered genes. For example, certain promoters, such as the 
cytomegalovirus (CMV) promoter are more powerful than others at driving gene 
transcription (Soneoka et aI., 1995). The use of Locus Control Regions (LCRs) is also under 
investigation to overcome this problem. LCRs are eis-acting elements that have the ability to 
confer position independent, cell-type specific expression of linked sequences (Cunliffe et 
aI., 1995). This is brought about by inducing an 'open' chromatin domain, which is 
transcriptionally active. Hence LCRs have great potential in controlling the expression of 
genes randomly inserted by retroviral vectors in specific cell types (provided vector size is 
not limiting). LCRs are tissue specific and may therefore be suitable for inducing the 
expression of transgenes in certain cell types. Unlike LCRs, so-called UCOEs (Ubiquitous 
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Chromatin Opening Elements) are not tissue specific and hence are more suitable where 
prolonged expression oftransgenes is required in all cell types (Antoniou, 2000). 
Difficulties in obtaining high titre vector supernatants from packaging cell cultures also 
hinders the use of retroviral vectors for clinical applications (see Section 1.3). Furthermore, 
retroviral vectors derived from the oncovirus subgroup can only infect actively dividing cells 
(limiting the number of cell types that can be targeted by these vectors). However, vectors 
derived from the lentivirus subgroup ofretroviruses can infect slowly dividing and quiescent 
cells (Lewis and Emerman, 1994). This is supposedly afforded by their possession of 
nuclear localisation signals which allow their entry into the nucleus without requiring nuclear 
fragmentation (Ferderico, 1999). Vectors derived from this subgroup of viruses (e.g. Human 
Immunodeficiency Virus, HIV; Simian Immunodeficiency Virus, SIV, and Equine Infectious 
Anaemia Virus, EIA V) are therefore currently receiving more attention in a number of 
research groups (Dutton, 1999). Due to the safety concerns over using HIV -derived vectors, 
many groups are turning to non-primate lentiviruses (Naldini, 1998; Federico, 1999). 
Approved clinical protocols using retroviral vectors for gene delivery have included a wide 
range of diseases e.g. haemophilia, ADA-SCID, HIV infection and Gaucher's disease 
(Morgan, 1995). Other diseases also targeted for retroviral vector gene delivery include ~­
thalassaemia (Cone et aI., 1987), muscular dystrophy and Parkinson's disease (Dutton, 
1999). The ability of vectors derived from the oncovirus group to selectively transduce 
cancer cells (which are usually more proliferative than normal cells) is an advantage of this 
type of retroviral vector for use in cancer treatment. Hence these vectors have been 
investigated for the treatment of a range of cancers including ovarian cancer, breast cancer, 
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brain tumours and lung cancer (Morgan, 1995; Dutton, 1999). Phase I clinical trials, using 
retroviral vectors for gene delivery, have demonstrated no toxicity (Nemunaitis et aI., 1999), 
which is a major advantage ofthis type of vector over adenoviral vectors. 
1.2.3.2 Adenovirus Vectors 
Adenoviruses are non-enveloped and possess a linear double stranded DNA genome, 
approximately 30-35k base pairs in length. This is encapsidated in a 70nm diameter 
icosahedral shell. The replication cycle of the adenovirus can be divided into 'early' and 
'late' phases. During the early phase the virus undergoes absorption onto the target cell, 
penetration into the cells (through receptor mediated endocytosis), transcription of the viral 
DNA, translation of the 'early genes' (El, E2, E3 and E4) and finally the induction of 
macromolecule synthesis by the host cell. The onset of DNA replication occurs during the 
late phase, as does initiation of the expression of 'late genes', which allow the assembly of 
the virus progeny. Unlike retroviruses, the replication and release of adenovirus particles 
from an infected cell, requires cell lysis. 
Adenoviruses can also be rendered replication incompetent for gene therapy use, by 
removing early region genes. The El gene, which is important for the induction of E2, E3 
and E4 promoters, can be removed, rendering the virus replication incompetent (Robbins et 
aI., 1998). Deletion of the E3 region provides space for the insertion of the therapeutic gene 
(Trapnell and Gorziglia, 1994). The production of such adenoviral vectors is performed in 
helper cells such as the human embryonic kidney cell line, HEK293, which constitutively 
expresses the El proteins (Benihoud et aI., 1999). However, there is a danger of 
homologous recombination between the adenoviral vector and the trans-complementing 
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cassette of the HEK293 helper cells, which can result in the production of replication 
competent adenovirus particles (Zhu et aI., 1999). A reduction in the risk of such 
recombination has been achieved by Fallaux et al. (1998) through the engineering of 
embryonic retinoblasts (PER.C6) which possess an El locus that does not overlap with the 
adenoviral vector sequences. 
In contrast, some research groups are also looking at the use of replication competent 
adenoviral vectors, where expression of the El gene is controlled by a tumour-specific 
promoter. In theory, the El gene in these vectors should only be expressed in tumour cells, 
where replication of adenoviral particles will occur and kill the tumour cells either directly 
(via cell lysis), or through the delivery of a 'suicide gene' (Robbins et aI., 1998). 
Adenoviruses have a reported immunogenic and cytotoxic potential (Benihoud et aI., 1999). 
Furthermore, most adenoviral vectors are E11E3 deleted and the E3 region is involved, in 
part, in evasion of the immune response. Hence E3- vectors are actually more immunogenic 
than E3+ vectors. 
Current targets for adenoviral vector delivery of genes include the cells of the airway 
epithelium in cystic fibrosis patients (Knowles, 1995). Delivery of the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene to these cells is not feasible ex vivo, and 
in vivo delivery requires high concentrations of the gene delivery vehicle. The ease of 
producing high titre adenoviral vector stocks is therefore a great advantage of these vectors 
(Tapnell and Gorziglia, 1994). Other advantages of adenoviral vectors include their 
increased stability compared to retroviral vectors (due to the lack of envelope and to the 
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possession of a DNA genome, as opposed to RNA) hence these vectors are more amenable 
to purification and concentration processes. They also possess the ability to infect both 
dividing and quiescent cells and the occurrence of integration is rare, minimising the risks of 
insertional mutagenesis or activation of oncogenes. This lack of gene integration means that 
gene expression in the target cell is only transient. In some applications transient expression 
may be more desirable (such as the delivery of suicide genes to kill off selected cells). 
However, where transient expression does not elicit sufficient gene expression to alleviate 
disease symptoms, repeat administration of the vectors may be required. A major 
disadvantage of the use of adenoviral vectors is their immunogenic and immuno-reactive 
potential. Where an immune response to the vector is observed, repeated administrations are 
unlikely to be feasible. Adenoviruses have been shown to cause both acute viral toxicity and 
a vigorous immune response, resulting in inflammation. In fact the first and only death to 
date, resulting from viral vector delivery of a therapeutic gene, involved the use of 
adenoviral vectors (Boyce, 1999). During a clinical trial led by James Wilson last year, the 
patient receiving the highest dose of adenoviral vectors suffered severe toxicity effects, 
leading to his death. This apparent dose-dependent toxic response to an adenoviral vector is 
not the first to be reported (Tapnell and Gorziglia, 1994; Knowles, 1995), but is the first 
known fatal response. More recently however, the reported success in the reduction of head 
and neck tumours, using adenoviral vectors, has revived the faith in these vectors for human 
gene therapy applications (Meek, 2000). 
1.2.3.3 Adeno-Associated Virus Vectors 
Adeno-associated viruses cannot replicate alone and require the presence of either adeno-
viruses or herpes-viruses to complete their life cycle. For this reason they are often referred 
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to as 'satellite' viruses (Fritz, 1996). These viruses are a defective sub-group of the 
parvovirus family. Their genome consists of single stranded DNA (either sense or anti-
sense), which is contained within an icosahedral particle of only 18-26nm diameter. The so-
called rep and cap genes of the adeno-associated viral genome encode for polypeptides, 
which are important in virus replication and encapsidation, respectively. 
Replication of the adeno-associated virus involves host cell lysis, however in the absence of 
helper viruses the adeno-associated virus remains latent and cell lysis does not occur. Latent 
infection can last for years but, if during latent infection a helper virus is added, the life cycle 
ofthe adeno-associated virus progresses and cell lysis ensues. 
Vectors derived from adeno-associated viruses (where the rep and cap genes are deleted) are 
becoming increasingly popular in the development of new vectors for gene delivery. Current 
targets include haemophilia (Dutton, 1999) and cystic fibrosis (Samulski, 1995). While 
these vectors may not be suitable for all cell types, high transduction efficiencies have been 
observed in muscle, brain and liver cells. Adeno-associated viral vectors offer a number of 
advantages as a gene delivery vehicles, namely the ability to induce gene expression for 
years (or perhaps permanently), the targeting of non-dividing cells, and the lack of apparent 
immunogenicity. Furthermore, natural infection of humans with adeno-associated virus 
appears to be asymptomatic (Clark et aI., 1995). The expression of genes inserted into an 
adeno-associated viral vector can be easily regulated due to their ability to carry regulatory 
elements without interference from the viral genome. Adeno-associated viruses also contain 
unique inverted terminal repeats (ITRs) at each end of the their genome, which allow site 
specific integration of their DNA into the host genome (at a specific site on chromosome 19). 
Hence the potential to produce integrating viral vectors whilst avoiding the problems of 
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random integration is a great attraction of these viruses. However, to date, vectors derived 
form these viruses have lost this ability for site-specific integration, probably as a result of 
the deletion of important genes such as the rep gene (Robbins et aI., 1998). Furthermore, 
removal of the rep and cap genes has sometimes been observed to reduce the rate of second 
strand synthesis and integration in some cell types is reduced, compared to the wild-type 
virus. Current research is focusing on ways to maintain site-specific integration sequences in 
recombinant vectors. Strategies to produce large amounts of adeno-associated viral vectors 
also require further development and simplification (Clark et aI., 1995). 
Disadvantages of adeno-associated viral vectors include the small genome, which allows the 
insertion of only 5kb or less foreign DNA. Preparations of these vectors must also be 
stringently screened for contaminating adeno- or herpes-viruses, which could render the 
adeno-associated viral vectors replication competent. 
1.2.3.4 Herpesvirus Vectors 
Herpesviruses are also undergoing increasing interest in the development of viral vectors for 
gene delivery. These viruses have a large genome (120-250kb), consisting of double 
stranded DNA. This is contained within 150-200nm diameter particles. Like adeno-
associated viruses, herpesviruses can infect a wide range of cell types and their life cycle 
causes host cell death through lysis. However, non-replicating viruses can remain latent in 
the host cell for extremely long periods of time. 
Herpes Simplex Virus, HSV, is a well-studied herpes-virus that replicates in the skin or 
mucous membranes of infected individuals, before infecting cells of the nervous system, 
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where latent infection ensues. Its specificity for latency within neuronal cells has led to 
significant research into the development of HSV vectors for the treatment of 
neurodegenerative disorders. However, the wide tissue tropism of these vectors makes it 
difficult to target specific neuronal cell types and avoid widespread infection of the nervous 
system (Vos, 1995). 
Herpes viruses can be rendered replication defective by removal of half their genome 
(including specific 'immediate early' genes). These vectors allow the incorporation of large 
DNA inserts (up to 20-50kb), which is a major advantage in their use for the delivery of 
large human genes, such as the dystrophin gene, which cannot be accommodated in a 
number of the above viral vectors. Furthermore, multiple genes can be inserted into these 
vectors. 
1.2.3.5 Poxvirus Vectors 
Poxviruses have also been used for the development of gene delivery vectors (Cox et aI., 
1995; Palu et aI., 1999). These viruses are large and oval in shape (200-400nm length), with 
a double stranded DNA genome. Members of this virus family replicate in the cytoplasm 
rather than the nucleus of the target cells. The Vaccinia virus, a member of the Poxvirus 
family, is the agent used to vaccinate humans against smallpox and has been widely studied 
in the laboratory. Viral vectors derived from these viruses are primarily used for the delivery 
of exogenous genes, usually those of pathogenic organisms, in order to elicit immunity 
against the pathogenic species (through the transient expression of antigens in host cells). 
This is quite a different approach in the use of gene therapy and is outside the realms of this 
review. However, Vaccinia virus vectors have more recently been developed for the 
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delivery of tumour associated antigens in an attempt to stimulate an immune response in 
cancer patients against tumour cells (Cox et aI., 1995). 
1.2.3.6 Alphavirus Vectors 
Worth mentioning, but far less common are vectors derived from alphaviruses, namely 
Semliki Forest and Sindbis viruses. Alphaviruses are positive strand RNA enveloped 
VIruses. The infection cycle of these viruses also takes place in the cytoplasm, thereby 
avoiding potential problems of RNA splicing or random DNA integration. Alphavirus 
vectors are currently being developed as prophylactic and therapeutic vaccines to treat 
infectious diseases and cancer (Schlesinger and Dubensky, 1999). Semliki Forest viruses 
have been reported to have a broad host range (Schlaeger and Lundstrom, 1998) and Sindbis 
virus replicons have been successfully targeted against neurons (Schlesinger and Dubensky, 
1999). A major drawback of these vectors for use in human gene therapy applications is 
their pathogenic effects, hence there is a need to find variants that are non-cytopathic. 
It is unlikely that one particular type of viral vector will be suitable for all gene therapy 
applications. Rather, the development of a range of vectors using a range of virus types will 
be necessary to fulfil the requirements of each treatment. For example, where 'suicide 
genes' need only be expressed for a short period of time, transient expression vectors such as 
adenoviral vectors may be more suitable. In contrast, the correction of a genetic disorder 
may require permanent expression of a therapeutic gene, hence retroviral vector gene 
delivery may be more suitable (to allow potentially permanent gene expression). The 
advantages and disadvantages of the viral vectors widely used for gene therapy applications 
are summarised in Table 1. As a means of incorporating the benefits of a range of viral 
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vectors, chimeric vectors are also under development. These vectors contain the desirable 
features of two or more virus types (Robbins et aI., 1998; Caplen et aI., 1999; Duisit et aI., 
1999). 
As mentioned earlier, retroviral vectors are currently the most common types of vector used 
in gene therapy clinical trials. As of September 2000, 165 of the 386 INDs allowed to 
proceed to clinical trial used retroviral vectors for gene delivery (personal communication, 
Julie Zawisza, CBER, FDA). The optimised production of these vectors requires immediate 
attention to enable their commercial scale manufacture (in the advent of product approval). 
The methods for production of retroviral vectors shall therefore be discussed, outlining the 
challenges in such production processes. . The limited fundamental research, which has been 
conducted to date, on the factors affecting retroviral vector production by packaging cells is 
also reviewed. 
1.3 Packaging Cells for Retroviral Vector Production 
To enable the production of large numbers of retroviral vectors, replication competency is 
provided in vitro through the use of so-called packaging/producer cells. Packaging cells 
contain the viral helper genes (gag, pal and env), removed from the retroviral vector genome 
and inserted as trans-complementing expression cassettes. Thereby providing the viral 
proteins, both structural and functional, required for the synthesis of new particles. The 
retroviral vector is inserted into the packaging cells on a separate plasmid and particles 
containing the gene of interest and/or selectable marker genes are packaged and released 
from these cells in a similar fashion to that seen in wild-type infections. Particles released 
from the packaging cells maintain the ability to infect target cells and insert their genome, 
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but cannot go on to replicate within these cells due to the lack of the viral helper sequences 
(provided the target cells do not contain endogenous viral sequences). This production of 
retroviral vectors by packaging cells for gene delivery to target cells is illustrated in Figure 
1.3. 
The constitutive release of recombinant retroviral vector particles by such packaging cell 
lines allows the potential production of large volumes of well-characterised vector stock 
(Rigg et aI., 1996). This is an advantage of using integrated retroviral vectors over transient 
transfection, where preparation of such stocks is not as easy (due to short production times 
and batch to batch variation). Furthermore, packaging cell cultures do not have to be 
sacrificed in order to harvest retroviral vector particles as is the case for many other vector 
types such as adenovirus vectors. However, the retroviral vector titre of stocks produced by 
packaging cells is relatively low, compared to other viral vector preparations and 
improvement of these titres through the modification of packaging cell lines and vector 
constructs is under investigation by a number of groups. In order to improve vector 
production by a packaging cell, many researchers have attempted to increase the expression 
of each viral helper gene. However, the over-expression of certain elements (such as gag 
proteins) has been shown to reduce the infectious titre of packaging cells, when not in 
balance with the expression of other vital genes (Duisit et aI., 1999). 
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Virus type Advantages Disadvantages 
Oncovirus 
Retrovirus • Integration of therapeutic gene • Risk of insertional 
• Highly efficient gene transfer mutagenesis / activation of 
• Wide host range oncogenes 
• Low immunogenicity • Difficult to target 
• Vector proteins not expressed in host • Difficult to obtain high titre 
• Well studied system from packaging cells 
Lentivirus • Only infects dividing cells 
• As for above, plus can infect non- (except Lentivirus and 
dividing cells Spumavirus) 
Spumavirus 
• As for above, plus large insert size 
Adenovirus • Infects both dividing and quiescent cells • Expression of therapeutic 
• Insertional mutagenesis unlikely gene only transient 
• High transduction efficiency • Viral proteins expressed 
• High titre easily achieved • Potentially immunogenic 
• Relatively stable (amenable to down- • Common human virus 
stream processing) (causes disease) 
Adeno-Associated • Can induce gene expression for years • Mechanism for transduction 
Virus (AAV) • Infects non-dividing cells unclear 
• Relatively easy regulation of inserted • Unknown effects of 
genes subsequent infection of 
• No immunity detected patient with adeno- or 
• 
Site specific integration (though this has herpes virus 
been lost in current vectors) • Small insert size (4kb) 
Herpes Virus • Large insert size (20-30kb) • Difficult to avoid 
• High titres cytotoxicity 
(namely, herpes • Episomal, but latent infection can be • Wide tissue tropism 
simplex virus, life-long • Lower transduction 
HSV) • Neuron specificity (HSV) efficiency 
• Potential to generate 
infectious HSV in humans 
Table I 
Summary of the main advantages and disadvantages of using various VIrus types for the 
development of vectors for gene transfer in humans. 
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Packaging cell 
Target cell 
no gag-pol or env genes, 
hence no viral particle 
production 
Figure 1.3 
integrated therapeutic gene 
translation 
e.g. expression on cell 
surface 
therapeutic ge e 
product 
)~ 
vector particle 
e.g. secretion/ release 
Therapeutic gene delivery using retroviral vectors produced by packaging cells (not to scale). Particles released 
by packaging cells are infectious, but replication incompetent. 
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Vector Safety 
In recent years, packaging cells have been further modified to reduce the risks of producing 
replication competent virus particles (potentially caused by recombination between vector 
DNA and helper DNA or endogenous viral sequences). One approach has involved the use 
of separate plasmids for the insertion of the gag-pal and env genes (Markowitz at aI., 1988; 
Morgenstem and Land, 1990; Cosset at aI., 1995), as illustrated in Figure 1.3. The reverse 
transcriptase, and integrase enzymes are derived from a gaglpol fusion protein, hence the 
gag and pal genes cannot be separated and must be inserted into the packaging cells on the 
same plasmid. Still, the use of three separate plasmids (for gag-pal, env and the retroviral 
vector) means that three homologous recombination events must occur before replication 
competent virus particles can be constructed. Obviously the probability of this occurring is 
low, hence the safety of these packaging cells for vector production is significantly improved 
(Miller and Buttimore, 1986; Cosset et aI., 1995). The risk of homologous recombination in 
a number of packaging cell lines is exacerbated by the fact that the pal and env coding 
sequences overlap in the wild-type genome, such that the pal gene ends after the env gene 
starts. Hence there will always be homologous sequences between the gag-pal 
transcriptional unit and the env transcriptional unit in packaging cells using helper genes 
from the same virus (Miller, 1990). One way to circumvent this problem is to use a gag-pal 
gene from one virus type and an env gene from another virus type (which has little sequence 
similarity). The risk of recombination between two such inserts is extremely low and this is 
a good strategy for producing safer packaging cell lines, provided the two inserts are 
compatible and do not result in reduced titres. Another problem particular to MoML V is the 
overlap of the gag gene and the \jf packaging sequence, making it impossible to avoid some 
homology between the gag insert and the vector insert (which contains the \jf sequence). 
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This situation again increases the risk of homologous recombination occurring (Miller, 
1990). The presence of endogenous retroviral sequences in the packaging cell line also 
increases the risks of recombination. Packaging cells should therefore be screened for the 
presence of such sequences (Miller and Buttimore, 1986; Rigg et aI., 1996). 
The production of replication competent retroviruses is also a risk after retroviral vector gene 
transfer in vivo, where there is a subsequent infection of the transduced cells by a wild-type 
retrovirus. So-called 'self-inactivating' vectors have therefore been developed, where the 
LTRs of the recombinant vector are inactivated upon integration into the target cell genome. 
This should prevent the LTRs being packaged in the event of a subsequent wild-type 
infection and hence avoid the spread of recombinant virus to other non-target cells 
(Andreadis et aI., 1999). The safety of retroviral vectors is also undergoing continual 
improvement by minimising the viral sequences retained in the vectors or in the helper 
constructs of the packaging cells (Miller and Rosman, 1989; Cosset et aI., 1995; Morgan, 
1995). In a very recent paper, Yu et aI., (2000) reported the development of a series of 
retroviral vectors that are absent of any retroviral coding sequences. This was achieved 
without compromising the vector titre. These vectors are claimed to be safer than other 
current vectors, which still contain one or more coding sequences from viral genes. 
Another potential hazard involved with retroviral vector-mediated gene delivery is the 
reportedly high error rate in reverse transcription (Kurian et aI., 2000). An error in reverse 
transcription of a therapeutic gene could result in the transduction of target cells with a 
mutant gene. 
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Vector Tropism 
The packaging cell determines the tropism of the vector, where the env gene is contained 
within a separate plasmid and could theoretically be derived from a number of virus types. 
For example, the Gibbon Ape Leukaemia Virus (GAL V) envelope, which has an increased 
affinity for human cell receptors, has been incorporated into a number of retroviral vector 
packaging cells (Glimm et al. 1998; Chuah et aI., 2000). 
The tropism of MML V vectors is often referred to as ecotropic, xenotropic or 
amphotropic/polytropic. Ecotropic vectors are targeted to receptors unique to murine/rat 
cells, whereas xenotropic vectors are targeted to receptors on most cell species except 
murine. Finally amphotropic vectors can target different cell receptors in both murine non-
murine species. 
Modifications of the viral envelope proteins can alter the viral vector tropism and this has 
been exploited to target specific cell types (Cunliffe et aI., 1995; Valsesia-Wittmann et aI., 
1996; Palu et aI., 1999). Such targeted delivery of a therapeutic gene is most desirable for 
gene therapy applications. The delivery of genes to non-target cells is not only wasteful, but 
can also lead to adverse side effects (such as cell death of 'normal' cells or the 
inappropriate/ectopic production of a gene product). Alternative methods for viral vector 
targeting include the use of antibody-mediated binding or cross-linkers to either restrict or 
redirect the host cell range (Peng and Russell, 1999). Furthermore, so-called 'pantropic' 
retroviral vectors have been developed which use VSV -G, an envelope glycoprotein, to 
mediate viral entry through lipid binding and plasma membrane fusion. These vectors 
negate the need for specific cell receptors and hence will transduce any dividing cell type 
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(Bums et aI., 1993). These vectors are obviously not licensed for human use (due to their 
indiscriminate transduction abilities), but can be used in the construction of cell lines for 
research purposes. Vector targeting can also be controlled at the level of gene 
transcription/expression, where 'switches' can be used to turn inserted gene expression on, or 
off, in certain cell types or under certain environmental stimuli (Coutre et aI., 1994; Cunliffe 
et aI., 1995; Miller and Whelan, 1997; Dutton, 1999). 
It has also been postulated that viral envelopes are involved in the inactivation of retroviral 
vectors by complement components in human serum (Takeuchi et aI., 1994; Cunliffe et aI., 
1995). This is a problem in gene therapy applications where the aim is to infect the target 
cells in vivo. However, the use of env genes from certain retroviral species, such as the cat 
endogenous virus, can afford resistance to such inactivation by human complement (Cosset, 
1995). A recent paper by Mason et aI., (1999) suggested that the role of envelope proteins in 
serum inactivation is not due to the binding of complement to these proteins, as has been 
previously hypothesised. This group proposed that the envelope proteins 'mask' epitopes on 
the viral membrane from complement attack, thereby conferring resistance to inactivation by 
serum. This theory may also explain why the level of serum resistance varies between 
different types of vector, since different envelope proteins will have different three-
dimensional conformations, and vector particles may have varying amount of envelope 
proteins on their surface (depending on the packaging cell system). 
Due to the important role of the env construct of a packaging cell in vector tropism 
(including fusion and gene entry) and serum resistance, a number of groups are investigating 
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the potential to improve gene transfer through modifications of the viral envelope proteins 
(Gordon and Anderson, 1994; Ragheb and Anderson, 1994a,b). 
1.4 Status and Challenges in Retroviral Vector Production 
Retroviral vectors can be harvested from the supematants of packaging cell cultures, where 
vector particles are constitutively released. The relatively low titre of such retroviral 
supematants (Braas et aI, 1996) can lead to their increased production costs. Improving the 
conditions for optimised titre is therefore essential for cost-effective production of retroviral 
vectors for gene therapy applications. Obviously, optimisation of the culture conditions of 
the packaging cells can only increase vector yields to the maximum productivity of the 
packaging cell system itself. However, cell culture conditions during production can also 
have a significant impact on the vector stock quality and consistency. 
The maximum titre ofretroviral vector supematants (produced by packaging cells) reported 
in the literature is typically 105_107 colony forming units per millilitre, cfulml, (Martinez, 
1995; Morgan, 1995; Rigg et aI., 1996; Glimm et aI., 1998). Though many reported titres 
have been much lower (Olsen and Sechelski, 1995; Shen et aI, 1996). While such titres may 
be high enough for some gene therapy applications (Eglitis et aI., 1995), certain applications 
such as the transfer of genes in vivo and the transfer of genes to haemopoietic cells in vitro 
require significantly higher titres. Most efforts to increase titres have focused on 
modifications of the packaging cells or viral vectors and titres up to ten-fold higher have 
been achieved (Sakoda et aI., 1999). 
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Andreadis et al. (1999) assessed the typical dose of retroviral vectors likely to be required in 
a typical gene therapy treatment and gave a conservative estimate of the annual production 
requirements in the U.S. alone as 107_1010 L. These figures were based on vector stock 
concentrations of 106_107 cfulml. Braas et al. (1996) also attempted to predict future 
requirements, with single doses ranging from lOll to 1014 particles. While sensible 
predictions of market requirements are obviously very difficult at present, these early 
indications suggest an urgent need to develop cost-effective methods, which can 
reproducibly supply large volumes of high titre retroviral stocks. Yet, surprisingly few 
reports have attempted to examine the factors affecting retroviral vector production in 
packaging cell cultures in order to develop such methods. A small number of groups have 
assessed a limited number of parameters, using murine packaging cell lines and these 
findings are reviewed below. 
Temperature 
Kotani et al. (1994) investigated the production of retroviral vectors in twenty-two different 
packaging systems, derived from the P A317 murine packaging cell line. These studies 
revealed a 5- to IS-fold increase in vector titre from supematants harvested from packaging 
cells cultured at 32°C, compared to cultures at 37°C. This group postulated that the increase 
in vector titre at this lower temperature could be a result of: (1) reduced metabolic 
activity/growth of the cells, causing their increased production of retroviral vectors and/or 
(2) increased stability of the retroviral vector activity at 32°C, resulting in an accumulation 
of active particles at the time of harvesting. The former hypothesis is highly unlikely, as a 
number of studies in this thesis and elsewhere indicate decreased vector production during 
decreased metabolic activity of packaging cells (Forestell et aI., 1995; Shen et aI., 1996). 
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Furthermore, Le Doux et al. (1999) have used a simple mathematical model to analyse the 
production and decay of retroviral vectors produced by packaging cells at both these 
temperatures. This group demonstrated that the vector production per cell is a weak function 
of temperature, whereas the decay rate of retroviral vectors is a strong function of 
temperature. Hence at the lower culture temperature of 32°C, there is a decrease in vector 
decay rate that is greater than the decrease in vector production. Hence an overall increase in 
vector titre is observed at 32°C. 
Increased retroviral vector titres at 32°C compared to 37°C were also reported by Kaptein et 
al. (1997). This group found a 5- to lO-fold increase in vector concentration during culture 
of POP Alneo-4 murine packaging cells at 32°C. They also reported an increase in vector 
half-life from 9h to 39h at storage temperatures of 37°C and 32°C respectively (further 
demonstrating a relationship between increased titre and reduced vector decay). 
Interestingly, the increased vector stability was only observed within a narrow window, as 
the vector half-life was not significantly increased at 30°C or 34°C. No explanation for such 
an unusual finding was given. 
Lee et al. (1996) also tested the effects of reduced culture temperatures on retroviral vector 
production. This group observed only a 2-fold increase in vector titre produced by 
PA3l7/LN and \jfCRIP/MFG murine packaging cell lines at 32°C, compared to 37°C. 
Forestell et al. (1995) reported similar titres in 32°C and 37°C cultures of PA3l7 packaging 
cells during the first six hours of culture. This finding further indicates that the increased 
titres at 32°C seen at later time-points, are due to the accumulation of active particles and , 
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not increased production. According to this argument, the titre of a 37°C culture will not be 
significantly lower than that of a 32°C culture until a significant number of active particles 
have thermally decayed at the higher temperature. The half-life of retroviral particles at 
37°C has been reported to be in the order of 5-8 hours (Lee et aI., 1996; Kaptein et aI., 1997; 
Le Doux et aI., 1999). Hence during the initial six hours of culture, titres would not be 
expected to significantly differ at 37°C compared to 32°C. 
Serum 
Reports to date on the effects of serum on retroviral vector production and/or activity have 
been conflicting. This may well be a result of different packaging systems used in each of 
the reported studies. Shen et al. (1996) showed increasing cell growth and retroviral vector 
titres in PMFGhjlCRIP murine packaging cell cultures when the serum concentration of the 
culture medium was increased from 1 % to 5% or 10%. A further increase in serum 
concentration from 10% to 20% only slightly improved the retroviral vector titres. It was 
postulated that a strong promotion of vector production by cell growth was the reason for 
increased titres with increasing serum concentration. 
Conversely, Lee et al. (1996) demonstrated no effect of decreasing serum concentrations 
from 20% to 1 % in culture medium on the retroviral vector titre of \jICRIP cell cultures. A 
component in serum was deemed to be essential for cell growth and vector production, as 
complete removal of serum from the culture medium caused a significant reduction in vector 
titre. This group suggested that 1 % serum would in fact be sufficient for the vector 
production by this cell line. However production in this low serum concentration was not 
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conducted for more than 24h, hence the long-term effects of low serum levels on cell growth 
and productivity was not tested. 
Gerin et aI., (1999a) have recently demonstrated a dose-dependent negative effect of serum 
on the titre of retroviral vectors produced by the human packaging cell line, FL YRD 18. This 
effect was demonstrated not to be attributable to greater adherence of the retroviral particles 
to the culture surfaces in the presence of higher serum concentrations or extra-cellular 
inactivation of the vectors by serum components. It was therefore hypothesised that the 
negative effect of serum was at the level of virus production/assembly or maturation. 
Further studies revealed pre-treatment of serum-containing medium with trypsin reduced the 
negative effect of this medium on vector titre. This data suggested a possible role of 
protease inhibitors present in serum, however the mechanism of such inhibition was not 
elucidated. 
It is possible that a similar negative effect of serum on virus production occurred with the 
packaging cell system used by Lee et al. (1996). If so, decreasing the serum concentration 
could increase vector production by reducing the negative effects of serum, but at the same 
time cell growth and/or metabolic activity could be decreased, thereby decreasing vector 
production via a separate mechanism. Hence the two effects of serum could mask each 
other, leading to no significant difference in vector production over a range of serum 
concentrations, as observed by Lee et aI., (1996). 
Aside from the reported negative effects of serum on retroviral vector titres, the presence of 
serum in vector stocks is undesirable due to the risks of potential contamination (such as 
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proteins, honnones, endotoxins, prions, and pathogenic organisms). The removal of serum 
components from vector stocks through down-stream processing will not only increase the 
costs of production, but will most likely result in reduced vector titres due to the time taken 
for such processes and the short half-life of retroviral vectors. As a raw material for vector 
production, serum can also present problems with batch to batch variation and cost. Serum-
free medium is therefore a desirable alternative, however only a few reports demonstrate the 
successful use of serum-free medium for retroviral vector production. 
Glimm et aI., (1998) demonstrated successful production of GALV-pseudotyped retroviral 
vectors from PG13/LN packaging cells, using defined serum-free media. Similar titres to 
those obtained in serum-containing medium were achieved over a 24h-culture period. 
However, the survival, growth and virus production of these cells during longer culture 
periods was not reported. 
Gerin et aI., (1999b) demonstrated similar vector production by FL YRD 18 packaging cells 
cultured in a commercially available serum-free medium, compared to basal medium 
supplemented with low serum concentrations. Vector titres increased throughout the 6-day 
culture period, however longer-tenn cultures in serum-free medium were not conducted. 
Additives 
A number of groups have attempted to obtain higher retroviral vector titres through the 
addition of activators/enhancers before harvest. For example, Pages et al. (1995) undertook 
a number of studies to detennine the effect of different activators (known to enhance the 
expression of MoMLV genes) on their ability to modulate the retroviral transcripts of two 
33 
different \jfCRIP murine packaging cell lines. Dexamethasone, TPA (phorbol 12-myristate 
13-acetate) and sodium butyrate have all been previously shown to enhance the transcription 
of retroviruses. These factors were therefore added alone, or in combination, to the 
packaging cells before harvesting the viral vectors from the culture supernatant in order to 
assess their effect on the expression of retroviral vectors. A five-fold increase in vector 
production was observed after the addition of sodium butyrate (5mM) and, in combination 
with dexamethasone (1/-lm), a IO-fold increase was measured. The addition of TPA alone 
(O.l/-lm) increased vector production 1.5-fold and in the co-presence of dexamethasone, 
production was increased 7-fold. However the addition of dexamethasone alone did not 
improve vector production. 
The increase in vector production in the presence of these additives was believed to be a 
result of upregulation of LTR transcripts (as indicated by northern blot analysis of the cell 
cultures stimulated by these additives). LTRs play a central role in the control of viral gene 
expression. In the \jfCRIP packaging cell line, the structural viral RNAs are under the 
control of the MoML V LTR. 
Soneoka et al. (1995) also demonstrated an increase in retroviral vector titre during sodium 
butyrate treatment, after transient co-transfection of a human cell line with three plasmid 
components. The three plasmids consisted of a Murine Leukaemia Virus-based retroviral 
vector and two packaging components (gag-pol and env) expressed from CMV promoters. 
Since sodium butyrate has been shown to activate a number of promoters, including the 
CMV promoter, the addition of this chemical prior to vector harvest was employed in an 
attempt to improve vector titres. A IO-fold increase in vector titre was observed after 
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treatment with sodium butyrate (10mM) for 12h and the titre peaked 48 hours post-
transfection. 
Sodium butyrate treatment has been reported to increase retroviral vector titres 20- to 1000-
fold in range of retroviral packaging cell lines tested by Olsen and Sechelski (1995). It is 
worth noting that this group measured a 50-fold increase in LTR-driven RNA transcripts, but 
only a 4-fold increase in SV40 promoter driven RNA transcripts in the same cell line. 
Hence, while sodium butyrate has been reported to increase the level of RNA transcription 
under the control of a number of promoters, the actual responsiveness is dependent on 
promoter type. It has also been reported that the responsiveness is dependent on the 
packaging cell system where location of the promoters is important. The exceptionally large 
increase in vector production in some packaging cell systems observed by this group after 
sodium butyrate addition, may also be due to the low starting titres without this additive (103 
- 104 cfu/ml). That is, low levels of transcription of some RNA components may well have 
been a limiting factor in active particle production. The other groups reported a higher titre 
in their systems before the addition of sodium butyrate hence, where transcriptional activity 
is already relatively high, exceptionally large increases after sodium butyrate addition may 
not be possible. Indeed, Cruz et aI., (2000a) reported only a slight increase in vector titre in 
P A317 cell cultures, after the addition of sodium butyrate. This group demonstrated 
relatively high titres in the absence of this additive, hence vector production may be near 
maximum levels for this cell line without the addition of sodium butyrate. 
The optimal effects of sodium butyrate were reported by Olsen and Sechelski (1995) to occur 
20 to 24 hours after its addition. Prolonged exposure of the cells to sodium butyrate (up to 
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48 hours) resulted in a reduced vector titre (possibly due to cytotoxicity of this additive). 
Hence the addition of sodium butyrate is only really suitable for batch production of 
retroviral vectors and is unlikely to be useful during continuous production. Furthermore, 
the effects of its presence in the final preparation of a vector stock are unknown and removal 
may be difficult. The pre-treatment of cells with sodium butyrate, followed by harvesting of 
vectors during a culture period in medium without sodium butyrate may be a preferred 
method (as used by Soneoka et al.). The efficacy of such a method would have to be tested 
for each system. 
Scale-Up 
Attempts by Kotani et al. (1994) to scale-up retroviral vector production to larger volumes 
have involved the use of a CellCube™ (Costar). An increased vector titre was measured in 
the CellCube™ cultures, supposedly as a result of higher cell numbers within this system, 
which provides a greater surface area for cell growth. The vector titre per cell was not given, 
hence actual productivity of the cells within this apparatus could not be compared to standard 
monolayer cultures in T-flasks. Vector production was maintained in the CellCube™ 
cultures for up to twenty-three days, which is the longest production period reported, prior to 
the studies within this thesis (and a recent paper by Pan and Whitley, 2000). It is desirable to 
increase the length of production time of retroviral vectors in order to limit operating 'down 
time' and hence reduce production costs. Longer production periods also results in fewer 
batches requiring costly quality assurance assays. However, for some packaging cell 
systems, the length of a production phase may be limited by a reduction in cell productivity 
with time. 
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More recently, Pan and Whitley (1999) have shown promising results with a hollow-fibre 
system for retroviral vector production (though these systems have been reported to be more 
suitable for anchorage-independent cell types). Microcarrier culture is often the choice for 
large-scale production of anchorage dependent cells, however, Kang et al. (2000) reported a 
10-fold reduction in vector titre during the microcarrier culture of packaging cells in spinner 
flasks, compared to monolayer cultures. In comparison, this group obtained reasonable 
vector titres (slightly lower than monolayer) using a packed bed system. 
The most common system for larger scale retrovira1 vector production is currently roller 
bottle culture (Andreadis et aI., 1999). The advantages and disadvantages of a number of 
culture systems that may be considered for the production of retroviral vectors are 
summarised in Table H. 
Vector Concentration and Storage 
Further attempts to increase the vector titres by the above groups have involved 
concentration processes. A tangential flow filtration system was demonstrated by Kotani et 
al. (1994) to increase titres by 15- to 24-fo1d with 91-96% recovery. Lee et al. (1996) also 
demonstrated successful ultra-filtration of their retroviral vector stocks, reporting a 16-fold 
increase in titre with only a 10% loss. 
In an attempt to develop a method for long term storage of retroviral vector stocks, samples 
were lyophilised (Kotani et aI., 1994). It was found that supplementation of vector 
supematants with glucose, or sorbitol, and gelatin was necessary for any recovery of vector 
activity after lyophilisation. Using these supplements, a 64-83% recovery of active vector 
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particles was achieved. However, Lee et aI., (1996) reported a 60% loss in vector activity 
after lyophilisation. 
Retroviral vectors can also be stored in liquid nitrogen or in -BoDe freezers, in order to 
prevent their decay. Kaptein et al. (1997) studied the effect of multiple freeze-thaw cycles 
on retroviral vector activity. They reported an initial activity loss of approximately 60% 
during the first few freeze-thaw cycles. However, very little effect on vector titre was 
observed during subsequent multiple freeze-thaw cycles (up to 14). Lee et al. (1996) also 
demonstrated sensitivity of retroviral vectors to freeze-thaw cycles, reporting a 30-50% loss 
of vector activity after just one cycle. However, this group found no apparent sub-population 
of resilient vectors, as a further five cycles resulted in only 10-20% of the infectious vector 
particles remaining. 
1.5 Aims 
The aim of this research was to determine the effects of various culture parameters on the 
production of retroviral vectors by a human packaging cell line, in an attempt to optimise 
conditions for large-scale production. Physical and chemical factors such as temperature, 
dissolved oxygen levels, pH, and nutrient levels were all assessed. The effect of the cell 
cycle of the packaging cells on vector release was also examined in detail. This systematic 
approach also included fundamental characterisation of the packaging cells and their released 
vector particles. Such information has practical implications in the manufacturing of vectors 
from these cells for achieving optimal culture and harvest conditions. It is evident from the 
current literature that no such systematic study on a wide range of parameters has been 
conducted to date. By determining which factors have a critical effect on vector production, 
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culture conditions of the packaging cells can be modified and controlled in order to optimise 
vector production. 
The apparent absence of a suitable process for large-scale production of retroviral vectors 
has been postulated to hinder future gene therapy applications (Birch, 1997; Andreadis et aI., 
1999). At present, laboratory methods used for the production of relatively large volumes of 
retroviral vector stocks (for clinical trials) typically involve roller bottles (Andreadis et aI, 
1999). Such methods are both costly and labour-intensive in large scale. A further aim of 
this research was to assess alternative culture systems, such as a packed bed, for their 
suitability as a scalable method for retroviral vector production in vitro. 
Most reports to date, which have examined the effects of a few culture parameters on 
retroviral vector production, have used murine packaging cell lines. The studies within this 
thesis have been conducted using a human packaging cell line (FL YRD 18) since it offers a 
number of benefits for human gene therapy applications (Gerin et. aI., 1999). This cell line 
was constructed to overcome a number of the potential problems with murine packaging cell 
lines (Cosset et. aI., 1995), namely, the inactivation of the released retroviral vectors by 
complement in human serum (Takeuchi et. aI., 1996). Furthermore, as with a number of 
recent packaging cell lines, the gag-pal and env genes have been inserted on separate 
expression cassettes and the viral sequences minimised to reduce the risk of producing 
replication-competent retrovirus particles. This cell line was therefore deemed suitable for 
the studies within this thesis. 
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Culture System Advantages Disadvantages 
T-Flask Simple Difficult to scale-up 
Long history of use, Labour intensive 
hence well characterised 
No continuous control of culture 
parameters 
No 2erfusion of culture medium 
Roller Bottle Large surface area to volume Still labour intensive in large 
ratio scale 
(relative to T-flask) 
No continuous control of culture 
parameters 
No 2erfusion of culture medium 
Cell-Cube™ Larger surface area to volume Expensive 
ratio 
Limited scale-up 
Culture medium can be perfused 
Microcarrier suspension Greatest surface area to volume Cells exposed to shear forces 
culture ratio 
Some cell types show reduced 
Culture medium can be perfused growth or vector production 
(compared to monolayer 
Culture parameters can be culture) 
continuousl~ controlled 
PackedBedl Culture medium can be perfused Mass transfer limitation may 
Fluidised Bed occur 
Culture parameters can be 
continuously controlled Requires development 
Low shear forces 
Table 11 
Advantages and disadvantages of various culture systems for the production of retroviral vectors. Increased 
surface area to volume ratio allows the potential for intensification of vector production. Continuous control of 
culture parameters will enable optimal conditions for production to be maintained throughout the culture 
period. Furthermore, perfusion of the culture medium allows the collection of supematants at a lower 
temperature. 
40 
1.6 Accuracy of Retroviral Vector Titres 
The concentration of infectious retroviral vectors is usually measured indirectly through the 
infection of target cells (using a so-called 'infection assay'). Such a method was used 
throughout the studies within this thesis. The values obtained from such infection assays are 
dependent on a large number of factors, apart from the actual vector concentration. 
Therefore the vector titres cannot be taken as absolute values, but allow a comparison of 
relative vector concentrations achieved under various conditions. 
The inherent variability in the titre (measured as colony forming units, CFU, derived from 
target cells cultured with vector-containing supematants) is a result of many contributory 
factors. This is because the ability of a vector to successfully infect a target cell, such that 
the cell will go on to express the inserted genes, is dependent on a number of parameters. 
These include: the metabolic state of the target cell culture, concentration of the vector stock, 
target cell density, ratio of vector particles to target cells, composition of infection medium, 
time of exposure of target cells to virus and target cell type (Morgan et aI., 1995; Palsson and 
Andreadis, 1997; Gerin et aI., 1999a; Emery et aI., 2000). Therefore the titres quoted in any 
study can only be used as an indication of increased or decreased virus production/stability 
as a result of various culture conditions. Where retroviral vector stocks are produced for 
clinical applications, the actual titres quoted should be those measured using a method 
applicable to the protocol used for transduction of patient cells. 
It is highly likely that a number of the infection assays, used to determine the titre of a 
retroviral stock, significantly under-estimate the actual vector concentration. This is evident 
from the work of many groups who have optimised the conditions for target cell transduction 
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and obtained increased vector titre values. For example, Kotani et al. (1994) demonstrated a 
4- to 18-fold increase in measured vector titre after centrifugation of vector supernatants 
covering target cell mono layers, compared to target cells exposed to the vector supernatant 
during static conditions. Palsson and Andreadis (1997) estimated the gravitational settling 
velocity of retroviral particles to be in the order of microns per hour. Therefore, under static 
conditions, such particles are governed by Brownian motion in the culture medium and 
hence their interaction with a target cell monolayer is random. Due to their short half-life , 
retroviral particles are quite likely to decay before they actually come into contact with a 
target cell. The use of centrifugal forces to bring more of these particles into contact with 
the target cells in a shorter period of time can therefore increase the chances of infection. 
Obviously such methods for increasing the transduction of target cells are only suitable for 
ex vivo delivery of genes. However it does demonstrate how infection assays that do not 
utilise this centrifugation procedure can significantly under-estimate the actual titre of a 
vector supernatant. 
The contact of a virus particle with a target cell will not guarantee virus binding to that cell. 
However by increasing the frequency of particle collision with a target cell, the chances of 
binding and successful infection are increased. This has been the theory behind a number of 
methods for improved target cell transduction. For example, fluid flow has been 
demonstrated to increase the transduction efficiency of retroviral stocks. Mixing of the 
vector supernatants while in contact with the target cells can allow particles remote from the 
target cell monolayer to come into contact with the cells. However this does not overcome 
the effects of Brownian motion at the boundary layer between the cells and the suspension. 
Fluid flow through a monolayer of target cells, inoculated onto a porous substratum, allows 
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continuous transport of the particles to the target cells and this method has been shown to 
yield significantly improved vector titres (Palsson and Andreadis, 1997). 
Other attempts to increase the transduction of target cells have involved the co-localisation 
of retroviral vector particles and target cells on fibronectin fragments (Hanenburg et aI., 
1996; Mortitz et aI., 1996), where cells and virus particles can be brought together to 
increase the chances of infection. 
The use of polycations such as Polybrene™ (hexadimethrine bromide) has been widely 
accepted to improve transduction efficiencies of retroviral stocks (Toyoshima and Vogt, 
1969; Coelen et aI., 1983). Like the target cells, retroviral vector particles have a negatively 
charged surface (since their outer membrane is taken from the packaging cells from which 
they bud off). Hence there is an electrostatic repulsion between the target cells and vector 
particles. The addition of positively charged Polybrene™ to a suspension of vector particles 
is believed to reduce the electrostatic repulsion between the particles and target cells, and 
thereby improve the contact between the two. Interestingly, the optimal concentration of 
Polybrene™ for high transduction efficiencies has been shown to be dependent on serum 
concentration (Andreadis and Palsson, 1997). Other groups have favoured the use ofDEAE-
Dextran (Lee et aI., 1996), which is believed to mediate the adhesion of virus particles to 
cells possibly through the reduction in osmotic pressure in the region between the bound 
virus and the cell. However, this polycation is somewhat toxic to some cell types and is 
therefore not suitable for all target cell transductions. 
43 
The above studies illustrate the arbitrary nature of a vector titre measured by the infection of 
target cells, since it is highly unlikely that all active particles will be detected. However, as 
mentioned earlier, these titres do serve a purpose when demonstrating an increase or 
decrease in vector production andlor stability as a result of modified culture methods. 
Infection assays were therefore used throughout the studies described in this thesis. In 
addition, the transduction efficiency, as determined by measuring the percentage of target 
cells successfully infected by a retroviral vector stock, was assessed in a select number of 
preparations. Forestell et al. (1995) found no correlation between end point titres and 
infection efficiency measurements. It is therefore pertinent to determine the transduction 
efficiency (in addition to the vector titre) of a retroviral vector preparation, which has been 
produced under modified conditions. 
Le Doux et al. (1999) has also observed a lack of correlation between transduction efficiency 
and end point titre. This group increased the titre of a retroviral stock by ultra-filtration, 
however this did not result in an increase in the transduction efficiency of that stock. Both 
Forestell et aI., (1995) and Le Doux et aI., (1999) attributed this phenomenon to an increase 
in inhibitory factors with increasing vector titre. Recently Seppen et aI., (2000) also 
demonstrated the presence of inhibitors which co-purify with retroviral preparations. A 
number of inhibitors could be present in the supematant of a packaging cell culture. For 
example, free envelope proteins present in a retroviral vector preparation (shed from the 
vector particles themselves, or released by the packaging cells) can compete with the 
retroviral vectors for binding sites on the target cells and thereby reduce the efficiency with 
which the vectors bind. If only some of the envelope proteins are shed from a particle, that 
particle may still be able to bind, hence titre measurements may not be affected. 
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So-called 'empty' particles, which contain no RNA and hence are inactive, may also be 
released by packaging cells. These non-transducing retroviral particles can also compete 
with active particles for binding. While it would be expected (for most supematants) that the 
number of retroviral receptors per cell is in excess of the number of vector particles to which 
they are exposed, competition for binding sites could occur in concentrated vector 
preparations. Vector titres are usually measured using diluted suspensions, hence such 
competition for binding sites is unlikely to have a measurable effect during titre 
measurements. In contrast, transduction efficiency measurements are conducted using neat 
vector preparations (where the receptor to particle ratio is much lower), hence competing 
particles may reduce transduction efficiencies. This could explain the poor correlation 
between titre and transduction efficiency reported by Forestell et aI., (1995). 
Earlier studies by Le Doux et aI., (1998) also demonstrated the presence of proteoglycans 
(released by packaging cells) to have a negative effect on vector transduction efficiency. 
Such inhibitory factors will be co-concentrated with vectors during standard concentration 
procedures such as ultra-filtration and centrifugation. Since the measurement of vector titres 
is conducted using diluted preparations, these proteoglycans may well be diluted to levels 
that are ineffective and hence do not cause a reduction in titre. However the concentration of 
proteoglycans will be at a maximum during transduction efficiency measurements, where 
vector preparations are used neat, hence inhibitors such as proteoglycans only exert an effect 
on transduction efficiencies. Again this may lead to a poor correlation between the titre and 
transduction efficiency of retroviral preparations. 
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The presence of transduction inhibitors may also explain why Forestell et aI., (1995) 
observed no increase in transduction efficiency while vector titres were observed to increase 
with time. This group postulated that with increasing production times, inhibitory factor 
concentrations also increased. This is a reasonable assumption as proteoglycans and 
envelope proteins will be continuously released by the packaging cells (and thereby 
accumulate), furthermore, envelope protein shedding and particle inactivation it likely to 
increase with incubation time. This theory can be used to explain the findings of this group, 
where a maximum transduction efficiency, of vector preparations in confluent roller bottle 
cultures, was achieved just 3-5 h after the start of production (addition of fresh medium), 
whereas the titre progressively increased for 30 h. For this reason, the optimal harvest time 
for these cultures was concluded to be 3-5 h after medium replacement. 
Other groups have reported optimal harvest times at 48 h (Kotani et aI., 1994), 3 days post-
confluence (Lee et al. 1996) or during sub-confluence of packaging cell cultures (Shen et aI, 
1996). These findings were based on measured retroviral vector titres. Optimal harvest 
times based on transduction efficiencies may correlate better between different research 
groups, though it is likely that it will dependent on packaging cell type and culture density. 
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Chapter 2: 
General Materials and Methods 
This section describes the materials and methods that are common to most studies 
throughout this thesis. Details of individual experiments are given, where appropriate, in 
each chapter. 
2.1 Cell Lines 
FLYRD18/LNC-hB7: 
The FL YRD 18 retroviral packaging cell line contains the retroviral helper genes gag-pol and 
env on two separate expression cassettes. This cell line was constructed by Cosset et al. 
(1995) using the HTI080 human fibrosarcoma cell line. The gag and pol genes originate 
from Moloney murine leukaemia virus (MoML V) and the env gene originates from the cat 
endogenous virus, RD1l4. 
FLYRD18 cells were used by M. Gilligan and P. Searle of the Cancer Studies Institute, 
University of Birmingham, to construct the FL YRD 18/LNC-hB7 cell line. In brief, a third 
plasmid was used to insert the human CD801B7 gene and the G418/neomycin resistance 
gene, from Tn5 (Miller and Rosman, 1989, Freeman et aI., 1989, Linsley and Ledbetter, 
1993, Daly and Gilligan, personal communication) under the control of the internal 
cytomegalovirus (CMV) promoter. The human CD80/B7 gene encodes the human B7 
protein, designated CD80. This protein is a member of the immunoglobulin superfamily and 
is expressed on the surface of antigen presenting cells. B7 protein is the natural ligand for 
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CD28 receptors on the surface of T -cells and is involved in their activation. The 
FL YRD l8/LNC-hB7 cell line was originally constructed for research purposes, aimed at 
invoking immunogenicity of cancer cells. A linear map showing the organisation of the 
retroviral vector and the helper functions in the FL YRD 18/LNC-hB7 cell line is given in 
Figure 2.1. 
A2780cp: 
Cisplatin resistant human ovarian carcinoma cells, A2780cp, (Khokhar et. aI., 1992) were 
used as target cells to measure retroviral vector titre in all the infection assays (also courtesy 
ofP. SearIe, Cancer Studies Institute, University of Birmingham). 
2.2 Monolayer Cell Culture 
Both the producer and target cell lines were maintained in monolayer cultures using standard 
tissue culture flasks (T-flasks). Cells were cultured in Dulbecco's Modified Eagles Medium 
and Ham's F-12 Nutrient Mix (DMEM:F-12,1:1) plus 5% (v/v) Foetal Calf Serum, (FCS, 
Life Technologies, UK). FLYRDI8/LNC-hB7 cells were inoculated at 2 x 104 cells /cm2 (5 
x 104 cells/ml) and passaged once confluent (every 3-4 days) in fresh medium. A2780cp 
target cells were inoculated at 1 x 104 cells/cm2 (2.5 x 104 cells/ml) and maintained as above. 
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LNC-hB7-1 vector: 
\jf+ 
env construct (Cosset et al.. 1995): 
~ LTR H env H phleo H poly ;:"=l-
gag-pol construct (Cosset et al., 1995): 
~ LTR H gag-poJ H bsr 
Figure 2.1 
Linear maps of the LNC-hB7 vector and helper constructs in FL YRD 18/LNC-hB7 packaging cells. The gag-
pol-bsr and env-phleo expression cassettes were transferred sequentially into the parental HTI080 cells. Clones 
with stable integration of the constructs in genomic DNA and expressing high levels of the encoded products 
were selected using the antibiotics blasticidin and pWeomycin, respectively (Cosset et aI., 1995) to generate the 
FLY RD 18 clone of packaging cells. Production of bsr and phleo proteins depends upon reinitiation of 
translation, shortly after the stop codon of the first open reading frame. The neomycin resistance gene in the 
LNC-hB7 construct is expressed from the upstream LTR of chromosomally integrated provirus and confers 
resistance to G418 in eukaryotic cells. The B7 protein is expressed from the internal CMV immediate early 
promoter. 
\v+ : packaging signal, CMV: cytomegalovirus promoter, polyA; polyadenylation signal. 
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2.3 Measurement of Vector Titre by an Infection Assay 
Active virus titres were assessed using an infection assay of the human ovarian carcinoma 
cell line, A27S0cp. In brief, A270S0cp cells were inoculated at 105 cells per well in 6-well 
culture plates (Nunc) and cultured in 2ml DMEM:F-12 plus 5% FCS (v/v) overnight. The 
spent medium from each well was replaced with 1ml diluted virus supernatant, 1:102 to 
1:104, in DMEM:F-12 (no serum) + S/-Lg/ml Polybrene™ (Sigma, UK). Undiluted virus 
supernatants were filtered through 0.45/-Lm pore size filters (to remove any suspended cells or 
cell debris) and stored in liquid nitrogen prior to assay. Diluted virus supernatants (two wells 
for each dilution) were left in the wells at 37°C for Sh before adding 2ml DMEM:F-12 + 5% 
FCS (v/v) + 1.125mglml Geneticin (G41S) per well, to give a final concentration of 
0.75mg/ml Geneticin. A control plate containing no retrovirus supernatant was also cultured 
under identical conditions, in order to confirm no colonies would survive in the presence of 
Geneticin (0.75 mg/ml). All plates were incubated at 37°C for 10 days, with a complete 
medium change in each well after 5 days (using fresh DMEM:F12 + 5% (v/v) FCS + 
0.75mglml Geneticin). On day 10 the medium was removed and each well rinsed with 1-
2ml phosphate buffered saline (PBS). After removing the PBS, 1ml crystal violet solution 
(0.3% (w/v) crystal violet, 70% (v/v) methanol in H20) was added to each well and left for 
15 minutes. The crystal violet solution was removed and each well was rinsed with water. 
The number of stained colonies in each well was counted and the number of colony forming 
units (CFU) per ml of neat virus supernatant calculated (by multiplying the number of CFU 
by the dilution factor). Figure 2.3 illustrates a typical colony of transfected A27S0cp cells 
stained with crystal violet. 
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Figure 2.3 
Photomicrograph of a typical colony of A27S0cp cells transfected with retroviral vectors 
from FLYRDlS/LNC-hB7 and selected in Geneticin-containing medium (0.75 mg/m! G41S) 
for 10 days, before staining with crystal violet. Magnification x 100. 
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2.4 Measurement of Transduction Efficiency of Vector Preparations 
The transduction efficiency of vector-containing supernatants was detennined by measuring 
the percentage of cells expressing the CD80/B7 surface antigen after exposure to vectors 
(carrying the gene encoding for CD80/B7). 
Target cells (A2780cp) were inoculated at a density of 105 cells per well in 6-well culture 
plates (Nunc) and cultured in 2ml DMEM:F-12 + 5% FCS (v/v) for 24h. The medium in 
each well was then replaced with neat vector-containing supernatant (lml) plus DMEM:F-12 
+ 5% FCS (v/v) + 8 Ilg/ml Polybrene™ and the plates left for a further 6-8h at 37°C. After 
this exposure to the vector preparation, DMEM:F-12 + 5% FCS (2ml) was added to each 
well and the plates cultured for 42h. Cells from each well were then detached by trypsin 
digestion and counted using a haemocytometer. Cells were washed in PBS before adding 
20111 per 106 cells of an FITC-conjugated anti-human CD801B7-1 antibody (BB1, 
Phanningen International). Cells were incubated with this antibody at 4°C for 60 minutes, 
washed in PBS and then fixed in 1 % paraformaldehyde for 30 minutes. Fixed cell 
preparations were washed again in PBS before analysing by flow cytometry. An EPICS 
Elite Flow Cytometer (Coulter Electronics, UK) with an argon laser (488nm emission) was 
used to measure the fluorescence intensity per cell. Control cells were treated as above, but 
incubated in medium without vectors for 6-8h (fluorescence levels in these cells were 
negligible). A further control was prepared where cells were exposed to the vector 
preparation, but subsequently labelled using an FITC-conjugated goat anti-murine IgG 
antibody. This irrelevant antibody was used to check for non-specific binding of FITC-
conjugated antibodies to the target cells (fluorescence levels in these cells were also 
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negligible). The expression ofCD801B7-1 on the surface of the target cells was detected by 
increased fluorescence (positive antibody labelling) relative to the controls. 
2.5 Cell Cycle Analysis using Flow Cytometry 
Cells were fixed in cold 70% (v/v) ethanol (1 x 106 cells per sample) and stored at -20°C 
until analysed. Immediately before analysis, cells were washed in phosphate buffered saline 
(PBS) then resuspended in RNase (250 !J.g/ml in PBS; Sigma, UK) and incubated at 37°C for 
20 minutes. The DNA stain, Propidium Iodide (PI), was then added to give a final 
concentration of 50 !J.g/ml and the samples incubated for a further 10 minutes at room 
temperature. An EPICS Elite Flow Cytometer (Coulter Electronics, UK) with an argon laser 
(488 nm emission) was used to measure the relative DNA content of each cell. The forward 
scatter (FS) was collected using a 488 nm band pass filter and the PI fluorescence collected 
using a 488nm long pass filter, followed by a 635 nm band pass filter. The FS integral, side 
scatter (SS) signal integral, PI fluorescence signal integral and the PI fluorescence signal 
peaks were all recorded. Any doublets or aggregates were 'gated out' using the PI 
fluorescence signal vs. PI fluorescence signal peak plots, hence only single cells were 
analysed. The relative PI fluorescence signal integral (relating to DNA content) in each cell 
was plotted as a frequency histogram and the proportion of cells in GI, S and G21M-phases 
of the cell cycle was determined using Multicycle software (Phoenix Flow Systems, San 
Diego, USA). 
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2.6 Determination of Cell Numbers using an MTT Assay 
Where cell numbers could not be counted directly (for example, where cells were attached to 
microcarriers), the ability of mitochondrial enzymes within viable cells to convert MTT (3-
(4,5-dimethylthazol-2-yl)-2,5-diphenyl tetrazolium bromide) to an insoluble coloured 
product (formazan) was exploited to estimate the cell number (Mosmann, 1983; Gerlier and 
Thomasset, 1986; Page et aI., 1988; AI-Rubeai et aI., 1990; Nomura et aI., 1996). 
In brief, a sample of carriers was added to PBS (Iml) plus 100).11 freshly prepared MTT 
solution, 5 mg/ml in PBS, (Sigma, UK). All samples were incubated at 37°C for 3h to allow 
the conversion of MTT to formazan. After this incubation period the formazan crystals were 
dissolved by the addition of acidic isopropanol (lml of 0.04N HCI in isopropanol). Samples 
were shaken at room temperature for 30 minutes, or until the carriers turned from blue to 
white (indicating all the formazan product had been released from the carriers into solution). 
The relative concentration of formazan in each sample was determined by measuring the 
absorbance using a Pharmacia LKB Ultrospec III spectrophotometer at 570nm. 
In order to convert the formazan concentration (absorbance) of each sample to cell number, a 
calibration curve was constructed using FL YRD 18/LNC-hB7 cells. A suspension of known 
cell number (determined by haemocytometer counts) was used to prepare pellets with a 
range of cell numbers (duplicate for each concentration). PBS (lml) and 5mglml MTT 
solution (l00).11) was added to resuspend each pellet, before incubating at 37°C for 3 h. The 
formazan concentration of each sample was then measured as described above. The 
resulting calibration curve is shown in Figure 2.6. 
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The MTT assay has the advantage of distinguishing viable from non-viable cells, however 
due to its dependence on the metabolic activity of each cell, determination of actual cell 
number may not be reliable. Where the activity of cells within a culture is not constant (as 
can be the case in batch cultures), the amount of formazan produced per cell will not be 
constant (Yamaji and Fukuda, 1992). In addition, the metabolic activity of cells varies 
throughout the cell cycle, hence the MTT assay is effected by the cell cycle. Hence 
estimated cell numbers determined by MTT conversion to formazan should be used with 
caution and taken only as an indication of increasing or decreasing cell density/activity or as 
a comparison of cell number between cultures from the same batch of cells. 
2.7 Calculation of Cell Growth Rate (Jl) 
In a number of studies, the cell growth rate (Jl) of FL YRD 18/LNC-hB7 cells was compared 
between different culture conditions. Cell growth rates were calculated using the following 
specific rate formula (Leelavatcharamas, 1997): 
Jl= 1 x 
Where Xl is the number of cells at the start ofthe culture period (at time tI) and X2 is the total 
cell number at the end of culture (at time t2). 
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Figure 2.6 
MTT calibration curve for determining FLYRD18/LNC-hB7 cell number. Known cell 
numbers incubated with MTT for 3 h and absorbance measured at 570 run. Error bars 
represent observed range, n==2. 
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2.8 Cell Counts 
Cell numbers from monolayer culture were estimated by counting replicate samples on an 
improved Neubauer haemocytometer under phase contrast microscopy. Viable cells were 
distinguished from non-viable cells by exclusion of the vital dye, Trypan Blue. Cells 
cultured in mono layers on tissue grade plastic were detached by trypsin digestion before 
counting. In brief, the spent culture medium was removed from each flask and the attached 
cells were gently washed with sterile phosphate buffered saline (PBS), to remove excess 
serum proteins. The PBS was then replaced with 1% v/v trypsin-EDTA (Life Technologies, 
Scotland), pre-warmed to 37°C. Cells were incubated in the trypsin solution at 37°C for 
approximately one minute, or until the cells were observed to start 'rounding up' and detach 
from the culture surface (cells were visualised using an inverted light microscope). Once all 
the cells had detached, fresh medium containing 5% FCS was added to the flasks to 
'inactivate' the trypsin solution. The cells and medium were gently mixed to obtain a single 
cell suspension before centrifuging. The supematant was removed and the cell pellets were 
resuspended in a known volume of medium. Replicate samples (100).11) of this cell 
suspension were mixed with 0.5% v/v Trypan Blue solution (100).11) and transferred to the 
haemocytometer for counting. 
2.9 ImmobaSjJTM Microcarriers 
A number of studies in Chapters 3 and 5 involve the use of microcarriers. Unless otherwise 
stated, the microcarriers used were ImmobaSil-FSTM or ImmobaSil-GTM (Ashby Scientific 
Ltd, U.K.). These microcarriers are composed of silicone rubber, engineered to give a 
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sponge-like structure with interconnecting pores (see Figure 2.9). The average pore size is in 
the order of 50 x 150~m. The properties of -FS and -G types are summarised below. 
IY:Rs: Shape 
-FS discs 
-G rods 
Approximate dimensions 
0.8mm diameter, 0.25mm depth 
0.8mm diameter, Imm length 
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Recommended use 
Spinners Istirred tanks 
Packed/fluidised beds 
Figure 2.9 
Scanning electron micrograph of an ImmobaSiFM micro carrier (without cells). Bar 
represents 5001lm. 
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2.10 Measurement of Glucose and Lactate Concentration in Culture Medium 
The glucose consumption and lactate production in various cell cultures was determined by 
measuring the concentration of each in fresh and spent medium. Glucose concentration was 
measured using the Refloflux II reflectance photometer (Boeringer Mannheim, u.K.). A 
sample of the culture medium (50j.ll) was added to a test strip and the glucose concentration 
determined by colourimetric analysis as per manufacturer's instructions. Lactate 
concentration was measured using the Biolyser Rapid Analysis System (Eastman Kodak Co., 
D.S.A). A sample of the culture medium (10j.ll) was added to a slide containing all the 
appropriate reagents (within a semi-permeable membrane) and the concentration of lactate 
determined as per manufacturer's instructions. 
2.11 Scanning Electron Microscopy 
In order to observe attached cells within the ImmobaSiFM microcarriers during culture, 
samples were taken periodically and fixed for scanning electron microscopy (SEM). In 
brief, samples were removed from culture, rinsed gently in PBS and fixed in 2.5% phosphate 
buffered gluteraldehyde (freshly prepared), overnight at 4°C. Samples were then dehydrated 
by immersion in a series of ethanol solutions of increasing concentration. Samples were 
soaked in each solution for approximately one hour before transferring to the next. 
Eventually samples were soaked in absolute ethanol and kept at 4°C until observing by SEM. 
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Chapter 3: 
Fundamental Characterisation of FLYRD18/LNC-hB7 Cells and 
Vector Particles 
3.0 Introduction 
Prior to any modifications of the typical culture conditions of FL YRD 18/LNC-hB7 cells, the 
fundamental characteristics of this cell line and their released vector particles were 
determined. These studies included assessment of the behaviour of these cells during batch 
culture, determination of cellular oxygen uptake rate, effects of cell cycle on vector 
production, maintenance of vector production, ability of the cells to adhere to microcarriers 
and effects of agitation. The stability of the vector particles was also assessed under various 
conditions. In addition, the method used to estimate vector concentration was tested for 
reproducibility in order to assess its suitability for future studies. Finally, the typical 
transduction efficiency of the vector-containing culture supernatants was determined. 
The results from these initial studies were used to determine the appropriate handling 
procedures of the cells and vector preparations in future experiments. These studies also 
allowed a basic understanding of some of the parameters likely to affect vector production. 
Cell Cycle 
Included in these studies was an investigation into the effects of cell proliferation and cell 
cycle phase on the vector production by FLYRDI8/LNC-hB7 cells. A wealth of literature 
exists concerning the determination of target cell cycle effects on infection by retroviral 
particles (Fritsch and Temin, 1977; Harel et aI., 1981; Springett et aI., 1989; Andreadis et aI., 
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1998; Sladek and Jacobberger, 1998). Such studies have demonstrated that target cells must 
be undergoing mitosis to allow successful infection by most retroviruses (Miller et aI., 
1990b; Roe et aI., 1993; Lewis and Emerman, 1994; Andreadis et aI., 1997) excluding 
lentiviruses (Lewis and Emerman, 1994). However, the effect of cell cycle of the packaging 
cells used for retroviral vector production has received no attention to date. While the effect 
of cell cycle of the target cells is important with respect to clinical applications (i.e. 
optimisation of gene transfer protocols), the cell cycle of packaging cells holds equal 
importance with respect to the production of viral vectors for gene transfer. If the cell cycle 
phase of packaging cells were to have an effect on vector production, this would have a great 
impact on the optimal culture conditions for maximising vector titres. 
In cell lines used for the production of recombinant proteins, under different promoters, the 
relationship between cell cycle phase and product expression has proven to be highly 
variable (Lloyd et aI., 1999a,b). A number of groups have reported maximal product 
expression during the Synthetic (S) phase (Matherly et aI., 1989; Gu et aI., 1993, 1996). 
While other researchers, using different cell systems, have found maximal expression during 
Gap-1 (Gl) phase (Al-Rubeai & Emery, 1990; Kubbies and Stockinger, 1990; Al-Rubeai et 
aI., 1992; Park and Ryu, 1994) or Gap-2lMitotic (G21M) phases (Aggeler et aI., 1982). 
Furthermore, many cell lines have shown aphasic production (Feder et aI., 1989; Matherly et 
aI., 1989). The relationship between cell cycle phase of FLYRD18/LNC-hB7 packaging 
cells and vector production was therefore investigated. 
In addition, the effect of cell proliferation rate on vector production was assessed. Work by 
Shen et al. (1996) suggested that retroviral vector production by the amphotropic \!,CRIP 
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murine packaging cell was dependent on cell proliferation, however this was not 
conclusively proven. The studies within this chapter employed a number of different 
methods to manipulate the proliferation ofFLYRDI8/LNC-hB7 cells, in order to determine 
whether vector production by this cell line was dependent on cell proliferation/cell cycle 
progression. 
Microcarrier Culture 
Methods for the large-scale culture of anchorage-dependent cell lines (beyond roller bottle 
scale) almost exclusively involve the use of carriers for cell immobilisation (Adamson and 
Schmidli, 1986; Scott, 1987; Looby and Griffiths, 1990; Hu and Peshwa, 1991; Hu and 
Aunins, 1997). Microcarrier culture of mammalian cells in vitro was first introduced by van 
Wezel (1967). Since then a wide range of cell types have been successfully cultured on 
various different microcarriers (Crespi et aI., 1981; Yamaji et aI., 1989; Chengzu, 1994a,b; 
Ong et aI., 1994; Kennard and Piret, 1995; Alves et aI., 1996; Yamaji and Fukuda, 1997; 
Berry et aI., 1999). The immobilisation of cells on such carriers provides an increase in the 
surface area to volume ratio during culture (especially with porous microcarriers), hence this 
is an attractive method for the scale-up of cell culture. The success of large-scale 
microcarrier cell culture has been demonstrated in a number of different systems, including 
stirred tanks, air-lift fermenters, fluidised beds and packed beds (Yamaji and Kukuda, 1991; 
Cosgrove et aI., 1995; Kong et aI., 1999; Portner et aI., 1999). The ability of 
FLYRDI8/LNC-hB7 cells to be cultured on microcarriers was therefore investigated to aid 
the future development of a scalable method for vector production by this cell line. 
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The importance of cell attachment to carriers in vitro has been reported extensively (Hu and 
Wang, 1985; Hu et aI., 1985; Forestell et aI., 1992; Ohlson et aI., 1994; Ng et aI., 1996). 
Therefore the first step in the development of a carrier culture of the FL YRD 18/LNC-hB7 
cell line was to study the attachment of these cells to carriers under different conditions. 
3.1 Materials and Methods 
3.1.1 Batch Culture of FL YRD18/LNC-hB7 Cells 
The behaviour of the FLYRDI8/LNC-hB7 cell line in typical batch culture (with respect to 
cell growth and vector production) was assessed over a lO-day period. Monolayer cultures 
were established in T-25 flasks using DMEM:F-12 + 5% FCS (as described in Chapter 2) at 
1 x 105 cells/ml and the culture medium in each flask was left unchanged for the entire 
culture period. The supematant in duplicate flasks was sampled daily for measurement of 
glucose concentration, lactate concentration and vector titre. After sampling, cells were 
detached from the flasks by trypsin digestion and counted with the aid of a haemocytometer. 
Total cell number and percentage viability were both determined. Cell samples were also 
fixed for cell cycle analysis using flow cytometry (as described in Chapter 2). 
3.1.2 Effect of 'Conditioned' Medium on Vector Production 
Monolayer cultures of FL YRD 18 cells (parent cell line of FL YRD 18/LNC-hB7 cells) were 
established as described in Chapter 2. These cells do not contain the retroviral vector 
carrying the neomycin resistance gene and the human CD801B7 gene and hence only 
produce 'empty' particles. The spent medium from these cultures (left unchanged) was 
collected from replicate flasks each day, for 10 days, before discarding the cultures. The 
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spent medium samples ('cell-conditioned' medium) were stored at 4°C until the last sample 
was collected on day 10. FLYRD18/LNC-hB7 cell cultures were established as before and 
cultured for 24h in the collected media samples (conditioned for 1 to 10 days) or fresh 
medium. Supematants from each culture were then sampled for vector titre measurements in 
order to test the effects of cell-conditioned medium on vector production. 
3.1.3 Re-selection of Vector-Producing Cells in G418 
Vectors released by the FL YRD18/LNC-hB7 cell line contain the neomycin resistance gene 
(conferring resistance to Geneticin, G418, antibiotic). Any cells that do not contain this gene 
will die in the presence of sufficient concentrations of G418. FLYRD18/LNC-hB7 cell 
monolayer cultures were therefore established (as described in Chapter 2) in the presence of 
0, 0.25, 0.50 or 0.75 mg/ml G418 for one week in order to check that all cells within the 
population did indeed contain the vector carrying the neomycin resistance gene. The culture 
medium was changed for fresh (with or without G418) on day 4 and 6. On day 7 the cell 
numbers and vector titres in each culture were compared. 
3.1.4 Relationship between Cell Proliferation, Cell Cycle Phase and Vector 
Production 
3.1.4.1 Effect of Thymidine-Arrested Cell Growth on Vector Production 
Replicate monolayer cultures of FL YRD 18/LNC-hB7 cells (as described in Chapter 2) were 
grown to sub-confluence in DMEM:F-12 + 5% FCS. The culture medium in each culture 
was then changed for fresh medium either with or without 4mM thymidine (Sigma, u.K.) 
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and samples of the supematants were taken on days 1, 2 and 3 for measurement of the vector 
titre. 
A second study using a range of thymidine concentrations was also conducted. Cells were 
cultured on 6-well tissue culture plates (1.8 x 105 cells per well) in DMEM:F-12 + 5% FCS 
for 24h before replacing the medium in each well (2ml) with fresh medium containing 0.5, 
1.0, 2.0, or 4.0mM thymidine (triplicate wells for each concentration). After a further 24h 
the supematant from each well was taken for subsequent vector titre measurements. The cell 
number and viability in each well was also determined after releasing the cells by trypsin 
digestion and counting with the aid of a haemocytometer (viability was determined by 
Trypan Blue exclusion). The released cells were then fixed in cold 70% ethanol and stored 
at -200C for later analysis of the cell cycle distribution by flow cytometry (as described in 
Chapter 2). 
3.1.4.2 Relationship between Cell cycle Phase and Vector Production 
Cells in different phases of the cell cycle were separated by centrifugal elutriation and the 
vector production in cell cultures enriched for specific cell cycle phases was compared. It 
was necessary to take samples for vector titre measurement soon after separation of the cell 
fractions, before a significant loss in cell cycle synchrony was incurred. To ensure that virus 
titres could in fact be measured after just a few hours in culture, (using the cell 
concentrations employed in this study), a set of preliminary monolayer cultures were set up 
and the supematant sampled 2, 4, 6 and 8 h after inoculation of cells. Results from this study 
confirmed the ability to detect vector production after just 2 h in culture. Therefore the titre 
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in cell fractions separated by centrifugal elutriation was measured 2 h after inoculation of 
each cell fraction into T-flasks. 
To prepare each cell fraction, FL YRD 18/LNC-hB7 cells were detached from monolayer by 
trypsin digestion, spun down and pooled in 10ml cold PBS (2 x 108 cells in total). This 
concentrated cell suspension was then added to the sample port of a Beckman J-6M!E 
centrifugal elutriator. During centrifugation, PBS was pumped through and 50ml samples 
were collected at increasing pump speeds (16 fractions collected in total). The collected 
fractions were kept on ice until the last fraction was eluted. Cells from each fraction were 
then taken for cell size determination using the Coulter Multisizer II (cells suspended in 
Isoton II) and cell cycle analysis by flow cytometry (cells fixed in cold 70% v/v ethanol). 
Results from this experiment allowed determination of the pump speeds required to elute 
FL YRDI8/LNC-hB7 cells in each phase of the cell cycle. The experiment was then repeated 
under aseptic conditions with the exception that only three fractions were collected: pump 
speed 2 _ 3 for cells in G}' pump speed 3.75 - 4.75 for cells in S and pump speed 5.5 - 6.5 for 
cells in G2 (pump speeds are arbitrary units). The cells in each fraction were then spun, 
resuspended in fresh medium (DMEM:F-12 + 5% FCS), counted, and plated down in 
triplicate flasks. Non-ellutriated cells were used as a control. After 2 hours the culture 
supematant was harvested for virus titre measurements (this short culture period allowed the 
production of enough virus particles to be detected, whilst minimising the loss of cell cycle 
phase homogeneity during cell cycle progression). Cell samples were also fixed before and 
after the 2-hour culture period for cell cycle analysis, in order to confirm fractions contained 
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cells enriched for a particular phase of the cell cycle and to assess cell progression through 
the cell cycle during the 2-hour culture period. 
3.1.4.3 Effect of Demecolcine-Arrested Cell Growth on Vector Production 
Cells were inoculated into T-flasks, as before, and incubated for 4 hours to allow cell 
attachment. The medium in each flask was then replaced for fresh, with or without 100 nM 
Demecolcine. On days I and 2, the supematant from each well was sampled for vector titre 
measurements and the cells counted and fixed for cell cycle analysis on day 2. 
3.1.4.4 Effect of Glucose Concentration on Cell Growth and Vector Production 
In an attempt to compare cell growth rate with the virus productivity per cell, 
FL YRD 18/LNC-hB7 cells were cultured in a range of glucose concentrations. The glucose 
concentration in the DMEM:F-12 medium used in all other experiments is 3.5 glL. In this 
study, the packaging cells were cultured in medium containing 0, 0.5, 1.0, 2.0 or 3.0 glL 
glucose for up to 3 days and the cell number and virus titre measured on day 3. The virus 
titre was calculated per cell in order to account for varying cell yields in the different glucose 
concentrations. The cell growth rate (~) in each culture was also determined, using the 
specific rate formula given in Section 2.7 (Leelavatcharamas, 1997). 
3.1.5 Attachment of FLYRD18/LNC-hB7 Cells to Microcarriers 
The ability to attach FL YRD 18/LNC-hB7 cells to microcarriers and maintain cell viability 
was assessed. These studies were conducted using ImmobaSil-FSTM carriers (Ashby 
Scientific Ltd., U.K.) in Bellco™ spinner flasks (IOOml volume). Each spinner flask was 
coated with Sigmacote™ silicone solution (Sigma, U.K.) to prevent cell attachment to the 
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glass walls of these culture vessels. After rinsing in Sigmacote™, the vessels were left to dry 
before autoclaving at 121°C for IS minutes. 
Earlier studies (using an alternative cell line) revealed intermittent stirring, rather than 
continuous stirring, of the ImmobaSil-FSTM microcarriers allowed a greater percentage of 
cells to attach to these carriers. This method was therefore used in the following studies. A 
sample of carriers (Sml settled volume) was added to each spinner flask with SOml PBS and 
the whole system sterilised in an autoclave at 121°C for IS minutes. The sterile carriers in 
each flask were then rinsed in culture medium before adding 30 x 10
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FLYRDI8/LNC-hB7 
cells in SOml fresh culture medium (to give a final cell density of 6 x 105 cells/ml). These 
cell suspensions were mixed with the carriers then left static at 37°C for up to S hours. 
During this attachment period, the cells and carriers were mixed for 30 seconds every 30 
minutes (so-called 'intermittent' agitation). A small sample of supernatant was removed 
from the spinner flasks every hour in order to determine the number of cells remaining in 
suspension (unattached cells). This data was used to estimate the number of cells attached to 
the carriers at each time point. 
An extra sample of ImmobaSil-FS™ carriers was soaked in foetal calf serum for 30 minutes 
at 370C before assessing the attachment of FLYRDI8/LNC-hB7 cells as described above. 
This study was conducted in order to determine whether the coating of ImmobaSil-FSTM 
carriers with serum components (such as fibronectin) could enhance the attachment rate of 
FL YRD 18/LNC-hB7 cells. 
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After 5 h, a sample of carriers was taken from each flask for an MTT assay, as described in 
Chapter 2. This data was used to estimate the number of cells attached to the carriers, in 
order to confirm that the loss of cells from suspension was due to attachment to the carriers. 
After the MTT assay was complete, the number of carriers in each sample was counted in 
order to determine the mean absorbance per carrier. This absorbance was converted to cell 
number, using the calibration curve shown in Figure 2.6 (Chapter 2). The total number of 
ImmobaSil-FSTM carriers in a settled volume of 5ml (added to each flask) is approximately 
6620. Therefore, in order to determine the total number of cells attached to the carriers after 
5 hours, the estimated number of cells per carrier was multiplied by 6620. 
3.1.6 Effect of Agitation on FL YRD18/LNC-hB7 Cell Cultures 
The above cell attachment procedure was repeated with non-treated ImmobaSil-FSTM carriers 
(using the same amount of carriers, cells and medium). After the 5h attachment period, the 
culture volume was made up to 100ml with DMEM:F-12 + 5% FCS and the cultures were 
stirred at 42 rpm. After overnight stirring of the cultures another MTT assay was performed 
on a sample of carriers, in order to ascertain whether the cells had remained viable on the 
beads during such culture conditions. 
Due to the inability to maintain cell viability on the ImmobaSil-FSTM carriers during stirring 
at 42 rpm, a study on the effects of agitation on FL YRD 18/LNC-hB7 cell cultures was 
conducted. A sample of ImmobaSil-FS™ carriers was inoculated with FL YRD 18/LNC-hB7 
cells as before and left static at 37°C overnight. The cell-seeded carriers were then spun at 
11 rpm and samples of the supernatant taken every 15 minutes for cell counting, in order to 
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determine whether cells detached from the carriers at this slow agitation speed. Samples of 
the inoculated carriers were also taken periodically for an MTT assay, in order to assess 
whether cells attached to the carriers remained viable during such agitation. The stir speed 
was progressively increased with periodic sampling of the supernatant (for cell counts) and 
carriers (for MTT assays). A control culture containing the same cell number per ml, 
without carriers, was stirred and sampled under identical conditions. 
In a further study, the ability of ImmobaSil-FSTM carriers to support FL YRD 18/LNC-hB7 
cell viability during non-agitated culture was assessed. This experiment was conducted in 
order to confirm whether the loss of cells attached to the carriers in stirred cultures was due 
to agitation effects or an adverse effect of the carriers themselves. ImmobaSil-FSTM carriers 
were once again inoculated with FLYRD18/LNC-hB7 cells as before, and cultured under 
static conditions overnight. The inoculated carriers were then divided into two vessels and 
one was returned to static culture while the other was stirred at 42 rpm. Both cultures were 
monitored for cell viability by sampling the carriers for an MTT assay. Where viable cells 
could be detected on the carriers, cultures were maintained for one week with replacement of 
the exhausted medium for fresh (50%) every 2 days. A sample of the culture supernatant 
was taken on Day 6 for measurement ofthe retroviral vector titre. 
3.1.7 Oxygen Uptake Rate of FL YRD18/LNC-hB7 Cells 
It is apparent from the above studies that large-scale culture ofFLYRD18/LNC-hB7 cells is 
likely to only be successful under conditions of low shear forces. For this reason, the 
suitability of a packed bed system (with low shear forces) for the production of retroviral 
vectors by the FLYRD18/LNC-hB7 cell line was investigated (Chapter 5). In order achieve 
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optimal cell growth in a packed bed system, the delivery of oxygen and various nutrients 
must be sufficient to support the required cell number. Hence the delivery of 
oxygen/nutrients in the packed bed should be compared to the uptake rates of these 
components by the cells to be cultured in this system. As part of this aim, the oxygen uptake 
rate (OUR) of FLYRDI8/LNC-hB7 cells was determined for cells attached to ImmobaSil-
GTM carriers (used to immobilise the cells in packed bed cultures) and cells in suspension 
(detached from tissue culture plastic by trypsin digestion). 
Oxygen uptake rates (OUR) of FL YRD18/B7 cells were measured using a respirometer 
(Digital Oxygen System Model 10, Ranks Brothers Ltd.) which incorporates a Clarke type 
electrode (platinum and silver chloride electrodes). Oxygen diffuses from the cell 
suspension across a thin Teflon membrane to the platinum electrode (Figure 3.1.7). 
A known number ofFLYRDI8/LNC-hB7 cells attached to ImmobaSil-GTM microcarriers, or 
in suspension, were placed in the chamber of the respirometer in 5ml DMEM:F-12 + 5% 
FCS. Samples were taken straight from incubation at 37°C and the chamber itself was 
maintained at 37°C by means of a water jacket re-circulating to a heated water-bath. 
Immediately before addition ofthe sample, the electrodes were calibrated. Saturated sodium 
citrate was used as a 'zero' reading and culture medium, warmed to 37°C and purged with 
air, was used to represent 100% dissolved oxygen. After addition of the sample, the drop in 
dissolved oxygen in the culture medium was traced with a chart recorder and the slope used 
to determine the OUR of the cells, as described below. Control slopes were obtained by 
adding 5ml of culture medium only to the chamber (warmed to 37°C and purged with air) 
and recording any drop in dissolved oxygen levels. 
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An accurate detennination of exact cell numbers attached to the ImmobaSil-GTM 
microcarriers is difficult. Therefore, in order to detennine the amount of oxygen consumed 
per cell per minute, cells were allowed to attach to the microcarriers for only 3 hours (with 
intennittent agitation) before measuring the OUR. This allowed the cell number to be 
estimated by the number of cells lost from suspension during the 3-hour inoculation period 
(during this time no significant increase in cell number is expected). As a control, cells were 
also inoculated onto tissue culture plastic and left for 3 hours before releasing and measuring 
the oxygen uptake rate. For this measurement the cell number could accurately be 
detennined by cell counts, hence the uptake rates from both groups could be compared to 
check that they were in the same order of magnitude. In addition, the OUR of cells cultured 
on tissue culture plastic for 2, 4 and 7 days was detennined in order to assess the variation in 
oxygen consumption over time in culture. This could not be perfonned with the cells 
attached to the micro carriers, due to the difficulty in detennining precise cell numbers, as 
mentioned previously. 
For each sample, readings were taken until the drop in dissolved oxygen level was observed 
to plateau. The slope was taken as the straightest part of the curve. As this straight line 
starts to level out, the oxygen concentration is considered to be below the 'critical oxygen 
concentration' where the OUR is reduced (Stanbury et al. 1995; Preissmann et aI., 1997), 
hence this part of the curve was not used to calculate the OUR. The gradient of the slope and 
that from medium only were determined and the 'medium-only gradient' subtracted from the 
'sample gradient' to give the actual drop in dissolved oxygen due to uptake by the cells. 
Where 0.2125 mmollL is assumed to be the saturated oxygen concentration in culture media 
(100% dissolved oxygen), the oxygen consumed (mollmllmin) could be detennined by 
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multiplying the percentage oxygen consumption per minute (slope) by 0.2125 mmollL. For 
a known cell number per ml, the oxygen uptake rate could be determined as mol/cell/min. 
An example ofthis calculation is given in Figure 3.1. 7. 
3.1.8 Stability of Vector Particles 
The activity of retrovirus particles is notoriously unstable. The loss of activity, that is, the 
loss of ability to infect target cells, has been shown to be temperature dependent (Lee et. al. 
1996; Kaptein et. al. 1997). The typical half-life of retrovirus particles at 37°C is 
approximately 8 hours, hence virus-containing supernatants in cultures of packaging cells 
must be harvested frequently in order to obtain the maximum yield. This leads to low titres 
of the harvested stocks. The half-life of retrovirus particles released by the FL YRD 18/LNC-
hB7 cell line was measured at various temperatures in order to (1) determine the optimal 
harvest time for 37°C cultures and (2) determine whether alternative culture temperatures or 
harvest techniques (e.g. harvest onto ice) could improve active retrovirus titres. 
Due to the instability of retroviral particles, long-term storage is usually carried out in liquid 
nitrogen or freezers at -80°C. The effects of freezing and subsequent thawing of retroviral 
vector stocks are likely to be detrimental to their activity. The activity loss with repeat 
freeze-thaw cycles was assessed in this section in order to determine whether stocks could be 
repeatedly frozen and thawed for research purposes. 
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3.1.8.1 Vector Half-life at Various Temperatures 
A stock of retrovirus-containing supernatant, harvested from a monolayer culture of 
FLYRDI8/LNC-hB7 cells (as described in Chapter 2), was passed through a 0.45J..lm filter 
and divided into lml samples. Replicate samples were stored at 37°C, 32°C or on ice for up 
to 72 hours. At various time points samples were removed from their respective storage 
conditions and frozen in liquid nitrogen. Control samples were placed in liquid nitrogen 
immediately after removal from culture and filtering. After all samples had been stored in 
liquid nitrogen for at least 24 h the active virus titre was measured simultaneously using the 
infection assay previously described in Chapter 2. 
3.1.8.2 Effect of Freeze-Thaw Cycles on Vector Stability 
A stock of virus-containing supernatant was collected from a monolayer culture of 
FLYRDI8/LNC-hB7 cells (established as described in Chapter 2). This supernatant was 
passed through a 0,45J..lm filter and divided into separate cryovials. One set of vials were 
placed in liquid nitrogen and kept under these conditions until analysed. The other set was 
frozen in liquid nitrogen overnight, then fully thawed before returning to liquid nitrogen 30 
minutes later. The next day both sets were thawed and the vector titre measured by an 
infection assay (described in Chapter 2). 
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For 5 x 105 cells/m!, and a decrease in dissolved oxygen from 80% to 40% over 56 minutes: 
Gradient = (0.80-0040) /56 = 7.143 x 10-3 per min 
Where gradient of medium only (control) is 1.5 x 10-3, the gradient due to cellular oxygen consumption is: 
7,143 X 10-3 _ 1.5 X 10-3 = 5.643 X 10-3 per min 
Assuming the saturated oxygen concentration of medium to be 0.2125 mmol/L, oxygen consumption rate is: 
(5.643 x 10-3) x 0.2125 = 1.199 x 10-3 mmol/minlL == 1.199 x 10-
9 
mol/minim! 
Divide by cell concentration to give OUR: 
1.199 x 10-9 mol/minlml + 5 x 105 cells/m! = 2.398 x 10-
15 
mol/cell/min 
Figure 3.1.7 
Schematic of respirometer used for measuring oxygen consumption of cells (not to scale) 
and an example of the calculation for determining OUR. 
75 
3.1.9 Reproducibility of Infection Assay 
The concentration of active vector particles in the culture supematant of FLYRDI8/LNC-
hB7 cell cultures is determined indirectly by the infection of target cells (as described in 
Chapter 2). The titre measured in such an infection assay is dependent upon a number of 
parameters and is prone to significant variation (as discussed in Chapter 1). The actual 
extent of this variation should be assessed before comparisons are made between the titres in 
various studies. Variation in the titre of a single batch of vector supematant was measured 
over several months, in order to assess both the inter-assay variation in titre and the effect of 
long-term storage in liquid nitrogen. 
A monolayer culture ofFLYRDI8/LNC-hB7 cells was established as described in Chapter 2. 
Once the cell monolayer reached confluence, the medium was replaced with fresh (50ml) 
and the cells incubated for a further 24h. The culture supematant was then removed, passed 
through a 0.45/-Lm filter and divided into fifty cryovials (lml per vial) which were stored in 
liquid nitrogen. In each subsequent infection assay that was performed, one of these vials 
was thawed and included in the set of samples for vector titre measurement. The results 
from this single batch of supematant allowed comparisons between assays. 
3.1.10 Determination of Transduction Efficiency of Vector Preparations 
A number of groups have reported a lack of correlation between the end point titre and 
transduction efficiency of retroviral vector preparations (Le Doux et aI., 1999; Forestell et 
aI., 1995). These findings are reviewed in Chapter 1. The typical transduction efficiency of 
retroviral vectors released by the FLYRDI8/LNC-hB7 cell line during monolayer culture 
was therefore determined. Such data can be used to assess the effects of different culture 
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conditions (e.g. in packed bed culture) on this parameter (in addition to end point titre 
measurements). 
The supernatant from monolayer cultures of FLYRD18/LNC-hB7 cells was collected and 
stored in liquid nitrogen before determination of the transduction efficiency (hereafter called 
'stored' samples). Alternatively, samples of supernatant were taken and measured 
immediately, without freezing (hereafter called 'fresh' samples). As described in Chapter 2, 
the transduction efficiency of vector preparations was determined by measuring the 
percentage of successfully transduced target cells, detected by labelling with an FITC-
conjugated anti-human B7 antibody. Target cells were exposed to 'fresh' or 'stored' vector 
preparations from monolayer cultures for 8 hours and cultured for a further 40 hours before 
labelling with antibody (method described in detail in section 2.4). The end point titre of the 
stored sample was also determined by an infection assay (described in section 2.3). 
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3.2 Results 
3.2.1 Batch Culture of FL YRD18/LNC-hB7 Cells 
Cell numbers increased in monolayer batch culture until day 7, after which a gradual 
decrease in cell number was observed. The percentage viability remained at 100% for the 
first 2 days and then decreased daily, dropping to 69% by day 10. The growth curve of this 
typical batch culture is illustrated in Figure 3.2.1.1. 
The glucose consumption of FL YRD 18/LNC-hB7 cells in batch culture was surprisingly 
low. The glucose concentration in the spent medium only dropped from 14 mmol/L to 10 
mmol/L over 10.5 days. Significant lactate production was only evident for the first 2 days 
of culture. The mean daily glucose and lactate concentrations in the supematant are shown 
in Figure 3.2.1.2. 
Cell cycle analysis revealed a change in distribution of cells in G1 (Gap 1), S (Synthetic) and 
G2 (Gap2) phases of the cell cycle with time in batch culture (Figure 3.2.1.3). That is, the 
percentage of cells in the S-phase decreased with time and accumulation in the G1-phase was 
observed. This is typical for cell growth arrest in batch culture, due to serum and nutrient 
deprivation (Schliermann et aI., 1987; Ray et aI., 1989; Adams, 1990; AI-Rubeai et aI., 
1991; Lloyd and AI-Rubeai, 1999; Holmes and AI-Rubeai, 2000). 
Mean daily vector titres, like the cell numbers, increased until day 7 and then decreased 
(Figure 3.2.1.4). This increase in vector titre from day 1 through to day 7 was greater than 
the increase in cell number between these two time points. The mean vector titre per cell 
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was calculated by dividing the daily vector titre by the corresponding cell number. These 
values increased from 8.6 x 10-3 cfu/cell on day 2 to 2.1 X 10-2 cfu/cell on day 7. 
3.2.2 Effect of 'Conditioned' Medium on Vector Production 
Exposure of FLYRD18/LNC-hB7 cell cultures to 'conditioned' (spent) medium for 24h 
caused a significant decrease in vector titre, compared to cultures in fresh medium. Medium 
that was conditioned for longer periods (three or more days) had a greater negative effect on 
vector titre than medium conditioned for 1 or 2 days. Figure 3.2.2. illustrates the decrease in 
vector titre with increasing 'age' of the spent medium. 
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Figure 3.2.1.1 
Mean cell number per ml and percentage viability during a 10-day batch culture of 
FL YRD 18/LNC-hB7 cells in monolayer. Error bars represent observed range, n=2. 
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Figure 3.2.1.3 
Cell cycle distribution of FL YRD 18/LNC-hB7 cells over 10-day batch culture. 
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Figure 3.2.1.4 
Mean daily vector titres during lO-day batch cultures of FLYRD18/LNC-hB7 cells III 
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3.2.3 Re-selection of Vector-Producing Cells 
The presence of G418 had a dose-dependent negative effect on the total cell yield in 
monolayer cultures of FL YRD 18/LNC-hB7 cells. After 7 days, the mean total cell number 
in 0.25, 0.50 and 0.75 mg/ml G418 was 7.73 x 106, 6.90 x 106, 6.37 x 106, respectively. In 
the absence ofG418 the mean total cell number on Day 7 was 8.16 x 106• The reduced cell 
numbers in the presence ofG418 indicate either a reduced cell growth rate in the presence of 
G418 or the death of a small proportion of cells lacking the neomycin resistance gene. 
In contrast, the mean vector titre increased in the presence of 0.50 and 0.75 mg/ml G418 (but 
titres were slightly reduced in the presence of 0.25 mg/ml G418). The mean vector titre per 
cell was calculated by dividing each vector titre by the corresponding cell numbers at each 
concentration of G418. The vector titre per cell in increasing concentrations of G418, 
compared to that measured in the absence ofG418, is plotted in Figure 3.2.3. In the higher 
concentrations of G418, the cell specific vector titre (cfu/cell) was significantly increased. 
This data suggests that the reduced cell number in the presence of G418 is likely to be a 
result of the death of cells without the neomycin resistance gene, rather than reduced cell 
growth rates (since vector productivity is increased). The cultures in 0.50 and 0.75 mg/ml 
G418 probably show a greater vector titre per cell due to the selection of cells containing the 
vector. 
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3.2.4 Relationship between Cell Proliferation, Cell Cycle Phase and Vector 
Production 
3.2.4.1 Effect of Thymidine-Arrested Cell Growth on Vector Production 
High concentrations of thymidine (4mM) were shown to arrest cell proliferation and reduce 
virus production over a 3-day culture period (Figure 3.2.4.lA). Furthermore, the virus titre 
per cell decreased with increasing thymidine concentration (0.5 - 4 mM) during overnight 
culture, where cell numbers at the time of sampling were not significantly different between 
each sample (Figure 3.2.4.1B). This data suggests a relationship between cell proliferation 
and virus production by the FL YRD 18/LNC-hB7 cell line. It should be noted that the 
concentrations of thymidine used may not result in complete arrest of the cells as it has been 
reported that between 5 and 10mM may be required to completely arrest the growth of some 
cell types (Adams, 1990). Hence some virus production is still observed in the thymidine-
arrested cultures, but at significantly reduced levels. 
Flow cytometric analysis of each culture showed an accompanying decrease in percentage of 
cells in the S-phase, (Figure 3.2.4.1 C). This is expected, as high concentrations of thymidine 
inhibit DNA synthesis and hence entry into the S-phase, thereby arresting cells at the Gj/S 
boundary (Fantes and Brooks, 1993). The relationship between cell cycle phase and vector 
production was therefore investigated in order to determine whether the decreased titres in 
the presence of thymidine were due to the altered cell cycle distribution, or reduced cell 
proliferation rates. 
3.2.4.2 Relationship between Cell cycle Phase and Vector Production 
To ensure that virus titres could be measured after a few hours culture, using the cell 
concentrations employed in this study, a set of preliminary cultures were set up and the 
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supernatant sampled 2, 4, 6 and 8h after inoculation of cells in the plates. In addition, a 
sample of supernatant from the same batch of freshly suspended cells was taken prior to 
inoculation, to use as a 0 h sample (at the same cell concentration as those inoculated onto 
plates). Figure 3.2.4.2A shows that titres were indeed measurable after just 2 h in culture 
(titres increased from 2 to 8 h post-inoculation). Since no virus was found in the sample not 
inoculated onto plates (0 h sample), this confirmed that the values for the 2-Sh time points 
were due to new virus production in these cultures and not residual virus from the previous 
passage. In addition, the cell cycle distribution before and after culture for 2, 4, 6 and 8 
hours was assessed by flow cytometry. Figure 3.2.4.2B shows that the cell cycle distribution 
did not change significantly for the first eight hours after inoculation. During the first four 
hours, a small increase in the percentage of S-phase and a small decrease in the percentage of 
G)-phase cells was observed, i.e. the cells did not arrest and accumulate in G) for the first 6 
hours of culture, as observed by Andreadis et aI., (1997). Here we show no such 
perturbation of cell cycle progression in the FLYRDI8/LNC-hB7 cell line as a result of cell 
detachment. This data showed that culture supernatants could be taken for virus 
measurements after 2 hours culture. 
Centrifugal elutriation was used to separate cells m different phases of the cell cycle. 
Figures 3.2.4.2C and 3.2.4.2D illustrate the cell diameter and cell cycle distribution, 
respectively, in sixteen fractions collected from the centrifugal elutriator with increasing 
pump speeds. As expected, the mean size of eluted cells increased with increasing pump 
speed. Cell cycle analysis confirmed that cells predominantly in G) were eluted at the lower 
pump speeds, while mainly cells in G2/M were eluted at the higher pump speeds. Cells in 
the S-phase were eluted in between these two ranges. From this data the optimal pump 
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speeds for eluting cell fractions enriched for G1, Sand G2iM were detennined (namely 2-3, 
3.5-4.5 and 5.5-6.5, respectively). After collecting cells at these three pump speeds, the cell 
cycle distribution was again detennined by flow cytometry. The cells from each fraction 
were then cultured for 2h at identical concentrations, as previously described, before 
collecting the supematant and releasing the cells to once again detennine the cell cycle 
distribution. The cell cycle distributions for each of these three fractions (before and after 2 
hours' culture) are given in Table 3.2.4.2. Figure 3.2.4.2E shows no significant difference in 
the vector titre taken from cell cycle enriched cultures two hours after inoculation. This data 
suggests that there is in fact no correlation between cell cycle phase and virus production. If, 
for example, virus particles were produced predominantly in the S-phase (and virus 
production was negligible in the Gl-phase), a 2-fold increase in virus titre would be expected 
in the culture from Fraction 2 (43% cells in S-phase), compared to Fraction 1 (22% cells in 
S-phase). 
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Figure 3.2.4.1 B 
Vector titres per cell and cell cycle distribution after 24h incubation of FL YRD 18/LNC-hB7 
cells in increasing thymidine concentrations. Error bars represent observed range, n=3. 
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Before 2h culture: After 2h culture: 
Fraction %G1 %8 %G2/M %Gl %8 %G2/M 
Number 
1 75 21.8 3.3 81.2 17.9 0.9 
2 44.2 43.2 13.6 35.9 38.1 26 
3 46 22.5 31.4 18.3 20.8 60.9 
Table 3.2.4.2 
Cell-cycle distribution of cell fractions collected from centrifugal elutriator (measured by 
flow cytometry), before and after 2-h culture period. Fractions 1,2 and 3 were enriched for 
cells in Gl, 8 and Gz/M respectively. Bold figures indicate percentage of cells in phase for 
which fraction was enriched. 
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3.2.4.2 Effect of Demecolcine-Arrested Cell Growth on Vector Production 
Demecolcine was chosen as an agent to arrest cell proliferation via a different mechanism to 
that of thymidine. This agent inhibits spindle fibre formation, thereby arresting cells in the 
mitotic phase (M-phase). FLYRD18/LNC-hB7 cells were cultured overnight with or without 
100 nM Demecolcine and the vector production and cell cycle distributions were compared. 
The cell cycle distributions (Figure 3.2.4.3A) clearly show an accumulation of cells in G2/M 
in the presence of Demeco1cine (approximately 30% cells in G2/M in the absence of 
Demecolcine and over 70% in 100nM Demecolcine), confirming the arrest of cells in the 
presence of this agent. Cell viability remained above 80% in all cultures. Figure 3.2.4.3B 
shows a decrease in daily virus titres when the cells are arrested in Demeco1cine. Virus titres 
were also calculated per cell, as cell numbers were lower in the Demecolcine cultures due to 
cell growth arrest (5 x 105 cells with Demeco1cine, 28 x 105 cells without). The cell specific 
titres were significantly reduced in the presence of Demecolcine (Figure 3.2.4.3C), further 
suggesting a correlation between cell proliferation and virus production. It should be noted 
that flow cytometry cannot distinguish between cells in G2 and cells in M, as both possess 
duplicate amounts of DNA. Therefore, not all the cells in G2/M peak will be arrested after 
Demecolcine addition, only those which have reached metaphase. Furthermore, cells in M 
that have reached anaphase or beyond, at the time of Demecolcine addition, will continue to 
pass through the cell cycle. In addition, those cells in G j and S (approximately 30%) are not 
immediately arrested by Demecolcine addition. For all these reasons, a significant amount 
of vector per cell was measured in the Demecolcine-arrested cultures. However, the titre per 
cell is significantly reduced compared to the non-arrested cultures, indicating little or no 
vector production by the non-cycling cells. 
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3.2.4.3 Effect of Glucose Concentration on Cell growth and Vector Production 
In an attempt to compare cell growth rate with the vector productivity, FLYRD18/LNC-hB7 
cells were cultured in a range of glucose concentrations (0.5-3.0 glL). A frequently 
employed method for the manipulation of cell growth rates is the use of increasing serum 
concentrations. However, it has been demonstrated that serum has a dose-dependent 
negative effect on vector titre in FLYRD18/LNC-hB7 cell cultures (Gerin et al. 1999a), 
therefore this method is not suitable for such studies using these cells. 
Above 19lL glucose, the cell growth rate and virus titre per cell was not significantly 
different, indicating that glucose levels above IglL are in excess of the requirements of these 
cells at the densities used. From 0 to 1 glL glucose the cell numbers increased and were 
accompanied by a significant increase in vector titre per cell (Figure 3.2.4.4). Hence, 
increased glucose concentrations increased both the cell growth rate ()l) and virus 
productivity, within this range. 
• 
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3.2.5 Attachment of FL YRD18/LNC-hB7 Cells to Microcarriers 
During intermittent agitation of FLYRD18/LNC-hB7 cells with ImmobaSil-FSTM 
microcarriers, over 80% of the cells in suspension were estimated to be attached to the 
carriers after 1 hour. After 5 hours, counts of the cells left in suspension indicated over 95% 
of the cells were attached to the micro carriers (Figure 3.2.5). No significant difference in 
cell attachment rate or the percentage of cells attached was observed between carriers coated 
in serum and non-treated carriers. The reduction of cell number in suspension with time , 
during incubation with the serum-coated and non-treated carriers is shown in Figure 3.2.5. 
An MTT assay was conducted on a sample of carriers from each flask, 5 hours post-seed. 
This data was used to estimate the total number of cells attached to the carriers (to confirm 
that the reduced cell number in suspension was due to attachment of the cells to the carriers). 
It should be noted, as discussed in Chapter 2, that the conversion of MTT to the coloured 
formazan product is dependent on the mitochondrial content of the cells (and hence the 
cellular metabolic activity). For this reason, the use of the calibration curve to convert 
absorbance (concentration of formazan) to cell number may not always provide accurate cell 
numbers. For instance, the metabolic activity of cells recently attached to microcarriers 
could be different to that of the cells used to construct the calibration curve. Hence the data 
given by this assay can only be used to confirm that the majority of cells lost from 
suspension had attached to the carriers and not as a measure of absolute cell number on the 
carriers. 
The approximate total cell number attached to the non-treated and serum-coated carriers was 
estimated to be 24.75 x 106 and 27.30 x 106 respectively, using the MTT assay. The 
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calculation ofthese figures, as described in section 2.6, is outlined in Table 3.2.5. Since 95% 
of the cells were lost from suspension in both samples after 5 hours, the estimated number of 
cells attached to the carriers, using cell counts, is 28.5 x 106, which correlates well with the 
MTT data. 
Table 3.2.5 
Abs 
(570nm) Abs Conversion to cell number 
Sample 5h post-seed per carrier (using calibration curve, Figure 2.6) 
Non-treated 0.07 2.59 x 10'3 3.7 X 10
3 
(27 carriers) 
Serum-treated 0.198 4.95 x 10,3 4.1 X 10
3 
(40 carriers) 
3.2.6 Effect of Agitation of FL YRD18/LNC-hB7 Cell Cultures 
x 6620 carriers: 
total number of 
attached cells 
24.75 X 106 
27.30 X 106 
After overnight stirring of ImmobaSil-FSTM carriers seeded with FLYRDI8/LNC-hB7 cells 
at 42rpm, an MTT assay failed to reveal the presence of any viable cells attached to the 
carriers. Likewise, no cells (viable or dead) were detected in the supernatant after overnight 
stirring of the cultures. 
A study on the effects of agitation on the survival of FL YRD 18/LNC-hB7 cells attached to 
ImmobaSil-FSTM carriers revealed a loss of cell viability on the carriers with increasing stir 
speeds. After 1 hour at 11 rpm no cells were released into the supernatant (as determined by 
cells counts of the supernatant every 15 minutes). Neither did the conversion of MTT to 
formazan appear to be affected, indicating the presence of viable cells still attached to the 
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carriers. At 11 rpm the carriers were not completely suspended, but the medium above was 
mixed. The agitation rate was therefore increased to 24 rpm. After 1.5 hours at this speed, 
no cells were released into the supernatant and again the MTT conversion by cells attached 
to the carriers appeared unaffected. The stir speed was then increased to 38 rpm. Once 
again no cells were released into the supernatant, even after 3.5 hours at this speed. 
However after just 1.5 hours at 38 rpm, a lack of MTT conversion was observed on some of 
the carriers sampled. After 3.5 hours at this speed, only 3 out of the 17 carriers sampled 
showed any signs of MTT conversion to coloured formazan. The stir speed of 38rpm is 
similar to that believed to have caused cell death due to agitation in the previous experiment. 
The agitation was therefore maintained at this level overnight and samples taken the 
following day, by which time no MTT conversion could be detected in any of the carriers 
sampled. 
The control suspension culture (no carriers) was stirred at the same speeds and for the same 
periods as the ImmobaSil-FSTM culture. During the progressive increases in agitation rate, 
the cell viability remained above 90%, however the cell number reduced by approximately 
50%. This finding suggests that cells may have been lost from culture due to bursting. After 
overnight agitation at 38 rpm the cell viability was reduced to only 27%. These results 
demonstrate the inability of this cell line to survive in stirred suspension culture. Table 
3.2.6.1 summarises the above findings. 
A comparison of stirred and static cultures of FLYRDI8/LNC-hB7 cells attached to 
ImmobaSil-FSTM carriers revealed a dramatic difference in cell survival. After 24 hours 
stirring at 42rpm, the inoculated carriers failed to show any conversion of MTT to formazan, 
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indicating the absence of viable cells on these carriers. Hence, as observed previously, the 
attached cells were assumed to have died due to the effects of agitation. This culture was 
therefore discarded. In contrast, the inoculated carriers cultured in static conditions showed 
a good MTT response after the same period of culture, which corresponded to approximately 
8 x 103 cells per carrier. This culture was therefore maintained for one week with 
replacement of the exhausted medium (50%) for fresh every 2 days. Table 3.2.6.2 shows the 
MTT data from carrier samples during this culture period. 
An infection assay of the culture supematant on day 6 revealed a titre of 8.1 x 103 cfu/ml, 
demonstrating the ability of the FL YRD 18/LNC-hB7 cells to produce retroviral vectors 
when cultured on ImmobaSil-FSTM carriers. 
107 
7.00E+OS -r-------------------~ 
'2 
.Q 
Vl 
c:: 
a. 
_ Vl 
E ::l 
...... Vl 
.!!l c:: ID .0, 
U c:: 
·c 
.(ij 
E g 
6.00E+OS 
S.OOE+OS 
4.00E+OS 
3.00E+OS 
2.00E+OS 
1.00E+OS 
-+-- fin non-treated 
••• El- " Irrm pre-treated 
with FCS 
........ 
......... 
O.OOE+OO -1-------+-------+-------1 
o 3 S 
hours post-seed 
Figure 3.2.5 
Attachment ofFLYRD18/LNC-hB7 cells to ImmobaSil-FSTM carriers (serum-coated or non-
treated) as indicated by a reduction in the number of suspended cells with time. Cells and 
carriers were incubated at 37°C and mixed intermittently (every 30 minutes). Error bars 
represent observed range, n=4. 
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ImmobaSiI-FS™ 
Suspension culture 
culture 
Stir speed/ time Cells in Conversion of 
Cell number Cell viability 
supernatant MTTto (x 10
5) (%) 
formazan 
(in carriers) 
Start of culture None 
yes 0.56 100 
1 I rpm, 0.25h None 
n.d. 0.43 lOO 
I I rpm, 0.75h None 
Yes 0.50 lOO 
I I rpm, Ih 
24rpm, O.5h None 
Yes 0.36 96.9 
I I rpm, Ih 
24rpm, Ih None 
Yes 0.29 96 
1 I rpm, Ih 
_24rpm, 1.5h None 
n.d. 0.42 lOO 
I I rpm, Ih 
24rpm, 1.5h None 
Yes 0.30 lOO 
38rpm,0.5h 
I I rpm, Ih 
24rpm, 1.5h None 
n.d. 0.38 91 
38rpm,lh 
llrpm, Ih 
24rpm, l.5h None 
Yes (but not all 0.40 94.4 
carriers) 
38rpm, 1.5h 
llrpm, Ih 
24rpm, 1.5h None 
Yes (but not all 0.33 90 
carriers 
38rpm, 2.5h 
1 I rpm, Ih 
24rpm, 1.5h None 
Only 3 out of 17 0.26 91 
carriers 
38rpm, 3.5h 
llrpm, Ih 
24rpm, 1.5h None 
No 0.24 27 
3~rpm, overnight 
Table 3.2.6.1 
Stirred cultures of FL YRD 18/LNC-hB7 cells attached to ImmobaSil-FSTM carriers or in 
suspension. Effect of increasing stir speeds on cell number and viability. (n.d. not done). 
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Day Number of carriers Absorbance (after Estimated number of cells per carrier 
in sample culture with MTT) (using calibration curve, Fig 2.6) 
1 16 0.123 7.97 x 10
3 
2 13 0.102 8.99 x 10
3 
5 40 0.255 4.84 x 10
3 
7 23 0.205 7.32 x 10
3 
Table 3.2.6.2 
Survival of FLYRD18/LNC-hB7 cells (as indicated by an MTT assay of sample carriers) 
during static culture on ImmobaSil-FS™ carriers. 
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3.2.7 Oxygen Uptake Rate of FL YRD18/LNC-hB7 Cells 
The oxygen uptake rate (OUR) of FLYRD I 8/LNC-hB7 cells in suspension (immediately 
after detachment from tissue culture plastic) was higher at 3 hours post-seed than at 2 days 
post-seed, (possibly the result of high oxygen demands during cell attachment). The OUR 
was observed to increase from day 2 to day 4 when cells were in the exponential phase of 
growth and decrease by day 7 (as cells reached late exponentiaVstationary phase). The OUR 
of cells attached to ImmobaSil-GTM microcarriers 3 hours post-seed was lower than that of 
the suspended cells (released from tissue culture plastic after the same culture period). Table 
3.2.7 shows the OUR ofFLYRDI8/LNC-hB7 cells measured in each of these conditions. 
3.2.8 Stability of Vector Particles 
3.2.8.1 Vector Half-life at Various Temperatures 
As expected, the decay rate of vector activity decreased with decreasing storage temperature. 
The active virus titre, for samples stored at O°C, 32°C and 37°C, was plotted against time 
(see Figure 3.2.8.1). An exponential curve fit was used to detennine the half-life of the 
active virus particles at each temperature. At 37°C, 32°C and on ice the half-life of the 
active retrovirus particles was calculated to be 6.9h, II.Oh and 64.3h respectively. 
3.2.8.2 Effect of Freeze-Thaw cycle on Vector Stability 
A slight drop in active virus titre was measured in the samples which underwent two freeze-
thaw cycles, as compared to the samples from one freeze-thaw cycle, though this difference 
Was not statistically significant (see Figure 3.2.8.2). 
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Oxygen Uptake Rate (moVceIVmin) x 10-15: 
Time (post seed) Suspended Attached to 
ImmobaSiI-GTM 
carriers 
3h 3.40 1.55 
2 days 0.75 n.d. 
4 days 5.20 n.d. 
7 days 2.00 n.d. 
Table 3.2.7 
Oxygen uptake rate of FLYRD18/LNC-hB7 cells attached to ImmobaSil-GTM carriers or 
released into suspension after culture on tissue culture grade plastic. 
(n.d., not done). 
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Figure 3.2.8.1 
Active vector titre after incubation at 37°C, 32°C or on ice for up to 73 hours. Error bars 
represent observed range, n=2. 
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3.2.9 Reproducibility of Infection Assay 
A single batch of vector-containing supematant was prepared and divided into lml aliquots, 
which were stored in liquid nitrogen. Figure 3.2.9 shows the vector titre in this supematant 
measured in sixteen separate infection assays, over a 9-month period. The titre varied up to 
2.S-fold, however, no decrease in titre with storage time in liquid nitrogen was observed. 
3.2.10 Determination of Transduction Efficiency of Vector Particles 
The transduction efficiency of retroviral vectors in the supematant of FL YRD 18/LNC-hB7 
cell monolayer cultures was determined by labelling vector-infected target cells with FITC-
conjugated anti-human B7 antibody. The distribution of fluorescence intensity of these cells, 
compared to target cells not exposed to the vector preparation, is shown in Figure 3.2.10 
(using 'fresh' and 'stored' vector preparations). For both samples, the fluorescence intensity 
increased in nearly all the cells exposed to vectors, compared to control cultures not exposed 
to vectors. This finding demonstrates the high transduction efficiency of retroviral vectors 
released by FLYRDI8/LNC-hB7 cells cultured in monolayer at 37°C. The end point titre of 
the 'stored' sample, as measured by an infection assay, was 1 x 105 cfulml. 
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Figure 3.2.9 
Vector titre in a single batch of supematant measured in sixteen separate assays. The storage 
period of each sample, in liquid nitrogen, is indicated on the x-axis. 
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Figure 3.2.10 
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Distribution of fluorescence intensity of A2780cp cells labelled with FITC-conjugated anti-
human B7 antibody (measured by flow cytometry). Comparison between cells exposed to 
' fresh ' or ' stored' vector preparations for 8 h and then cultured for 48 h (thick solid line and 
thin solid line respectively), and control cultures not exposed to vector (dotted line). 
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3.3 Discussion 
Batch Culture of FL YRD18/LNC-hB7 Cells and Effects of Conditioned Medium 
Batch culture of the FLYRDI8/LNC-hB7 cells revealed how these cells respond to 
decreasing nutrient concentrations and increasing levels of metabolic by-products. As 
expected, cell numbers increased for a number of days before decreasing, with a concomitant 
decrease in percentage cell viability. Figure 3.2.1.3 shows a decrease in the percentage of 
cells in the S-phase and an accumulation of cells in GJ, which is typical for batch cultures 
where serum and nutrient deprivation causes cell growth arrest (Schliermann et aI., 1987; 
Ray et aI., 1989; Adams, 1990; Al-Rubeai et aI., 1991; Lloyd and Al-Rubeai, 1999; Holmes 
and AI-Rubeai, 2000). Surprisingly, this occurred after only 3 days in culture. Glucose 
levels were not limiting at this time point and lactate concentrations had not reached toxic 
levels, hence another factor, or factors, may have limited cell growth at this stage. 
Microscopic observations revealed the establishment of a confluent monolayer by day 2, 
hence available surface area may be a limiting factor for cell growth in these cultures after 
this time point. However medium components not measured, such as glutamine 
concentration, cannot be ruled out as contributory factors in reducing cell growth and 
survival. 
The oxidation of glutamine to C02 is an essential source of energy for cells in culture. 
Zielke et aI., (1984) reported that this oxidation of glutamine provides 30-50% of the cells' 
energy source, in the presence of sufficient glucose. However, as glucose concentrations 
decrease, the rate of glutamine oxidation increases. Over the 10-day batch culture, increased 
glutamine consumption rates, along with its decomposition (glutamine also decomposes at 
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37°C, with a loss of approximately 2-3% per day), may have caused glutamine levels to 
become limiting. 
Vector titres followed the same trend as cell growth. Interestingly, the cell specific titres 
(cfu/cell) also increased from day 2 to day 7. This increase in vector titre per cell is not 
likely to be due to accumulation of vectors in the supematant, due to the short half-life of 
these vector particles at 37°C (determined to be 6.9h, see 3.2.8). It was hypothesised that the 
increased cell specific vector titre may be due to a change in the composition of the medium, 
during culture with the FLYRD18/LNC-hB7 cells. During batch culture, factors may be 
released by the cells themselves, which have a stimulatory effect on vector production. An 
increase in concentration of these factors during the 10-day culture period could explain the 
increasing cell specific vector titre from days 2 - 7. 
This hypothesis of 'cell-conditioned' medium was tested in a further study where cells were 
cultured in such medium for 24h. In order to avoid the inclusion of active vector particles in 
the cell-conditioned medium, the FLYRD18 parent cell line, which only releases 'empty' 
particles, was used to prepare the cell-conditioned medium. Results showed a negative 
effect of cell-conditioned medium on vector titre. Furthermore, the length of time the 
medium was exposed to the FLYRD18 cells (during conditioning) correlated with the 
reduction in vector titre. This data suggests that medium conditioning during batch culture 
of the FL YRD 18/LNC-hB7 cells was not the cause of the increased cell specific vector titres. 
The decrease in vector titre in the presence of 'cell-conditioned' medium is likely to be due 
to depletion of nutrients and/or increased metabolic by-product concentrations in the medium 
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(during previous culture with the parental cell line). The FL YRD 18 parental cell line also 
produces a large number of 'empty' particles, which may compete with the active vector 
particles during infection of the target cells. Inhibition of active particle infection by such 
empty particles would lead to a decrease in measured vector titre. Hence this may also 
explain the decrease in vector titre with increasing 'age' of the conditioned medium. A more 
suitable cell line for production of the cell-conditioned medium may have been the human 
fibrosarcoma cell line, HTI080, from which the FL YRD 18 cell line was constructed. 
HTI080 cells do not contain any proviral sequences and hence do not produce empty 
particles. 
A more probable explanation for the increasing vector titre per cell observed during the first 
few days of batch culture, is the higher cell growth rate during this exponential phase of 
growth. Where cells are in the exponential phase of growth, their physiological state is at an 
optimum (including mitochondrial activity). This may result in increased vector production 
rates. Indeed, a study of the relationship between cell proliferation and vector titre (section 
3.1.4) indicated vector production to be related to cell proliferation. 
The increasing cell density during batch culture could also affect cell specific vector titre. 
When the cells became more tightly packed (as they reached confluence) their morphology 
changed from an elongated, bipolar shape to a more polygonal shape. A relationship 
between cell morphology and cell function/physiology has been reported for a number of cell 
lines (Curtis, 1997; Tighe, 1994; Folkman and Moscona, 1978). Furthermore, Lee et al. 
(1996) reported an optimal retroviral vector production by \}'CRIP cells only after a 
confluent monolayer of cells was established. 
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The degradation of factors in the culture medium, which may inhibit virus production, could 
also play a role in the increasing cell specific vector titre during batch culture of 
FL YRDI8/LNC-hB7 cells. Studies in Chapter 4 and those by Gerin et al. (I999a) show FCS 
to have a dose-dependent negative effect on the vector titre of FL YRD 18/B7 cell cultures 
during early time points. However, after prolonged culture at 37°C this inhibition is lost. 
Hence during a I a-day batch culture it is possible that such inhibitory factors in the serum 
are gradually degraded, thus eliciting a daily increase in virus production per cell until all 
such factors are degraded. 
If the above hypothesis were true, it would be expected that the 'la-day old' cell-conditioned 
medium used in this study would contain the lowest concentration of inhibitory factors and 
hence yield the highest virus titres (which was not the case). However, if increased 
concentrations of 'empty' particles in the conditioned medium do indeed reduce the 
measured virus titres, such benefits oflow serum inhibitor concentrations may be masked. 
'Re-Selection' of FL YRD18/LNC-hB7 Cells in G418 
It was found that the incubation of FL YRDI8/LNC-hB7 cells in Geneticin-containing 
medium could significantly increase the cell specific vector titre, compared to cultures 
without Geneticin. This data suggests that some of the FLYRD18/LNC-hB7 cells in our 
cultures did not contain the retroviral vector carrying the neomycin resistance gene and that 
culture in Geneticin for one week caused the death of these cells. The presence of cells 
without this vector can explain the apparently lower vector titre per cell before culture in 
Geneticin-containing medium. During construction of the FL YRD 18/LNC-hB7 cell line, 
those cells possessing the retroviral vector were selected for in G418-containing medium. 
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However, it is possible that during multiple passages, this vector is lost from a small 
proportion of these cells. It is therefore recommended that these cells are periodically 're-
selected' in Geneticin in order to ensure all cells in the population contain the retroviral 
vector. 
Relationship between Cell Proliferation, Cell Cycle Phase and Vector Production 
A common method for arresting cell growth is serum deprivation (Adams, 1990). However, 
it has been clearly demonstrated that serum has a dose-dependent negative effect on the virus 
titre in FLYRD18/LNC-hB7 cell cultures (Gerin et aI., 1999a). Therefore, serum deprivation 
was deemed to be unsuitable for determining the effect of cell proliferation of this packaging 
cell line on virus production. For this reason, alternative methods for inhibiting or reducing 
cell growth were adopted. However, it is recognised that each method may also have 
secondary effects that could alter virus production rates. Therefore a range of methods, 
normally used for studies of cell cycle synchronisation and arrest, were employed. These 
methods all affect the cell proliferation rate/progression through the cell cycle via different 
mechanisms. This allowed discrimination between direct effects of cell proliferation and 
secondary effects of the inhibitors. 
Cell specific vector titres in thymidine-arrested cultures were significantly reduced, 
compared to non-arrested cultures of FL YRD 18/LNC-hB7 cells. This finding indicates a 
relationship between cell proliferation and vector production. However the decrease in 
vector titre was accompanied by a decrease in the percentage of cells in the S-phase of the 
cell cycle. This is because thymidine inhibits DNA synthesis, thereby inhibiting cell entry 
into the S-phase. At the time of this experiment, the effect of cell cycle phase on vector 
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production was unknown. Therefore, it could not be ruled out that the reduced vector 
production was due to a reduced percentage of cells in the S-phase, rather than reduced cell 
proliferation rates (if in fact virus production occurred predominantly during the S-phase 
rather than the Gr or G2/M phases). In order to ascertain which factors were primarily 
responsible for the decrease in virus production, the effects of cell cycle phase on virus 
production were assessed using centrifugal elutriation to separate cells in different phases of 
the cell cycle. 
Centrifugal elutriation has been shown to have little or no secondary effects on cell 
productivity, hence this method was most suitable for determination of the effects of cell 
cycle phase on virus production (Adams, 1990; Holmes and Al-Rubeai, 2000). The 
centrifugal elutriator consists of a chamber in which cells of the same size or density are held 
in position when their velocity is counterbalanced by a medium flowing in the opposite 
direction. When this medium flow is increased (by increasing the pump speed), cells are 
eluted from the chamber, the size of the eluted cells increasing with increasing pump speed. 
Hence cells are separated by size (where their density remains constant), which in turn is 
related to their DNA content. The DNA content per cell changes according to their position 
in the cell cycle (e.g. cells in Gr are nearly half the size and possess half the total DNA of 
cells in G
2
). While other chemical methods exist (Adams, 1990; Fantes and Brooks, 1993; 
Holmes and Al-Rubeai, 2000), this physical method was chosen in order to avoid any 
adverse conditions which may perturb subsequent cell cycle progression. If cell proliferation 
is indeed essential for virus production, it is important to maintain progression through the 
cell cycle in order to measure the virus titre in each separated cell fraction. Centrifugal 
elutriation also avoids a number of artefacts possible with chemical methods for cell 
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synchronisation. For example, nutrient deprivation or the addition of cytomodulators can 
lead to unbalanced cell growth (Holmes and AI-Rubeai, 2000), the consequences of which 
on virus production are unknown. Furthermore, cell fractions separated by centrifugal 
elutriation are produced at the same time and hence can be plated down together and grown 
in synchrony for easy comparisons. 
Cell fractions enriched for a particular cell cycle phase can lose synchrony within a few 
hours. Therefore, in order to measure virus titre produced in a particular cell cycle phase, 
samples from separated cell fractions need to be taken within this time period. However, a 
number of groups have reported temporary inhibition of cell cycle progression (up to 6 
hours) following the detachment of some cell types from the culture substratum (Campisi 
and Medrano, 1983; Andreadis at aI., 1997). As mentioned above, if cell cycle progression 
is essential for virus production, the cells need to be cycling immediately after inoculation in 
order to compare virus levels produced during the first few hours. A preliminary experiment 
showed that FL YRD 18/LNC-hB7 cells underwent no such inhibition in cell cycle 
progression after cell detachment (Figure 3.2.4.2B) and that active vectors could be 
measured just a couple of hours after the cells were re-plated (Figure 3.2.4.2A). 
No significant difference in the virus titre was observed between cultures enriched for cells 
in different phases of the cell cycle. Although each fraction was by no means pure, the 
predominance of virus production in one particular phase would certainly have lead to a 
significant difference in the titre measured from each cultured fraction. For example, in the 
second fraction the percentage of cells in the S-phase was double that of the other fractions 
(see Table 3.2.4.2), hence if virus particles were produced predominantly in the S-phase, a 2-
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fold increase in virus titre would be expected in the culture from this fraction. The data in 
Figure 3.2.4.2E suggests there is in fact no correlation between cell cycle phase and virus 
production. Hence the decreased cell specific titre observed with thymidine-arrested cells 
was probably due to decreased cell proliferation rates, suggesting that cell cycle progression 
is indeed essential for virus production. 
An alternative explanation for the decreased virus titre in the presence of high concentrations 
of thymidine, is a possible secondary effect of the thymidine itself. High concentrations of 
thymidine inhibit the synthesis of deoxyribonucleotide triphosphates, dNTPs, (through 
inhibition of the ribonucleotide reductase enzyme), thereby inhibiting DNA synthesis 
(Adams, 1990). Reduced dNTP pools could in itself have an effect on measured virus titres. 
It has been reported that increasing the dNTP concentration in virus-containing supernatants 
can increase the transduction efficiency of these virus stocks (Zhang et aI., 1995). This is 
brought about by an increase in reverse transcription in the virus particles (due to increased 
dNTP availability). This in turn can lead to an increased infection efficiency in the target 
cells, as more of the viral RNA may be reverse transcribed into DNA for integration into the 
target cell genome. If the reverse is true, then decreased dNTP pools could lead to reduced 
reverse transcription within the virus particles, resulting in lower infection efficiencies and 
hence lower measured virus titres. Hence the reduced cell specific titres in the thymidine-
arrested cell cultures could also be due to reduced dNTP pools. Further studies, using 
alternative methods for cell arrest were therefore investigated. 
Demecolcine (Colcemid™) disrupts tubulin assembly, thereby inhibiting spindle fibre 
formation. As a result, cells cultured in Demecolcine cannot exit metaphase and are arrested 
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in the cell cycle at the M-phase (Fantes and Brooks, 1993). This agent was therefore chosen 
to arrest cell proliferation via a different mechanism to that of thymidine. The cell specific 
titres were significantly reduced in the presence of Demecolcine (Figure 3.2.4.3C), further 
suggesting a correlation between cell proliferation and virus production. 
Finally, the growth rate of FL YRD 18/LNC-hB7 cells was shown to increase with increasing 
glucose concentrations, within a range. The cell specific vector titre increased with these 
increasing growth rates (Figure 3.2.4.4). These data again suggest that there is a correlation 
between the growth rate of FLYRD18/LNC-hB7 cells and their vector production. However , 
as with all nutrient manipulations, (despite their recommendation for such studies), it must 
be borne in mind that altering nutrient levels can alter the transcriptional and translational 
machinery of the cells. These effects cannot be ruled out as a contributory factor in the 
reduced vector levels at lower cell growth rates. 
In Chapter 4, a study on the effects of culture temperature on vector production demonstrated 
a significant inhibition in proliferation of FLYRD18/LNC-hB7 cells at 27°C. This was 
accompanied by significantly reduced cell-specific vector titres, despite an increase in vector 
half-life at this lower temperature (cell viability was unaffected). This study avoids the use 
of chemical inhibitors and nutrient deprivation and the findings once again suggest a 
correlation between cell proliferation and vector production. 
It is practically impossible to separate the effects of proliferation and metabolic state of 
packaging cells on vector production. However, the above studies certainly demonstrate that 
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FL YRD 18/LNC-hB7 cells that are highly proliferative, that is, cells with a high metabolic 
activity, are likely to produce higher retroviral vector titres. 
Cell Attachment to Carriers and Effects of Agitation 
FLYRD18/LNC-hB7 cells were found to attach readily to ImmobaSil-FSTM carriers, with or 
without pre-coating with serum. However, subsequent stirring of such cell-seeded carriers 
lead to the loss of attached viable cells (as indicated by an MTT assay of carrier samples). 
It was postulated that the lack of viable cells on the carriers after overnight agitation could be 
due to the susceptibility of the FL YRD 18/LNC-hB7 cell line to shear forces exerted during 
stirring of the carriers, or, the inability of the ImmobaSil-FSTM carriers to maintain cell 
viability during prolonged culture. Both these possibilities were tested in subsequent studies. 
Firstly, the effect of increasing agitation rates on the viability of cells attached to the carriers, 
was assessed. Culture at stir speeds necessary to completely suspend the cell-seeded carriers 
resulted in a rapid loss of viable cells on the carriers. No cells were detected in the 
supernatant of these cultures, indicating that the loss of viable cells on the carriers was not 
due to cell detachment during stirring. These findings suggest that cell death is brought 
about by shear forces experienced by the cells during stirring of the suspended carriers. 
Cells stirred in suspension (not attached to carriers) also failed to survive at these agitation 
rates (probably due to a combination of the shear force effects and the inability of these 
anchorage-dependent cells to survive in suspension for long periods). 
In a further study, cell-seeded carriers were cultured under static conditions and compared to 
stirred cultures. Unlike the stirred cultures, viable cells were detected on carriers for up to 
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one week in the static cultures. Furthermore, retrovira1 vector production was still 
measurable after static culture of the FL YRD 18/LNC-hB7 cells on these carriers. These 
results confirm that the loss of cells on the carriers in previous experiments was not due to 
any adverse effects of culturing the cells on ImmobaSi1-FSTM carriers, but rather an effect of 
agitation during stirring. 
The effects of agitation on cell growth and viability in vitro has been researched extensively 
(Thomas and Zhang, 1998; A1-Rubeai et aI., 1995a, 1995b, Thomas et aI., 1994; Oh et aI., 
1993; Zhang et aI., 1993a, 1993b; Born et aI., 1992; Dodge and Hu, 1986). Recently is has 
been recognised by a number of groups that cell death in stirred cultures is usually due to air 
sparging (as a result of the forces incurred during bubble bursting). Thomas and Zhang 
(1998) claim that agitation without sparging is unlikely to cause significant breakage of 
animal cells in stirred bioreactor cultures. This is because animal cells are significantly 
smaller than the smallest eddy likely to exist in a stirred culture (at typical stir speeds). 
Where eddies are larger than a suspended particle, they will tend to entrain it and the 
particles will be exposed to little or no shear forces. In contrast, eddies which are smaller 
than a particle cannot entrain it and hence will act on the particle surface and, in the case of 
animal cells, cause damage. In microcarrier cultures the particle size is significantly larger 
and hence cell-seeded carriers may not be entrained by the smallest eddies during stirring. 
For this reason, it is generally believed that cells attached to microcarriers are more 
susceptible to shear forces during stirring than cells in suspension culture. Gregoriades et aI., 
(1998) studied the damage of cells attached to microcarriers as a result of local energy 
dissipation. In typical spinner cultures, a majority ofthe energy introduced by the impeller is 
dissipated in regions near the imp ell er, which are typically characterised by vortices. The 
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energy dissipation required to damage the attached cells was orders of magnitude lower than 
that reported to kill suspended cells. Furthermore, it has been postulated by Croughan et al. 
(1986) that unlike suspended cells, cells attached to carriers cannot freely rotate and hence 
cannot reduce the net forces and torque experienced when they are exposed to excessive 
hydrodynamic forces. It has also been suggested that carrier to carrier bombardment can 
cause cell damage, in stirred microcarrier cultures (Papoutsakis, 1991). 
A number of robust cell lines can tolerate the forces exerted during stirred microcarrier 
culture (e.g. CHO cells). However, the inability to maintain viable FLYRD18/LNC-hB7 cell 
cultures attached to carriers, when stirred at speeds necessary to fully mix the carriers , 
suggests that suspended microcarrier cultures are unlikely to be a suitable method for the 
large-scale production of retroviral vectors by this cell line. High-density cultures in stirred 
tank fermenters are likely to require even higher agitation rates than those used in the studies 
described here. Hence, the death of FL YRD 18/LNC-hB7 cells, due to their susceptibility to 
shear forces in such culture systems, is inevitable. Alternative culture systems for the large-
scale production of retroviral vectors by FLYRD18/LNC-hB7 cells, which use the same 
carrier material but expose the cells to very low shear forces, were therefore assessed 
(Chapter 5). 
Oxygen Uptake Rate (OUR) 
Knowledge of the oxygen uptake rate (OUR) of a cell line is critically important in the 
selection and design of a bioreactor for their large-scale culture (Pugh, 1988; Yoon and 
Konstantinov, 1994). The oxygen transfer capability of a bioreactor should exceed, or at 
least meet the OUR of the whole cell culture. The relationship between OUR of 
, 
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FL YRD l8/LNC-hB7 cells and the oxygen transfer rate of a packed bed system is assessed in 
Chapter 5. The determination of OUR of FLYRD1 8/LNC-hB7 cells was therefore essential 
for these studies as well as providing information on the physiological properties of these 
cells. 
The OUR of FLYRD18ILNC-hB7 cells was measured whilst attached to ImmobaSil-GTM 
carriers (to mimic the conditions used in the packed bed cultures) as well as after detachment 
from monolayer culture (to allow assessment of the OUR over 7 days). The OUR was 
highest after just a few hours of culture. It has been reported that the oxygen requirement of 
cells increases during their attachment to a substratum (Rottem et aI., 1992). This group 
suggested that such increased oxygen uptake rates are due to the high metabolic state of cells 
during their spreading onto the culture surface. This may explain the higher oxygen uptake 
rate at this early time point. 
During culture of the cells, the OUR increased over the first few days, perhaps due to 
increasing cell proliferation rates during this exponential phase of growth. By the end of the 
culture period the oxygen uptake rates markedly decreased. Cell proliferation rates and 
vector production also started to decrease by this time in previous batch cultures of 
FLYRD18/LNC-hB7 cells (see lO-day batch culture, section 3.2.1). Hence a correlation 
between cell activity and oxygen consumption is likely to be the cause of this decrease in 
OUR (as the cells entered the stationary phase of growth). The maximum OUR was also 
observed on day 4 in monolayer cultures of rat hepatocytes (Balis et aI., 1999). This group 
also reported a decrease in OUR from day 4 to 30% of maximal levels by day 15. These 
findings also correlate with those ofYoon and Konstantinov (1994) who reported a decrease 
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in specific oxygen uptake rate during a 10-day culture of an NSO myeloma cell line. 
Furthermore, Radlett et aI., (1972) demonstrated an increase in OUR during the exponential 
growth phase of BHK21 cells, followed by decreasing OURs as the cells entered the late 
exponential and stationary phases of growth (as observed for FLYRD18/LNC-hB7 cells). 
Finally, Kioukia (2000) showed a range in OUR, during different stages of batch culture of 
hybridomas and insect cells. 
Wohlpart et aI., (1990) reported a decrease in OUR of cultured cells with increasing cell 
densities. This could also play a role in the decrease in OUR observed in the above studies 
during prolonged culture. Wohlpart and co-workers also demonstrated a negative effect of 
high glucose levels on cell specific oxygen consumption, while glutamine was shown to 
increase cellular OUR. Such findings demonstrate the range of factors that can effect 
cellular oxygen consumption. As a further example, Kioukia et aI., (1995) revealed a 40% 
increase in OUR in insect cells after infection with baculovirus. This group suggested that 
this increase was associated with viral multiplication and was not due to recombinant protein 
production. 
The OURs ofFLYRD18/LNC-hB7 shown in Table 3.2.7, are comparable to those reported 
for a number of mammalian cell types (Emery et al. 1995). The reported OUR of murine 
hybridoma cells, Chinese hamster ovary (CHO) cells and NSO myeloma cells falls within the 
range 1.25 x 10-15 to 1.34 X 10-14 mol/cell/min (Hiller et al.,1991; Lovrecz and Gray, 1994; 
Yoon et aI., 1994; Bonarius et aI., 1995; Zupke et aI., 1995; Gray et aI., 1996; Jan et aI., 
1997). In comparison, the OUR of porcine and rat hepatocytes has been reported to be 
significantly higher, ranging from 1.88 x 10-11 to 5.40 X 10-11 mol/cell/min (Balis et aI., 
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1999), though Bratch (2000) demonstrated an OUR of 2.18 x IQ-14 mol/celVmin in rat 
hepatocyte cultures. Hence the OUR of FLYRD18/LNC-hB7 cells (in the order of IQ-15 
mol/celVmin) is not considered to be high. 
The oxygen uptake rate of FL YRD 18/LNC-hB7 cells cultured on ImmobaSil-GTM carriers 
was lower (perhaps due to less cell spreading), but of the same order of magnitude, as that 
measured in cells released from tissue culture plastic. Bratch (2000) also reported a 
decreased OUR of hepatocytes cultured on carriers compared to hepatocytes released into 
suspension (2.12 x IQ-15 and 2.18 x IQ-14 mol/celVmin, respectively). The OUR of other 
attached cell types has been reported to be 3.54 x IQ-15 mol/cell/min (Smith et aI., 1996) and 
1.5 x IQ-15 mol/cell/min (Foy et aI., 1994), hence the values for FLYRD18/LNC-hB7 cells 
attached to ImmobaSiFM carriers are fairly typical. 
This data can be used to gIve an approximation of the oxygen requirements of 
FL YRD 18/LNC-hB7 cells, in order to check the oxygen transfer rates in the packed bed 
system are sufficient to support cell proliferation, and hence virus production, over long term 
cultures. 
Retroviral Vector Stability 
The half-life of active retrovirus particles produced by the FLYRD18/LNC-hB7 cell line 
correlates well with the half-life quoted for a number of murine and human retroviral 
vectors, at 37°C (see section 1.4). Reducing the storage temperature led to an increased half-
life, suggesting the stability ofthe virus particle activity is indeed temperature dependent. 
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The virus half-life was increased almost lO-fold when stored on ice as compared to 37°C. It 
would therefore seem probable that an increase in daily virus titre could be obtained if the 
supematant from cultures was continually harvested onto ice instead of remaining in the 
culture at 37°C. This was investigated in a later study (Chapter 5). 
An increase in half-life was also measured when the virus supematant was stored at 32°C as 
compared to 37°C. Therefore culture of FLYRD18/LNC-hB7 cells at this reduced 
temperature may also be a useful method for obtaining increased titres. However, reduced 
culture temperatures are likely to reduce cell proliferation rates, leading to reduced cell 
numbers. Furthermore, retroviral vector production may be reduced at this lower 
temperature. A study was therefore conducted to determine the effect of this reduced culture 
temperature on subsequent virus titres and cell proliferation rates (Chapter 4). 
In order to compare the vector titre of various cultures, samples must be measured at the 
same time due to the inherent variation of the infection assay (see Introduction). It is 
therefore necessary to store samples in liquid nitrogen until all samples are collected and 
ready for analysis. In most circumstances samples can be thawed once for analysis then 
discarded. However, in the event of a failed assay, or where samples are re-frozen for later 
co-analysis with another set of samples, multiple freeze-thaw cycles may be necessary. For 
this reason the effect of two successive freeze-thaw cycles on active vector titre was , 
assessed. In this study, an additional freeze-thaw cycle did not markedly decrease the mean 
vector titre of duplicate samples. Therefore vector stocks may be re-frozen after analysis in 
case further analysis is required, provided that samples are not thawed for longer than 30 
minutes (longest time tested). If samples are thawed for a second time they should be 
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discarded after analysis, as the effect of further freeze-thaw cycles is unknown for this cell 
line. 
Reproducibility of Infection Assay 
Figure 3.2.9 illustrates the inter-assay variation in measured vector titre using an infection 
assay. Due to this variation, a comparison of the vector titres between different cultures 
should be made by measuring each sample in the same assay. Where this is not possible 
(e.g. too many samples) the incorporation of a sample of known vector titre can be used to 
determine the inter-assay variation. This data can allow the adjustment of vector titres from 
one assay to compare to those from another assay. This has been done in a number of 
studies in Chapter 5 where samples from multiple packed bed cultures could not all be 
measured in the same infection assay. 
The vector titre did not significantly decrease in samples stored in liquid nitrogen for over 
nine months (Figure 3.2.9). This finding demonstrates the suitability of liquid nitrogen for 
the long-term storage of vector preparations. 
Transduction Efficiency of Vector Preparations 
The successful transduction of target cells, after exposure to vector preparations, was 
determined by labelling with a fluorescent anti-human B7 antibody. The increase in 
fluorescence intensity of these cells, relative to control target cell cultures not exposed to 
vectors, was detected by flow cytometry. This increase in fluorescence was shown not to be 
due to non-specific binding of FITC-conjugated antibodies to the vector-exposed target cells. 
This was demonstrated by labelling a further culture of target cells with an irrelevant FITC-
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conjugated antibody (namely, FITC-conjugated goat anti-mouse IgG) after exposure to the 
same vector preparations. The fluorescence intensity in these samples was the same as that 
of control samples labelled with the anti-B7 antibody (not exposed to vectors). Hence the 
increased fluorescence of the target cells in Figure 3.2.10 was due the direct labelling of 
human B7 protein expressed on their surface, after successful infection by the vectors. This 
data demonstrates the high transduction efficiency of vectors harvested from monolayer 
cultures ofFLYRD18/LNC-hB7 cells at 37°C. 
The transduction efficiency, unlike vector titre, has been shown by Forrestell et aI., (1995) to 
remain fairly constant throughout culture (once a maximum is reached). This group 
postulated that this is due to the increase in transduction inhibitor concentration with 
increasing vector concentration (see section 1.6). Hence the transduction efficiency of a 
vector stock is an important parameter to measure when determining optimal harvest times, 
since the relationship between transduction efficiency and time is not the same as that 
between vector titre and time. 
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Chapter 4: 
Influence of Various Physical and Chemical Factors on Vector 
Production by FL YRD18/LNC-hB7 Cells 
4.0 Introduction 
In order to detennine the optimum culture conditions of FL YRD 18/LNC-hB7 cells for the 
production of high titre retroviral vectors, the effects of a number of culture parameters were 
assessed. Cell growth and vector concentrations were measured during the culture of the 
packaging cells over a range of different temperatures, pH levels and dissolved oxygen 
concentrations. In addition, the effect of various serum concentrations and additives such as 
sodium butyrate, dexamethasone, peptone and fibroblast growth factor were assessed. 
The dissolved oxygen level (dOz) in culture medium has been reported to have a dramatic 
effect on cell productivity. For example, KlOppinger et aI., (1990) demonstrated the effects 
of reduced dOz levels on the virus production and cell growth of Sf-9 cells infected with Ac-
NPV baculovirus. This group reported a 50% decrease in virus production when the dOz 
level of the culture was reduced from 40% to 20%, thus illustrating the importance of dOz in 
certain culture systems. Other groups have reported beneficial effects of low oxygen levels. 
Lin et aI., (1993) reported that under mild hypoxic conditions, the oxygen consumption rate 
of cells decreased, thereby allowing a 2-fold increase in the maximum cell concentration. 
This increase in cell production was obtainable only when glucose was supplemented to 
offset the increased glycolytic activity of the cells. Shi et aI., (1993) also reported increased 
glucose and glutamine consumption rates and lactate production rates by hybridoma cells in 
oxygen-limiting conditions. However, extreme oxygen limitation or deprivation can reduce 
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cell viability (Mercille and Massie, 1994, Simpson et aI., 1997). Simpson et aI., (1997) 
reported complete cell death in hybridoma cell cultures after 32 hours of oxygen deprivation. 
High oxygen levels have been also shown to be detrimental to cell growth and viability 
(Emery et aI., 1995; Simpson et aI., 1997). An excess of 400% d02 (based on the oxygen 
tension of air sparging) was demonstrated by Simpson et aI., (1997) to cause complete death 
of hybridoma cell cultures after just 20h. These hyperoxic conditions are believed to cause 
toxic stress to the cells through the formation of free radicals and peroxides (Ellis, 1991; 
Simpson et aI., 1997). In this chapter, the effects of dOz level on the growth and vector 
production of FLYRD18/LNC-hB7 RD18 cells was tested between 20% and 80% dOz in 
order to avoid any adverse effects of hypoxia or hyperoxia. 
A wealth of literature exists on the effects of pH on mammalian cell growth, however 
nothing is known about the effects of pH on retrovirus production. Schmid et aI., (1990) 
have reported the beneficial effects of low pH levels (PH 6.7) on mono clonal antibody 
production by hybridoma cells. In contrast, Harbour et aI. (1989) showed a negative effect 
of low pH levels on mono clonal antibody production. These findings illustrate the 
variability of optimum pH values for growth and production of various cell lines. The effect 
of a range of pH levels on vector titre was therefore assessed in order to determine the 
optimum for vector production by the FL YRD 18/LNC-hB7 cell line. 
The reported effects of various additives such as serum, sodium butyrate and dexamethasone, 
during the culture and vector production by various retroviral packaging cells, has been 
reviewed in Chapter 1. The effects of serum concentration on vector titre have been 
conflicting (Lee et aI., 1996; Shen et aI., 1996; Gerin et aI., 1999a) possibly due to the 
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different packaging cells and vectors used in each study. Likewise, the responsiveness of 
vector production to sodium butyrate and/or dexamethasone addition has been reported to 
vary greatly between different promoter types in various packaging cell systems (Olsen and 
Sechelski 1995; Pages et aI., 1995; Soneoka et aI., 1995). Studies were therefore undertaken 
to determine the effects of such additives on the production of active vector particles by the 
FLYRD18/LNC-hB7 cell line. 
It has been clearly demonstrated by Gerin et al. (1999a) that serum has a dose-dependent 
negative effect on vector production by the FLYRDI8/LNC-hB7 cell line. The growth of 
FLYRD18/LNC-hB7 cells during long term culture in 5% serum is not significantly different 
to that in 10% serum. Therefore the studies throughout this thesis were conduced using 5% 
serum (as opposed to 10%, as previously used by other groups). In this chapter the effect of 
lower serum concentrations (1-2%) on cell growth and vector production was further 
investigated since previous reports only assessed vector production after 24h exposure to 
such low serum concentrations. 
In order to confirm that the negative effects of serum on the vector titre ofFLYRDI8/LNC-
hB7 cell cultures was not due to inactivation of the vector particles by serum components, 
the decay rate of vector stock activity was compared between stocks with and without serum. 
Since the decay rate is lower at 32°C, the effect of serum on vector stability was tested at 
both 32°C and 37°C, in order to confirm that the lower decay rate at 32°C is not due to a 
lower activity of potential inhibitory factors in serum. Furthermore, 'heat-inactivated' serum 
was compared to non-treated serum to further check that factors such as complement 
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components and antibodies (which are denatured by heat treatment) are not responsible for 
the lower titres in higher serum concentrations. 
Two commercially available serum-free media were tested for their suitability for long term 
culture and vector production by the FLYRDI8/LNC-hB7 cell line. Aim-VTM (Life 
technologies, Scotland) was selected as a suitable candidate as this medium has previously 
been demonstrated to support vector production by FLYRDI8/LNC-hB7 cells at titres 
similar to that achieved in low serum concentrations, over a 24 hour culture period (Gerin et 
aI., 1999a). EpiserfTM (Life technologies, Scotland) was also chosen as this medium was 
developed by the manufacturer for the culture of adherent cells and has been claimed to 
promote the propagation of viruses (technical literature, Life Technologies). A further six 
different serum-free media under development by BioWhittaker Ltd. (not commercially 
available) were also assessed for their suitability to support the growth and vector production 
by FLYRDI8/LNC-hB7 cells. These media, referred to as Hyb-F, Hyb-F/Version 2, 
Modified Hyb 2, LC-15, KF23 and Jab- 4F, were chosen for their ability to support the 
growth of HTI080 cells (personal communication, Lee Edwards, BioWhittaker U.K. Ltd.), 
as the FL YRD 18 cell line was constructed from these fibrosarcoma cells (Cosset et aI., 
1995). 
The addition of peptone to culture medium has been demonstrated to improve the growth and 
productivity of mammalian cells in batch and continuous culture (Jan et aI., 1994). Meat 
peptone is a mixture of compounds derived from the digest of animal tissue and animal 
products and has been used as an inexpensive alternative to serum in animal cell culture 
medium. Jan et al. (1994) demonstrated an increased cell density and cell specific 
mono clonal antibody productivity in hybridoma cell cultures after the addition of meat or 
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protease peptone to the serum-containing culture medium. Earlier studies in this thesis 
indicate that increased proliferation rates of the FLYRD18/LNC-hB7 cell line can lead to 
increased vector titres. The effect of meat peptone on the growth and vector production by 
these cells was therefore investigated. In another attempt to increase cell growth rates (and 
hence vector production) fibroblast growth factor (FGF) was added to the culture medium of 
FLYRD18/LNC-hB7 cells and the vector titres were compared to cultures without this 
additive. 
4.1 Materials and Methods 
4.1.1 Culture of FL YRD18/LNC-hB7 Cells at Various Temperatures 
Replicate monolayer cultures of FL YRD 18/LNC-hB7 cells were established as described in 
Chapter 2. Sample flasks were incubated at 27°C, 32°C or 37°C for up to 8 days and the 
relative daily vector titres were compared. At the end of culture the cells were released from 
the flasks by trypsin digestion and counted using a haemocytometer. The vector 
concentration was divided by the total cell number in order to determine the mean vector 
titre per cell at each culture temperature. 
4.1.2 Culture of FL YRD18/LNC-hB7 Cells at Various pH Levels 
FLYRD18/LNC-hB7 cells were inoculated into T-flasks as described previously and left 
overnight. The culture medium from each flask was then replaced with medium adjusted to 
pH 6.0, 6.4, 6.6, 7.2 or 7.8 (triplicate flasks for each pH value). The cultures were incubated 
for a further 24h before removing the supernatant for measurements of the virus titre and 
detaching the cells by trypsin digestion for determination of cell numbers. Cells were not 
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cultured at the various pH levels for longer than 24h, due to the lack of pH control in 
monolayer cultures. The pH of the culture medium in each flask decreased by approximately 
0.4 units after 24 hours incubation. 
4.1.3 Culture of FLYRD18/LNC-hB7 Cells at Various Dissolved-Oxygen 
Concentrations 
A 'Maestro' bioreactor (LSL Biolafitte, France) was used to control dissolved-oxygen 
concentration (d02) during the culture of FLYRD18/LNC-hB7 cells. In brief, two flat-
bottomed glass vessels (connected to pH and oxygen probes) were inoculated with 8.5 x 106 
cells in a small volume (20ml) of culture medium (DMEM:F-12 + 5% FCS) and the cells left 
to attach to the bottom of each vessel for 4 hours. After this time the number of cells 
remaining in suspension was counted to ensure over 95% of cells had attached before 
increasing the media volume to 200ml and leaving overnight at 37°C. The following day 
both vessels were connected to the controller, after replacing the medium in each for fresh. 
The pH control was set at pH 7.2, temperature at 37°C and d02 at 20% in one vessel and 
50% in the other. The controlled cultures were maintained for 2 days before sampling the 
medium in each vessel for virus titre measurements and detaching the cells by trypsin 
digestion for determination of the final cell number cultured at each dissolved-oxygen 
concentration. The above experiment was then repeated using 50% and 80% d02. The use 
of 50% d02 in both runs allowed comparison between the two experiments by excluding 
inoculum conditions as a variable factor. 
141 
4.1.4 Culture of FL YRD18/LNC-hB7 Cells at Various Serum Concentrations 
FL YRD 18/LNC-hB7 cells were seeded into 6-well tissue culture plates at 1.6 x 105 cells per 
well in 3ml culture medium containing 2%, 4%, 6% or 8% FCS. After 24h incubation at 
37°C, the culture medium in each well was changed for fresh (2-8% FCS) and after a further 
24h the supernatant from each well was sampled for vector titre measurements (day 2). 
Cultures were then left for a further 3 days before sampling again for vector titre (day 5) and 
detaching the cells by trypsin digestion in order to determine the total cell number at each 
serum concentration. 
In a further study, FLYRDI8/LNC-hB7 cells were seeded into T-25 flasks at 2 x 104 
cells/cm2, as described in Chapter 2. In order to avoid any effect of the different serum 
concentrations on the percentage of cells which adhere, cells were seeded in medium 
containing 5% FCS. These cultures were left overnight before replacing the medium with 
fresh medium containing 1 % or 5% FCS. The medium in each culture was replaced for fresh 
every day for up to 6 days. The culture supernatants were sampled on days 2 and 6 and the 
cells counted on day 6 as before. Replicate cultures were also maintained for up to 10 days, 
however no measurements from these cultures were taken, as a large proportion of the cells 
cultured in 1 % FCS detached from the flasks and died during this prolonged culture period. 
4.1.5 Effect of Serum on Stability of Vector Particle Activity 
Vector Decay Rate in Culture Supernatants with or without Serum 
The supernatant was collected from monolayer cultures of FL YRD 18/LNC-hB7 cells (as 
described in Section 2), after overnight culture in medium with or without 5% FCS. The two 
supernatants were passed through a 0.451lm filter and divided into 1ml aliquots in cryovials. 
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Replicate vials were either stored immediately in liquid nitrogen (Oh), or incubated at 320C 
or 37°C for 3, 6, 9 and 24 hours before storing in liquid nitrogen. After all the samples were 
collected and stored in liquid nitrogen for at least 24h, they were thawed and used for vector 
titre measurements in order to determine the decay rate of the vectors at each temperature in 
the presence or absence of serum. 
Effect of Heat-Inactivated Serum 
The complement and antibody components of serum were denatured by incubation at 56°C 
for 30 min. FL YRD 18/LNC-hB7 cells were seeded into 6-well plates at 2 x 105 cells per 
well in culture medium containing non-treated FCS (5%). After leaving the cells to attach 
overnight, the culture medium in each well was replaced for fresh medium containing heat-
inactivated or non-treated FCS (5%). Each plate was cultured for 2 days and the supernatant 
in each well was sampled every day for vector titre measurements. On day 2 the cells in 
each well were counted to allow determination of the vector titre per cell. 
4.1.6 Culture of FL YRD18/LNC-h87 Cells in Serum-Free Medium 
Aim- VTM and EpiserfTM Serum-Free Medium 
Monolayer cultures of FLYRD18/LNC-hB7 cells in T-25 flasks were established as 
described in Chapter 2. Cells in triplicate flasks were cultured in Aim-VTM serum-free 
medium (Life Technologies, Scotland), EpiserfrM serum-free medium (Life Technologies, 
Scotland), or DMEM:F-12 + 5% FCS. The medium in each flask was changed for fresh 
daily for up to 6 days. The supematant from each flask was sampled on Day 1, 4 and 7 for 
vector titre measurements and the cells from each flask were counted at the end of the culture 
period. 
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A further set of cultures was established in an attempt to adapt the FL YRD 18/LNC-hB7 cell 
line to EpiserfrM serum-free medium. Cells were seeded into T-25 flasks as before, in 
DMEM:F-12 + 5% FCS. After 24h the culture medium was changed for 50% EpiserfrM in 
DMEM:F-12 +5% FCS or DMEM:F-12 +5% FCS alone (control). Cells were maintained in 
monolayer culture, as described in Section 2, and after 7 days the concentration of EpiserfrM 
medium was increased from 50% to 75% (excluding the control flasks). Cells were 
maintained in 75% EpiserfrM serum-free medium for up to 17 days. The cells were counted 
at each passage and the specific growth rates determined and compared to the control 
cultures. On Day 11 samples were taken for vector titres measurements. 
Other Serum-Free Media 
Six different serum-free media (courtesy of BioWhittaker V.K. Ltd.) were also tested for 
their ability to maintain the growth and vector production of FLYRDI8/LNC-hB7 cells. 
These media are not commercially available, but are under development and referred to as: 
Hyb-F, Hyb-F/Version 2, Modified Hyb 2, LC-15, KF23 and Jab- 4F. Six-well plates were 
seeded with 2 x 105 cells per well in DMEM:F-12 +5% FCS and left overnight for cell 
attachment. The medium in each well was then replaced with one of the above serum-free 
media, or serum-containing medium (5%), using replicate wells for each. Each plate was 
cultured for up to 8 days and the medium sampled and changed for fresh daily. On day 8 the 
cells in each well were counted as before. 
Further cultures in the serum-free media were maintained for up to 3 weeks, however no 
further cell growth was detected in any of the cultures and none of the mono layers reached a 
confluent state. Hence no data was collected from these cultures. 
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4.1.7 Effects of Sodium Butyrate and/or Dexamethasone on Vector Production 
Sodium Butyrate Alone 
Six-well plates were seeded with cells as described above and incubated until the monolayer 
of cells in each well was almost confluent (2 days). The medium in each well was then 
replaced for fresh medium containing 0, 1,5, 10, 15 or 30mM sodium butyrate (Sigma, UK) 
and the plates incubated for a further 24h. The supernatant from each well was then sampled 
for vector titre measurements and the cells counted as before. 
In a separate experiment, the above was repeated with the exception that the sodium butyrate 
was added at the start of the culture period. In this experiment the cells were exposed to 
sodium butyrate for up to 3 days. 
Dexamethasone with/without Sodium Butyrate 
Six-well plates, seeded with cells as described above, were incubated overnight before 
replacing the culture medium for fresh medium containing 0, 1 or 5/-LM Dexamethasone 
(Sigma, UK) alone or in the presence of sodium butyrate (5mM). After 24h, samples were 
taken for vector titre measurements and the cells in each well counted as before. 
4.1.8 Effect of Fibroblast Growth Factor (FGF) on Vector Production 
Tissue culture grade fibroblast growth factor (Sigma, UK) from bovine pituitary gland, was 
selected as a potent mitogen of various fibroblastic cell lines. A range of concentrations was 
assessed in order to determine whether cell proliferation and vector production could be 
further improved. Six-well plates were seeded with 2 x 105 cells per well, as described 
previously, and cultured in medium containing 0, 1, 10 or 100 nglml FGF for up to 3 days. 
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The medium in each well was sampled for vector titre measurements and changed for fresh 
daily. On day 3 the total number of cells per well was counted as before. 
4.1.9 Effect of Peptone on Vector Titre 
Six-well plates were seeded with FLYRDI8/LNC-hB7 cells as described above and replicate 
wells cultured with 0, 1 or 2.5 mg/ml meat peptone (Sigma, UK) for up to 3 days. The 
medium in each well was sampled for vector titre measurements and changed for fresh daily. 
On day 3, the total number of cells per well was counted as before. 
4.2 Results 
4.2.1 Culture of FL YRD18/LNC-hB7 Cells at Various Temperatures 
Daily retroviral vector titres in the culture supematant of FL YRD 18/LNC-hB7 cells cultured 
in monolayer at 32°C were compared to those from 37°C cultures (Figure 4.2.1.1). After day 
2, virus titres were significantly higher in the 32°C cultures compared to the 37°C cultures, 
with a lO-fold increase by day 7. The mean cell concentration on day 8 was 6.3 x 105 
cells/ml and 1.3 x 106 cells/ml at 32°C and 37°C, respectively (specific cell growth rate, /l, 
over 8 days was 7.6 x 1O-3/h at 32°C and 9.0 x 1O-3/h at 37°C). As a result of the higher 
virus titre and lower cell concentration in the 32°C cultures, the specific virus productivity 
(cfu/cell) was over 20-fold higher than 37°C cultures on day 8. 
In contrast, the virus titres were negligible when this cell line was cultured at 27°C for 7 days 
(Figure 4.2.1.2). Cell proliferation was markedly inhibited at this lower temperature (the 
mean cell concentration on day 7 was 8.6 x 104 cells/ml and 1.7 x 106 cells/ml at 27°C and 
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37°C respectively). The specific virus productivity was 14-fold lower at 27°C compared to 
37°C. The low virus production is likely to be due to the low cell proliferation at this culture 
temperature (as indicated by earlier studies in Chapter 3). 
4.2.2 Culture of FL YRD18/LNC-hB7 Cells at Various pH Levels 
The highest vector titre was measured in the supernatants from packaging cells cultured at 
pH 7.2. The titre at this pH was taken as 100% and all other titres calculated as a percentage 
of this (Figure 4.2.2). Since it is unlikely, under normal culture conditions, for the pH of the 
culture medium to increase, the effect of pH below 7.2 was of more concern than that above 
pH 7.2. Figure 4.2.2 illustrates the effect of such low pH on virus production and cell 
viability. While the cell viability remained above 90% at all pH levels tested except pH 6 
(85% viability), the specific virus titre (cfu/cell) in cultures below pH 6.8 was significantly 
decreased compared to cultures at pH 7.2 (87%, 34% and 12.5% at pH 6.8, 6.4 and 6.0, 
respectively). 
4.2.3 Culture of FL YRD18/LNC-hB7 Cells at Various Dissolved Oxygen Levels 
No significant difference in cell numbers or vector titres was observed in cultures maintained 
for 2 days at 20%, 50% or 80% dOz (Figure 4.2.3). Hence the dissolved-oxygen 
concentration was not limiting to cell growth or virus production under the conditions 
employed in this study. Cell numbers increased almost 3-fold during the two days in culture. 
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Figure 4.2.1.1 
Virus titre and cell number during monolayer culture of FL YRD 18/LNC-hB 7 cells at 32°C 
or 370C. Error bars represent observed range, n=2. 
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Figure 4.2.1.2 
Daily vector titres produced by FL YRD 18/LNC-hB7 cells during culture at 27°C compared 
to 370C. Error bars represent standard deviation, n=6. Cell proliferation at 27°C was 
negligible. 
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Figure 4.2.2 
Specific virus titre (cfu/cell), as a percentage of that measured at pH 7.2. Samples measured 
after 24h culture at various pH levels. Error bars represent standard deviation, n=3. 
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4.2.4 Culture of FL YRD18/LNC-hB7 Cells at Various Serum Concentrations 
After 2 days culture of FL YRD 18/LNC-hB7 cells in various serum concentrations, a dose-
dependent negative effect of serum on vector titre was observed. The mean vector titre was 
6.3 x 104, 5.1 X 104, 3.7 X 104 and 3.3 x 104 cfulml in 2%, 4%, 6% and 8% serum, 
respectively (Figure 4.2.4.1). However by day 5, no significant difference in vector titre was 
observed between each serum concentration (mean titre 3.0 x 105 cfu/ml). The mean total 
cell number on day 5 was 20.4 x 105, 15.5 X 105, 16.5 X 105 and 13.6 x 105 cells per well at 
8%, 6%, 4% and 2% serum, respectively. The differences in cell number at each serum 
concentration were only significant between 2% and 8% serum, hence the vector titre per 
cell on day 5 was only significantly lower in the 2% serum cultures. 
In a second experiment, cultures were maintained in 1 % or 5% FCS for up to 6 days and the 
medium replaced for fresh every day. In contrast to the previous study, where the medium 
was left unchanged for 3 days, the cell specific vector titre (cfu/cell) was significantly higher 
in the 1 % serum culture compared to the culture in 5% serum even after 6 days (Figure 
4.2.4.2). 
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Figure 4.2.4.1 
Virus titre after 2 days culture of FL YRD 18/LNC-hB7 cells in various serum concentrations. 
Error bars represent standard deviation, n=6). 
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4.2.5 Effect of Serum on Stability of Vector Particle Activity 
Vector Decay Rate in Culture Supernatants with or without Serum 
Vector stocks were prepared in DMEM:F-12 with or without 5% FCS, hence the 
concentration of vector in each was different. Each stock was stored at 32°C or 37°C and 
samples were transferred to liquid nitrogen storage after 3,6,9 and 24 h. Figures 4.2.5.1 and 
4.2.5.2 illustrate the decrease in vector activity with time at 32°C and 37°C, respectively. 
The decrease in vector activity, demonstrating vector decay with time, occurred at the same 
rate in the vector stocks with and without serum. Hence the presence of serum had no effect 
on vector stability at 32°C or 37°C. As expected, the vector activity decay rate was greater 
at 37°C than at 32°C (this reduced vector half-life at higher storage temperatures has 
previously been demonstrated in Section 3). 
Effect of Heat-Inactivated Serum 
FL YRD 18/LNC-hB7 cells were cultured in 5% heat-inactivated or non-treated serum for 2 
days and the medium changed for fresh in each sample daily. The mean viable cell numbers 
Were the same after 2 days culture in each type of serum (mean 4.4 x 105 cells per well). 
Similarly, there was no significant difference between the vector titres on Day 1 and 2 in the 
presence of heat-inactivated serum, compared to non-treated serum (Figure 4.2.5.3). 
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Figure 4.2.5.1 
Vector activity decay during storage at 32°C, in the presence or absence of 5% FeS. Error 
bars represent observed range, n=2. 
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Figure 4.2.5.2 
Vector activity decay during storage at 37°C, in the presence or absence of 5% pes. Error 
bars represent observed range, n=2. 
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Daily vector titre in PLYRD18/LNC-hB7 cell cultures in 5% heat-inactivated foetal calf 
serum (H.I. PCS) or non-treated foetal calf serum (PCS control). Error bars represent 
standard deviation, n=4. 
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4.2.6 Culture of FL YRD18/LNC-hB7 Cells in Serum-Free Medium 
Aim-VTM and EpiserfTM Serum-Free Medium 
FL YRD 18/LNC-hB7 cells were maintained in monolayer culture for up to 7 days in Aim-
yTM or EpiserfJ"M serum-free media, or DMEM:F-12 + 5% FCS, with daily medium changes. 
On day 3, the mean vector titre sampled from cultures in Aim-yTM serum-free medium was 
similar to that measured in serum-containing cultures. However, after this time point the 
daily vector titres dramatically decreased to negligible values by day 7 (Figure 4.2.6.1). 
Microscopic observations of the monolayer cultures in Aim-yTM medium revealed cells with 
normal spread morphology until day 3. On day 4 these cells appeared more rounded and 
were starting to detach from the culture surface. By day 7, very few cells were left attached 
in the Aim-yTM cultures. 
Vector titres sampled from cultures in EpiserfTM serum-free medium also reached similar 
levels to those measured in serum-containing medium by day 3. These levels continued to 
increase and correlate well with the titres in 5% FCS until Day 4 (Figure 4.2.6.1). After this 
time point the vector titres in the EpiserfTM cultures also dramatically decreased. On day 7 
the mean vector titre in EpiserfTM cultures was only 30% of that in the serum-supplemented 
cultures. Microscopic observations of the monolayer cultures in EpiserfTM medium revealed 
the cells to be growing in clusters with a 'stellate' morphology from the start of culture. By 
day 4, the cells began to 'pile-up' in clusters instead of spreading across the culture surface. 
In comparison, the cells cultured in 5% FCS had a normal spread morphology and had 
formed a confluent monolayer by day 4. On day 7 the mean total number of cells per flask in 
EpiserfJ"M medium was 1.8 x 106, compared to 1.23 x 107 cells in serum-containing cultures. 
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Due to the inability of the FLYRDI8/LNC-hB7 cells to survive in either Aim-VTM or Episerf 
™ serum-free medium for more than 4 days, adaptation of the cells to EpiserfTM medium over 
a period of weeks was attempted. Cultures were established in 50% EpiserfTM (in DMEM:F-
12 + 5% FCS). After 11 days, the concentration of EpiserfTM medium was increased to 75% 
and the cells maintained for another week. No vector titre was measurable in the 
supematants sampled on day 11, indicating no vector production in the presence of 50% 
EpiserfTM medium. Furthermore, as the percentage of EpiserfTM medium was increased, the 
specific cell growth rate decreased and was consistently lower than that of cells cultured in 
serum-containing medium. The cell viability also decreased during culture in EpiserfTM 
medium. The mean specific cell growth rates and percentage viability, compared to those 
measured in DMEM:F-12 +5% FCS alone, are given in Table 4.2.6. After 17 days, the cells 
were transferred to culture in 100% EpiserfTM medium and once again the cells were 
observed to detach from the culture surface and die within a few days. Hence no adaptation 
of the cells to EpiserfTM serum-free medium was achieved. 
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Figure 4.2.6.1 
Daily vector titre measured in FL YRD 18/LNC-hB7 cell cultures using two commercially 
available serum-free media compared to 5% serum. Error bars represent standard deviation , 
n=6. Decreased vector titres after Day 4 were due to cell death in the serum-free media. 
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Other Serum-Free Media 
Six different serum-free media, under development by BioWhittaker Ltd., were tested for 
their ability to maintain cell growth and vector production by FL YRD I8/LNC-hB7 cells. 
Figure 4.2.6.2 illustrates the mean vector titre and total cell numbers after 8 days culture in 
each media, compared to control cultures in medium containing 5% FCS. The cell numbers 
and vector titres in all six serum-free media were significantly lower than those obtained in 
5% FCS. While cell numbers were similar between the different serum-free media, the 
vector titres measured on Day 8 varied markedly. No vector activity was detected in the 
culture supematants of Hyb-F or Jab4F serum-free medium. The highest mean vector titre 
was in the LC-I5 cultures, however this titre was less than 30% of that measured in the 
control cultures with 5% FCS. Microscopic observations of the cultures revealed different 
cell morphologies in the different media. Cells became rounded and withdrew into clusters 
in Hyb-F, Hyb-F/version 2 and LC-I5 media. Cells maintained a spread appearance (similar 
to that of the control cultures) in KF23 medium, however, after reaching confluence on day 
4, a number of 'holes' appeared in the cell monolayers. Cells in the Modified Hyb-2 
medium showed mixed morphologies, some being rounded and some elongated. After 5 
days, a number of cells started to detach from the culture surface in all serum-free media 
except Jab4F. The percentage cell viability remained above 80% in all media except KF23 
and Modified Hyb-F which were only 50% and 77% viable, respectively. Surprisingly, the 
serum-free medium that yielded the highest cell number and greatest percent viability, 
namely J ab4F, showed no evidence of active vector production. 
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Day Media Type Specific Cell 
Growth Rate, J.l Viability 
(h-1) (%) 
2 50% Episerf 2.1 x 10-
2 95 
DMEM:F-12 + 5% FeS 2.8 x 10-2 96 
4 50% Episerf 1.4 x 10-
2 93 
DMEM:F-12 + 5% FeS 2.6 x 10-2 99 
7 50% Episerf 1.3 x 10-
2 83 
DMEM:F-12 + 5% FeS 2.1 x 10-2 96 
11 75% Episerf 0.5 x 10-
2 72 
DMEM:F-12 + 5% FeS 1.5 x 10-2 94 
Table 4.2.6 
Specific cell growth rates and percentage viability of FL YRD 18/LNC-hB7 cells in various 
concentrations of EpiserfTM serum-free medium, compared to cultures in 5% foetal calf 
serum. 
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Figure 4.2.6.2 
Vector titre and total cell number after 8 days culture of FLYRD18/LNC-hB7 cells in 
various serum-free media, compared to medium containing 5% FCS. Error bars represent 
observe range, n=2. 
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4.2.7 Effects of Sodium Butyrate and/or Dexamethasone on Vector Production 
Sodium Butyrate Alone 
Na-butyrate (1-30 mM) was added to monolayer cultures ofFLYRD18/LNC-hB7 cells either 
at the onset of culture or overnight. Where cells were exposed to this additive for 3 days, a 
cytotoxic effect was observed at all concentrations and vector production was dramatically 
reduced. Whereas, cells survived at all Na-butyrate concentrations after overnight exposure, 
however the cell growth was significantly reduced. Cell numbers and vector titres at each 
concentration are shown in Figure 4.2.7.1. No significant increase in vector titre was 
observed in the presence of Na-butyrate, compared to control cultures. In fact, in 
concentrations greater than SmM the vector titre was significantly reduced. Taking into 
account the reduced cell numbers in the presence of Na-butyrate, the vector titre per cell was 
higher in the presence of 1 mM, but again significantly reduced in 5mM and above. 
Dexamethasone with/without Sodium Butyrate 
Dexamethasone (1-50 IlM) was added alone or with Na-butyrate (5 mM), to replicate 
cultures of FL YRD 18/LNC-hB7 cells. Where Na-butyrate was included, cell numbers at the 
end of the culture period were only 60% of those in cultures with dexamethasone alone, 
again due to the apparent cytotoxic effects of Na-butyrate. Likewise, vector titres were 
significantly reduced. 
Cell numbers in the cultures with dexamethasone alone, up to 10 IlM, were similar to those 
in control cultures with no additives. However, in 50 IlM dexamethasone nearly all the cells 
died. Figure 4.2.7.2 illustrates the mean vector titre per ce1l24h after exposure of the cells to 
dexamethasone alone. A slight increase in vector titre was observed with increasing 
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dexamethasone concentration up to 5 IlM, however above this concentration vector titres 
were significantly reduced. 
4.2.8 Effect of Fibroblast Growth Factor (FGF) Addition on Vector Titre 
After 3 days culture of FLYRD18/LNC-hB7 cells in a range of FGF concentrations (in 
DMEM:F-12 + 5% FCS), the cell numbers were not significantly increased, compared to 
cultures without FGF addition. Likewise the daily vector titres over 3 days were not 
significantly different (Figure 4.2.8). 
4.2.9 Effect of Peptone Addition on Vector Titre 
The addition of meat peptone to FLYRD18/LNC-hB7 cell cultures (in DMEM:F-12 + 5% 
FCS) had no effect on cell number after 3 days. The vector titre on day 2 was slightly higher 
in the presence of 2.5mglml peptone, however by day 3 there was no significant difference in 
the vector titres in cultures with or without peptone (Figure 4.2.9). 
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Mean vector titre per cell, after 24h exposure to increasing concentrations of dexamethasone, 
compared to control cultures with no dexamethasone addition. Error bars represent observed 
range, n=4. 
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Figure 4.2.8 
Daily vector titres in FLYRD18/LNC-hB7 cell cultures in a range of FGF concentrations, 
compared to control cultures without FGF addition. Error bars represent standard deviation, 
n=4. 
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Daily vector titres sampled from FLYRD18/LNC-hB7 cell cultures in the presence of 1 or 
2.5 mg/ml peptone, compared to cultures without peptone addition. Error bars represent 
standard deviation, n=4. 
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4.3 Discussion 
The virus titres achieved in monolayer cultures of FL YRD 18/LNC-hB7 cells at 27°C, 32°C 
and 37°C were compared in order to assess whether the benefits of increased virus stability 
at lower temperatures outweighed any loss in titre due to decreased cell metabolic activity. 
Despite a decrease in cell growth rate and hence a reduced total cell number in the 32°C 
cultures, a significant increase in virus titre was obtained compared to the 37°C cultures. 
The increase in cell specific vector titre at 32°C was significantly greater than that reported 
for a number of murine cell lines (Kotani et aI., 1994; Lee et al. 1996; Kaptein et aI., 1997). 
Hence it would appear that the increase in titre due to reduced culture temperatures varies 
between different cell lines. This is possibly due to different half-life values of the vectors 
produced by these cells. Cruz et aI., (2000a) reported no increase in vector titre at 32°C, 
compared to 37°C, in P A317 packaging cell cultures. This group suggested that this was a 
consequence of the faster decay rates of the vectors used in their work, compared to others. 
The reduced stability of retroviral vectors at higher temperatures (37°C) has been 
hypothesised to be due to the inherent instability of the RNA genome or loss of reverse 
transcriptase activity (Palsson and Andreadis, 1997). It has also been suggested that loss of 
labile heterodimeric envelope glycoproteins causes loss of vector activity (Forestell et aI., 
1995; Pages et aI., 1995). 
In order to rule out the possibility of an increased activity of certain serum components at 
370C compared to 32°C as a cause of reduced titres at 37°C, the stability of vector stocks 
with and without serum at 37°C and 32°C was compared. It was found that the vector decay 
rate was not affected by the presence of serum at either temperature. Hence it is likely that 
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the increased titre at 32°C is due to reduced thennal decay of the vector particles as opposed 
to reduced extra-cellular inactivation of vector particles by serum components. Le Doux et 
al. (1999) have used a mathematical model to analyse the effects of temperature on vector 
production and decay rates. The findings by this group also strongly suggest that increased 
titres at 32°C are due to reduced vector decay rates, despite slight reductions in vector 
production rates. 
Conversely, culture of the FLYRD18/LNC-hB7 cells at 27°C resulted in a significant 
reduction in vector titres, compared to 37°C. While vector stability is expected to increase 
even further at this lower temperature, the cell proliferation rate at 27°C was also markedly 
reduced. Earlier studies in Chapter 3 demonstrated a correlation between cell proliferation 
and vector production. Hence it is likely that at this lower culture temperature, the vector 
production is reduced to negligible levels due to very low cell proliferation rates. 
A range of pH levels were assessed in order to detennine the effects on cell growth and 
vector production by FLYRD18/LNC-hB7 cells. An optimum vector titre was obtained at 
pH 7.2 and a significant decrease resulted from higher or lower pH levels. This observation 
has implications where packaging cells are cultured under batch, fed-batch or semi-
continuous culture conditions where the pH is not nonnally controlled. In high cell density 
cultures the pH of the culture medium can drop as low as pH 6.5 over a 24-hour period 
(Smiley et aI., 1989), hence where daily medium changes are employed for vector 
harvesting, it is unlikely that the optimum titre will be achieved. The use of a culture system 
where the pH is continuously controlled is therefore recommended for optimised continuous 
production of retroviral vectors. 
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The effect of dissolved-oxygen concentration on the production of retroviral vectors has not 
previously been reported. Surprisingly, at dissolved-oxygen concentrations between 20% 
and 80% air saturation, no difference in vector titre was observed, under the conditions 
employed in this study. Lower dissolved-oxygen concentrations were not tested but indeed 
should be assessed if concentrations below 20% are expected in any culture system used for 
vector production, as any oxygen limitation or deprivation could reduce cell viability by 
inducing apoptosis (Mercille and Massie, 1994; Simpson et aI., 1997). 
Serum was found to have a dose-dependent negative effect on vector titre over short-term 
culture. Reduced serum levels were found to significantly increase cell specific vector titres, 
however where the medium was left unchanged, the difference in titre between cultures in , 
1 % or 5% serum was lost after a few days. When this study was repeated, with daily 
medium changes, the negative effect of higher serum concentrations was apparent 
throughout culture. It is possible that where the medium was unchanged, inhibitory factors 
within the serum were either depleted or decayed with time and hence no difference was 
observed after a few days (between cultures in 1 % or 5% serum). In contrast, where the 
medium was replaced with fresh on a daily basis, lost inhibitory factors would have been 
continuously replaced. This could explain why the negative effect of serum was apparent 
throughout culture in the latter study. 
While reduced serum (1 %) was found to significantly increase vector titres, compared to 5% 
serum, this serum level was found not to be sufficient to sustain cell cultures for longer than 
one week. For this reason, a low serum concentration is not suitable for increasing vector 
production in long-term cultures. Rather, it is recommended that the serum levels be reduced 
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prior to vector harvest in short-term cultures (less than one week). In addition to a 
significant Increase In vector titre, reduced serum levels may also aid down-stream 
processing of vector stocks where the removal of proteins of animal origin is desirable. 
It has been reported that retroviral vectors can be inactivated by complement or antibody 
components within serum (Takeuchi et aI., 1994; Mason et aI., 1999). In order to confirm 
that the negative effect of serum observed in the above studies was not due to extra-cellular 
inactivation of the vector particles, the stability of vector stocks with and without serum was 
compared, as mentioned previously. The vector decay rate was not significantly different in 
the presence or absence of serum, indicating that the negative effect of serum is not due to 
extra-cellular inactivation of vector particles. Furthermore, vector titres were not 
Significantly different in cultures using heat-inactivated serum, compared to non-treated 
serum. The components in serum that could potentially cause extra-cellular vector particle 
inactivation would themselves be denatured after heat-treatment, therefore an increase in 
vector titre would be expected in cultures containing heat-inactivated serum, compared to 
non-treated serum. Since this was found not to be the case, this finding again confirms that 
serum did not reduce vector titres through extra-cellular inactivation of vector particles. It is 
suggested that the negative effect of serum on vector titre is due to inhibition of vector 
production or maturation, however the mechanism of this remains unknown. 
Although not statistically significant, there was a slight decrease in the vector titre during 
culture in heat-inactivated serum. If this is indeed a real effect, this could be due to loss of 
nutrient/growth factor activity of various serum components during heat-treatment. 
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A range of serum-free media (commercially available or under development by the 
manufacturers) were assessed for their ability to support cell growth and vector production in 
FL YRDI8/LNC-hB7 cell cultures. It was hoped that the use of a defined serum-free 
medium would eliminate the negative effects of serum on vector titre, whilst supplying 
essential nutrients to allow survival of the cells in culture. However, none of the serum-free 
media tested proved to be able to sustain cell growth during long-term culture. During the 
first few days of culture, the cell specific vector titres in a number of the tested media were 
similar to that measured in serum-containing cultures. Hence, while not suitable for long-
term production of retroviral vectors, these media could be used to replace serum-
supplemented medium prior to harvest of vector stocks from batch cultures as a means of 
eliminating serum from the final product. 
Vector titres were not dramatically increased after the addition of sodium butyrate to the 
culture medium of FL YRD 18/LNC-hB7 cells. In fact, where cells were exposed to this 
additive for more than 24h a cytotoxic effect was observed. Sodium butyrate is known to 
disrupt cell cycle progression, (Pages et aI., 1995), thus explaining the cell death during long 
term exposure to this additive. Despite this apparent cytotoxicity, a number of groups have 
demonstrated markedly increased vector titres after short-term (overnight) exposure of 
packaging cells to sodium butyrate, (reviewed in Chapter 1). Pages et al. (1995) suggested 
that sodium butyrate can increase vector titres through modulation of MoMLV LTR 
expression. Despite the selectable marker gene of the FL YRD 18/LNC-hB7 cell line being 
under the control of the MoMLV LTR, we observed only slight increases in vector titre after 
overnight exposure to low concentrations of sodium butyrate (higher concentrations resulted 
in reduced vector titres due to cytotoxic effects). At these low concentrations, the cell 
175 
specific titres were calculated to be greater than that of control cultures. This apparent 
increased titre per cell is probably misleading, as the cell number in cultures with sodium 
butyrate were significantly reduced and hence cells that were later killed in the presence of 
this additive could have previously produced a number of the vector particles harvested. 
Cruz et al (2000a) demonstrated only a small increase in vector titre produced by P A317 
packaging cells in the presence of sodium butyrate. This group also found a decrease in cell 
number (due to the inhibitory effects of this additive) hence the cell specific titres were 
calculated to be higher in the presence of sodium butyrate. 
Pages et aI., (1995) claimed that the modulation of the MoMLV LTR is dependent on the site 
of integration. This could explain the differences in responsiveness of a number of cell lines 
to sodium butyrate addition. Indeed, the responsiveness of different cell clones to sodium 
butyrate addition can vary lOO-fold (Olsen and Sechelski, 1995). The dramatic increase in 
vector titre after addition of sodium butyrate seen by other groups could also be due to the 
low titres reported without this additive. For example, Olsen and Sechelski (1995) reported a 
lOOO-fold increase in vector titre after sodium butyrate addition in cultures that previously 
produced very low titres. Where titres are already relatively high without sodium butyrate 
addition (as for Cruz et aI., 2000a), other factors may well be limiting any further increase in 
vector titre, hence sodium butyrate may not have such a dramatic effect, if any, on vector 
titre in these cultures. 
The above argument could also fall true for dexamethasone addition. We observed only 
slight increases in vector titres in the presence of dexamethasone, whereas Pages et al. (1995) 
reported 7-10 fold increases in the presence of dexamethasone and sodium butyrate. 
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Interestingly, this group reported no effect of dexamethasone alone. The synergistic effect of 
dexamethasone and sodium butyrate was not observed in FLYRD18/LNC-hB7 cell cultures 
, 
probably due to the sensitivity ofthis cell line to sodium butyrate induced cell death. 
The addition of fibroblast growth factor (FGF) to cultures of FLYRD18/LNC-hB7 cells in 
serum-supplemented medium gave no improvement on cell growth or vector production. It 
is likely that sufficient concentrations ofFGF exist in the serum added to these cultures such 
that this growth factor is not limiting under the conditions employed in this study. However 
this does not rule out any potential benefits of using FGF in, for example, serum-free 
cultures or higher cell density cultures where growth factors may be limiting. This is also 
likely to be true for peptone additions, which also showed no benefits for cell growth or 
vector production during culture in serum-supplemented medium. 
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Chapter 5: 
Alternative Culture Systems for Retroviral Vector Production 
5.0 Introduction 
The aim of this work was to assess culture systems alternative to simple monolayer cultures, 
which may be more suitable for larger scale production ofretroviral vectors. The anchorage-
dependence of the FL YRD 18/LNC-hB7 cell line prohibits the use of typical suspension 
cultures, more suited for large volume cultures. Furthermore, studies in Chapter 3 showed 
the susceptibility of the FL YRD 18/LNC-hB7 cell line to agitation during microcarrier 
culture caused cell death. For this reason, culture of these cells on suspended microcarriers 
in a stirred tank fermenter is also unlikely to be a suitable method for large-scale production 
of retroviral vectors. We therefore investigated the use of a packed bed culture system. In 
addition, the use of an alternative culture substratum with an expanded surface area was 
investigated. 
Packed Bed 
Packed bed systems have been used for the large-scale culture of a number of anchorage 
dependent mammalian cells (Looby and Griffiths, 1990). These systems offer a number of 
advantages including low surface shear, high cell density and productivity, ease of separation 
of product from cells, prolonged production times and potential for radial scale-up. 
Disadvantages include the poor homogeneity of the systems (though this may have less 
impact on products harvested from the supernatant, such as retroviral vectors), channel 
blockage and little potential for linear scale-up. The use of a packed bed system where the 
cells are immobilised on porous carriers (ImmobaSiFM) was investigated as a potential 
method for large-scale production of retroviral vectors. 
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The packed bed system used throughout this chapter has already been well characterised 
(Bratch, 2000). However, in these latter studies, Fibra-CeFM carriers were used, whereas in 
most of the present studies ImmobaSil-G ™ carriers were used. The effect of using a 
different carrier type on the media flow and oxygen transfer characteristics within the packed 
bed system was therefore assessed. 
Expanded Surface Area T-Flasks 
The porous silicone material of ImmobaSiFM carriers offers the benefits of a large surface 
area. This material has been incorporated into a tissue culture flask (T -flask) such that the 
culture surface (base) is comprised of porous silicone. This dramatically increases the 
available surface area for cell growth, thereby providing a potential means for scale-up of 
vector production by cells grown in these flasks. The cell growth and virus production in 
these flasks (prototypes constructed by Ashby Scientific Ltd.) was compared to standard T-
flasks in order to assess their suitability as an intermediate scale-up of retroviral vector 
production. 
5.1 Materials and Methods 
5.1.1 Packed Bed 
The packed bed system consists of a cylindric~l glass reactor with medium entry and exit 
ports at the bottom and top of the reactor respectively (Figure 5.1.1). Medium is 
continuously circulated through the reactor via a peristaltic pump. In addition, a sampling 
port for removal of carriers (to check viability of attached cells during culture) is located on 
the side. The centre of the reactor contains coiled silicone tubing for delivery of oxygen 
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along the whole length. Carriers (ImmobaSiFM or Fibra-CeFM) were packed into the reactor 
around this silicone tubing. 
5.1.2 Packed Bed Characterisation 
Fluid Flow 
A stimulus-response technique was used to determine the Residence Time Distribution 
(RTD) of fluid elements passing through the reactor. The information given by the RTD in 
continuous flow reactors is described in the discussion (Section 5.3). The packed bed vessel 
was filled with approximately 5.5 x 104 ImmobaSil-GTM porous silicone carriers (Ashby 
Scientific Ltd., u.K.) before filling the reservoir with 200ml water and re-circulating at 6 
mllmin. A tracer dye, 0.5% Phenol Red solution (lml), was injected as rapidly as possible 
into the feed stream, immediately adjacent to the inlet. Samples were subsequently taken 
immediately adjacent to the outlet, at one-minute intervals. The absorbance of each sample 
was read at 470nm, using a spectrophotometer (Pharmacia LKB Ultrospec Ill). This data 
was used to plot the concentration of dye in the outlet stream as a function of time, in order 
to calculate the RTD of this dye bolus. This experiment was repeated using open perfusion 
as opposed to closed, at the same fluid flow rate. 
Oxygen Transfer 
This experiment was conducted at 37°C, in order to obtain the same dissolved oxygen levels 
at air saturation as would be expected under normal culture conditions. A polarographic 
dissolved oxygen probe (Ingold) connected to an amplifier (LSL Ltd., Luton) was used for 
dissolved oxygen measurements. This probe was calibrated using medium saturated with 
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nitrogen gas for 0% dissolved oxygen and medium saturated with 5% CO2 in air for 100% 
dissolved oxygen, before placing within the medium reservoir. The packed bed was filled 
with approximately 5.5 x 104 hnmobaSil-GTM carriers and 500ml of medium re-circulated 
through the vessel at 6ml/min. The whole system was initially purged with nitrogen to 
remove the dissolved oxygen from the re-circulating medium. Once the dissolved oxygen 
levels reached zero, the nitrogen source was removed and 5% CO2 in air passed through the 
silicone tubing at approximately 20mVmin. The increasing dissolved oxygen levels were 
recorded every minute until saturation was reached. This data was used to determine the 
oxygen transfer coefficient in the packed bed system under these conditions. 
5.1.3 Retroviral Vector Production in Packed Bed Cultures 
Each packed bed was filled with 85ml settled volume of ImmobaSil-GTM porous silicone 
carriers, equivalent to approximately 5.5 x 104 carriers (Ashby Scientific Ltd., UK), except 
one study where 6g Fibra-CeFM carriers (polyester fibre discs) were used. After addition of 
the carriers, the packed beds were sterilised in an autoclave at 121°C for 15 minutes. 
Prior to inoculation of the packed bed with FLYRDI8/LNC-hB7 cells, 100ml culture 
medium (DMEM: F-12 + 5% FCS) was re-circulated through the packed bed (containing 
sterile carriers) at 37°C for 30 minutes. Meanwhile the cells were detached from the T-flasks 
by trypsin digestion. The rinse medium was removed from the packed bed and the cells, 
suspended in fresh culture medium, were added through the top port (typically 1.8 x 108 cells 
in total). The packed bed system was rotated during this inoculation period to aid uniform 
cell attachment to the carriers. The percentage cell attachment was estimated by determining 
the number of unattached cells remaining in the medium (using haemocytometer counts). 
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When over 80% of the cells were attached (typically 4 hours post inoculation), the packed 
bed was connected to a reservoir containing an appropriate volume of culture medium to 
give a final cell concentration 3.6-6.0 x 105 cells/ml. This medium was re-circulated at a 
flow rate of 6 mVmin. Medium samples were taken daily for virus titre and glucose 
measurements and the culture medium changed for fresh every 1 or 2 days. Each sample 
was assayed twice for virus titre. 
An exception to the above method involves open perfusion of the culture medium. In one 
study, the medium was perfused at a flow rate of21.6 mllh into a separate harvest bottle kept 
on ice, outside the incubator (Figure 5.1.3.1). This flow rate was chosen in order to obtain 
the same volume of medium per cell, per day, as used in all previous packed bed cultures. 
The aim of this study was to store the virus-containing supernatant at a lower temperature in 
order to reduce virus decay before collection. 
A further exception to the above method is the use of a controller (,Maestro', Biolafitte, 
France) which was connected to the medium reservoir of a packed bed system (Figure 
5.1.3.2). In this study, the temperature, pH and dissolved oxygen level in the medium 
reservoir was maintained at 32°C, pH 7.2 and 50% d02 respectively. The temperature of the 
medium reservoir (outside the incubator) was maintained at 32°C through the use of a water 
jacket, whilst the packed bed containing the cell-seeded carriers was kept within an incubator 
at 37°C. The pH was maintained throughout the culture period by the addition of 1M 
sodium hydroxide or C02 gas (monitored with a pH probe and controlled through the 
Maestro control unit). The dissolved oxygen levels were likewise monitored and controlled 
by the addition of oxygen or nitrogen gas. 
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Cell numbers in each packed bed culture were estimated by taking carrier samples and 
performing an MTT assay as described in Section 2. 
5.1.4 Cell Growth and Retroviral Vector Production in ImmobaSil Flasks 
FLYRD18/LNC-hB7 cells were inoculated into T-25 tissue culture flasks (surface area of 
base: 25cm2), either with a standard tissue culture grade polystyrene culture surface, or with 
a porous silicone (lmmobaSil) culture surface. Cells were inoculated at 1 x 105 cells/ml and 
cultured at 37°C for 13 days. Vector titre and cell number in each culture were compared. 
Another study was performed in order to determine whether the ImmobaSil flasks could be 
re-used. One flask from the first experiment was rinsed in sterile PBS (after removal of the 
cells by trypsin digestion) and then soaked for 30 min in 70% (v/v) ethanol. The ethanol was 
removed and the flask was left to dry (under aseptic conditions). This flask was used, as 
above, in a 4-day culture. The cell number and vector titre from this culture was compared 
to that from a 'fresh' ImmobaSil flask. Cells were released from the flasks by trypsin 
digestion and counted using a haemocytometer. Two successive digestions were carried out 
to ensure all cells were removed. The second digestion released only 4% of the total cell 
yield. 
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Schematic of packed bed bioreactor. Air is passed through silicone tubing via filters (O.2/-tm 
pore size). 
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Schematic diagram of 'controlled' packed bed system. Medium is perfused through packed 
bed (closed circulation) via a medium reservoir. Dissolved oxygen concentration, pH and 
temperature of medium in the reservoir is monitored by relevant probes and the parameters 
maintained at set levels by a control unit (through the addition of O2 or N2, CO2 or NaOH 
and a water jacket, respectively). 
186 
5.2 Results 
5.2.1 Packed Bed Characterisation 
Fluid Flow 
A bolus of Phenol Red (lml) was injected into the inward stream of a packed bed, during 
perfusion, and the dye concentration (absorbance at 470nm) in the effluent stream measured 
as a function of time. Figures 5.2.1.1 and 5.2.1.3 show the absorbance of samples from the 
effluent stream versus time during closed and open perfusion in the packed bed, respectively. 
These plots, representing the concentration of tracer exiting the system as a function of time, 
are referred to as C curves. The data from these curves can be normalised as follows: 
foOO C(t) d(t) = 1 
Since the area under the C curve represents the total amount of tracer added, the data can be 
normalised by dividing the tracer concentration at time t, C(t), by the area under the curve. 
These values represent the age distribution function, B(t), of fluid elements leaving the 
packed bed (Fogler, 1992; Levenspiel, 1972). Hence: 
B(t) = C(t) / fooo C(t) d(t) 
Where C(t) is the tracer concentration at time t and the integral in the denominator is the area 
under the C curve. The area under the curve in Figures 5.2.1.1 and 5.2.1.3 was determined 
using Simpson's graphical rule, which can be used for curves which fit a zero, first, second 
or third order polynomial function (Fogler, 1992). Figures 5.2.1.2 and 5.2.1.4 show B(t) 
versus time in the packed bed during closed and open perfusion respectively. The 
information given by these residence time distribution curves (B curves) is described in the 
discussion (Section 5.3.1). 
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It should be noted that during closed perfusion, the absorbance levels will not fall back to 
those measured before injection of the tracer because the 1ml bolus of Phenol Red has 
become mixed with the bulk of re-circulating fluid in the reservoir. This is illustrated in 
Figure 5.2.1.1. 
Oxygen Transfer 
The packed bed system was purged with nitrogen gas to remove all dissolved oxygen from 
the re-circulating medium. When the dissolved oxygen level reached zero, 5% CO2 in air 
was passed through the silicone tubing at 20 ml/min. Figure 5.2.1.5 illustrates the increase in 
dissolved oxygen levels in the reservoir bottle, as a function of time. This data was used to 
construct Figure 5.2.1.6, where the natural log of the maximum dissolved oxygen level 
(95%) minus the percentage dissolved oxygen at time t, was plotted as a function of time. 
The slope ofthis plot was used to calculate the oxygen transfer coefficient (KT) in the packed 
bed system under these conditions, using the following equation (Boraston et aI., 1984; Hu et 
aI., 1986; Bratch, 2000): 
Slope ofln(D1 OO%-Dot) vs. time = -aKT 
Hence, KT = slope I -a 
(a=NVT) 
Where A is the total surface area ofthe silicone tubing (149.9cm2) and VT is the total volume 
of re-circulating medium (500ml). Hence 'a' equals 0.2998cm2/ml. The slope from Figure 
5.2.1.6 is -1.6 x 10-4 sec-I, hence KT was calculated as 
5.3 x 10-4cm/s. 
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C curve: absorbance versus time for samples taken from the effluent stream in a packed bed 
after injection of a lml bolus of Phenol Red, during closed perfusion. Fluid flow rate of 6 
mllmin and total fluid volume of 500ml. Packed bed filled with ImmobaSiI-GTM carriers , 
void volume of 40ml. 
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Figure 5.2.1.2 
E curve: Residence Time Distribution in packed bed system during closed perfusion. Fluid 
flow rate of 6 mIlmin and total fluid volume of 500ml. Packed bed filled with ImmobaSil-
GTM carriers, void volume of 40ml. 
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Figure 5.2.1.3 
C curve: absorbance versuS time for samples taken from the effluent stream in the packed 
bed after injection ofa lml bolus of Phenol Red, during open perfusion. Fluid flow rate of6 
mVmin and total fluid volume of 500ml. Packed bed filled with ImmobaSil-GTM carriers , 
void volume of 40ml. 
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Figure 5.2.1.4 
E curve: Residence Time Distribution in packed bed system during open perfusion. Fluid 
flow rate of 6 mllmin and total fluid volume of 500ml. Packed bed filled with ImmobaSil-G 
carriers, void volume of 40ml. 
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Figure 5.2.1.5 
Dissolved oxygen levels in packed bed as a function of time, during perfusion of 5% C0 2 in 
air through silicone tubing at 20 mllmin (system initially purged with N2). Packed bed was 
filled with ImmobaSil-GTM carriers and 500ml medium re-circulated through the system at 6 
mllmin. Experiment conducted at 37°C. 
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Natural log of maximum dissolved oxygen (95%) minus percentage dissolved oxygen at time 
t, plotted as a function oftime. Data derived from Figure 5.2.5. The slope of this plot was 
used to determine the oxygen transfer coefficient in the packed bed system under these 
conditions. 
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5.2.2 Retroviral Vector Production in Packed Bed Cultures 
Closed Perfusion at 370C 
The first packed bed culture was conducted at 37°C, where 6 x 105 cells/ml were cultured on 
ImmobaSil-GTM carriers during closed perfusion of the culture medium. The daily glucose 
levels and vector titres in the packed bed culture were compared to that of monolayer 
cultures from the same batch of cells, seeded at the same concentration. The glucose levels 
of the culture medium between daily changes, in both the packed bed and the monolayer 
cultures, were similar (Figure 5.2.2.1). Capiaumont et aI., (1993) demonstrated a good 
correlation between cell growth and glucose depletion in culture medium. However, Zielke 
et aI., (1984) claimed that in cultures with identical growth rates, the glucose utilisation was 
significantly lower when the initial glucose concentration was high (5mM) compared to 
cultures with low initial glucose concentrations (80)lM). The use of glucose concentrations 
to monitor cell growth should therefore be used with caution. However, since the glucose 
levels did not drop below 7 mM, the data in Figure 5.2.2.1 indicates similar cell growth rates 
in the packed bed and monolayer cultures. 
Scanning electron microscopy revealed the presence of attached cells throughout the pores of 
carriers removed from the packed bed on day 11. Some vacant areas were still present on the 
surface of some carriers (Figure 5.2.2.2), whereas some carriers were densely populated with 
attached cells (Figure 5.2.2.3). 
On day 4, the daily vector titres in the packed bed culture were similar to those achieved in 
monolayer (packed bed titres were initially lower on day 2, but higher on day 3). From day 7 
onwards, the titre appeared to decrease in the packed bed, whereas titres were maintained in 
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the monolayer cultures (Figure 5.2.2.4). An MTT assay of sample carriers (approximately 
10 carriers per sample) on days 7 and 11 revealed no increase in cell number during this 
culture period (mean absorbance per carrier was 5.3 x 10-3). 
While vector concentrations were not greater in the packed bed, the total amount of active 
vectors collected from the packed bed system was obviously much greater than that collected 
from the monolayer cultures, due to the significantly larger volumes of culture medium 
harvested each day from the packed bed. Hence the volumetric productivity of the packed 
bed was IS-fold greater than that of the smaller scale T-flasks. 
Open Perfusion onto Ice 
A similar packed bed culture was conducted, using the same cell number as above, with open 
medium perfusion. The perfused medium was collected in a harvest bottle stored on ice 
outside the incubator (whereas the rest of the packed bed system was incubated at 37°C). A 
medium flow rate of21 mllh was selected in order to feed the cells with the same volume of 
medium over a 24 h period as was used in the above study (where the total volume was 
changed every 24 h). Figure 5.2.2.5 illustrates the daily vector titre in the packed bed 
culture, compared to monolayer cultures at 37°C using the same cell density. Initial daily 
vector titres in the packed bed culture were lower than those measured in the monolayer 
cultures. However, after day 3, titres in the packed bed reached or exceeded those in the 
monolayers. The maximum vector titre in this packed bed was achieved on day 3, and was 
almost 3-fold higher than the maximum titre of the earlier packed bed during closed 
perfusion at 37°C. Figure 5.2.2.6 shows the relative titres measured in both these packed 
bed cultures. Titres from each culture were calculated as a percentage of the maximum titre 
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achieved in the open perfusion system (measured on day 3). The increase in titre due to 
storage of the supernatant on ice, was not as high as would be expected from the increased 
vector stability at this lower temperature. 
Closed Perfusion at 37'C - Fibra-CeJTM Carriers 
In order to compare the performance of the ImmobaSil-GTM carriers to alternative 
commercially available carriers, a further packed bed, filled with 6g Fibra-CeFM carriers 
(Bibby Sterilin, u.K.) was cultured at 37°C during closed perfusion. Slightly lower cell 
numbers were used in this study (3.9 x 105 cells/ml), approximately 65% of the cell 
concentration used in the previous studies. The maximum vector titre in this packed bed 
culture was approximately 60% of that measured in the previous packed bed culture using 
ImmobaSil-GTM carriers (Figure 5.2.2.7). Taking into the account the different cell densities 
inoculated into each system, the vector production per cell on Fibra-CeFM and ImmobaSil-
GTM carriers appears to be similar. 
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Figure 5.2.2.1 
Glucose levels measured III the culture medium (changed daily) of packed bed and 
monolayer cultures of FLYRD18/LNC-hB7 cells. Packed bed culture conditions: 370C, 
closed perfusion, ImmobaSil-GTM carriers. 
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Figure 5.2.2.2 
Scanning electron micrograph of an ImmobaSiFM carrier seeded with FL YRDI8/LNC-hB7 
cells and cultured in packed bed at 37°C (day 11). Bar represents 200/lm. 
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Figure 5.2.2.3 
Scanning electron micrograph of an ImmobaSiFM carrier seeded with FL YRDI8/LNC-hB7 
cells and cultured in packed bed at 37°C (day 11). Bar represents lOOJlm. 
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Daily vector titres in packed bed and monolayer cultures of FL YRD 18/LNC-hB7 cells. 
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ImmobaSil-GTM carriers 
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Figure 5.2.2.6 
Comparison between virus titres in packed bed cultures during closed perfusion at 37°C or 
open perfusion with supernatant harvested onto ice. Relative virus titres were calculated as a 
percentage of the titre in the supernatant collected onto ice on day 3 (maximum titre 
measured). Error bars represent observed range, n=2. 
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Figure 5.2.2.7 
Daily vector titres in packed bed culture of FLYRD18/LNC-hB7 cells on Fihra-CeJTM 
carriers (370C; closed perfusion). Error bars represent observed range, n=2. 
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Closed Perfusion at 32 'C 
Studies in Chapter 4 demonstrate the ability to increase vector titres in monolayer cultures of 
FLYRDI8/LNC-hB7 cells by reducing the culture temperature from 37°C to 32°C. 
However, it has been reported that the optimal temperature for retroviral vector production in 
monolayer may not be the same in bioreactor cultures (Andreadis et aI., 1999). This 
surprising phenomenon may be due to the production of different levels of inhibitors in 
different culture systems. Therefore a packed bed culture was conducted at 32°C to 
determine whether similar increases in vector titre, to those observed in monolayer cultures, 
could in fact be achieved. A packed bed was cultured with 6 x 105 cells/ml (as for previous 
370C packed bed culture) with closed perfusion at 32°C. Figure 5.2.2.8 illustrates the daily 
glucose consumption in this packed bed system. As expected, less glucose was consumed by 
the cells cultured at 32°C, compared to 37°C. The daily vector titres increased throughout 
the culture period of 10 days (Figure 5.2.2.9). This was not observed in the previous packed 
bed cultures conducted at 37°C. The increase in titre was accompanied by an increase in 
absorbance per carrier, measured in an MTT assay conducted on sample carriers taken on 
day 3, 6 and 10 (Figure 5.2.2.10), indicating an increase in cell number throughout the 
culture period. Interestingly, such an increase in cell number was not observed in packed 
bed cultures at 37°C. The mean absorbance per carrier at 32°C was initially lower than that 
measured in carriers sampled from the 37°C culture (up to day 6). This is to be expected, as 
the cell growth rate ofFLYRDI8/LNC-hB7 cells is reduced at 32°C, compared to 37°C (see 
Chapter 4). However, by day 10 the mean absorbance per carrier was higher in the 32°C 
packed bed compared to day 11 in the 37°C packed bed (10 x 10-3 and 5.2 x 10-3 
respectively). It is not expected that cell numbers at 32°C would be greater than those 
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reached at 37°C, hence this result is surprising. It is possible that cell numbers in the packed 
bed at 37°C reached a maximum between days 7 and 11, when carriers were not sampled for 
MTT assay. Cell numbers may have decreased by day 11 due to sub-optimal culture 
conditions. In contrast, the cell numbers in the packed bed at 32°C may reach a maximum at 
a later time point (due to the reduced cell growth rate at this temperature), hence a decrease 
in cell number was not measured before day 10. 
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Figure 5.2.2.8 
Glucose levels measured in the culture medium (changed daily) of a packed bed culture of 
FL YRD 18/LNC-hB7 cells. Packed bed culture conditions: 32°C, closed perfusion, 
ImmobaSil-GTM carriers. 
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Figure 5.2.2.9 
Daily vector titres in packed bed culture ofFLYRD18/LNC-hB7 cells. Error bars represent 
observed range, n=2. 
Packed bed culture conditions: 32°C, closed perfusion, ImmobaSil-GTM carriers. 
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Figure 5.2.2.10 
MTT Assay: Absorbance per carrier (mean of 10 carriers), as a function of time. Carriers 
sampled from packed bed culture of FLYRD18/LNC-hB7 cells: closed perfusion, 32°C, 
ImmobaSil-GTM carriers. 
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Long Term Packed Bed Culture 
In order to determine whether the culture of FLYRD18/LNC-hB7 cells on ImmobaSil-GTM 
carriers within a packed bed system is suitable for the long term production of retroviral 
vectors, a similar closed perfusion culture was conducted for 35 days (inoculated with 3.6 x 
105 cells/ml). The culture temperature was maintained at 37°C for the initial four weeks , 
then reduced to 32°C for the final week. As for previous packed bed cultures, the medium 
was changed for fresh daily. Vector titres were maintained between 1 x 104 and 2 x 105 
cfulml throughout the 35-day culture period and again significantly increased after the 
culture temperature was reduced to 32°C (Figure 5.2.2.11). The mean daily vector titre 
increased from 3 x 104 cfu/ml at 37°C to 2 x 105 cfulml at 32°C respectively. The maximum 
vector titre was measured on day 35 at 32°C (2.5 x 105 cfulm!). 
A sample was also taken to determine the transduction efficiency of the vector preparation on 
Day 5. As described in Chapter 2, successfully transduced cells were detected by labelling 
vector-exposed target cells with an FITC-conjugated anti-human B7 antibody. A high 
proportion of the target cell culture was successfully transduced by this vector preparation 
(as indicated by an increase in fluorescence intensity with respect to control cultures not 
exposed to vector preparations). This demonstrates the ability of the packed bed system to 
allow the production of good 'quality' vector supematants with similar transduction 
efficiencies to that produced in monolayer cultures (see Chapter 3). The distribution of 
fluorescence intensity per cell, compared to target cells not exposed to the vector 
preparation, is shown in Figure 5.2.2.12. 
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Figure 5.2.2.11 
Daily vector titres during long term packed bed culture of FL YRD 18/LNC-hB7 cells. Error 
bars represent observed range, n==2. 
Packed bed culture conditions: closed perfusion, ImmobaSil-GTM carriers, 37°C for four 
weeks, followed by 32°C for one week. 
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Distribution of fluorescence intensity of A2780cp cells labelled with FITC-conjugated anti-
human B7 antibody (measured by flow cytometry) 48h after exposure to vector preparation, 
compared to control cultures not exposed to vector. 
Vector preparation: day 5 of long term packed bed culture of FL YRD 18/LNC-hB7 cells at 
Dotted line represents cells not exposed to vector preparation (control), solid line represents 
cells exposed to vector preparation for Sh. 
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Packed Bed Culture with Continuous Control 
Studies in Chapter 4 demonstrated the effects of varying pH levels on vector titre in 
FLYRDlS/LNC-hB7 cell cultures. Optimal vector titres were obtained at pH 7.2 and 
significant decreases in titre were observed above and below this pH. These results suggest 
vector production may be improved in controlled cultures where the pH is continuously 
monitored and maintained through a feed-back system. Such control is not possible in 
simple monolayer culture apparatus such as T-flasks and roller bottles. On the other hand, 
the packed bed system used in the above studies can easily be connected to most stirred tank 
fermenters which possess a control unit for maintaining the pH, temperature and dissolved 
oxygen levels in the medium. The culture vessel of such stirred tank reactors can be used as 
a medium reservoir for the perfusion of medium to and from a packed bed containing 
immobilised cells. The medium in this reservoir can be monitored by pH, temperature and 
dissolved oxygen probes and the conditions maintained at set levels via a control unit. 
Such a packed bed culture (filled with ImmobaSil-GTM carriers) was inoculated with 3.6 x 
105 cells/ml and the medium in the reservoir maintained at pH 7.2, 50% dissolved oxygen 
and 320C. The packed bed vessel itself was placed within an incubator at 37°C. Hence the 
cells were maintained at a temperature optimal for cell growth, whereas the bulk of vector-
containing supematant was maintained at 32°C, in an attempt to reduce the vector decay rate. 
The system was initially tested with water alone in order to confirm that the medium leaving 
the reservoir and entering the incubator could reach 37°C before entering the packed bed 
vessel. This occurred at a flow rate of 4 mllmin. The bulk of medium in the reservoir was 
changed daily for fresh. Figure 5.2.2.13 shows the daily vector titre in this packed bed 
culture. Daily levels were less variable compared to previous packed bed cultures. The 
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mean vector titre was higher than that achieved in non-controlled packed bed cultures 
conducted at 32°C or 37°C (except where the supernatant was harvested onto ice). 
At the end of the 11-day culture period, the medium in the packed bed system was replaced 
with MTT solution (S mg/mI) which was re-circulated through the vessel at 37°C for 3 hours. 
Photographs of the MTT stained system were taken after 1 and 3 hours in order to assess the 
distribution of attached, metabolically active, cells throughout the vessel (Figures 5.2.2.14 
and 5.2.2.15a). The intensity of purple formazan staining of each carrier was seen to vary 
throughout the packed bed, indicating a non-uniform distribution of viable cells within the 
culture. Such variation in staining was even more noticeable when a number of carriers were 
removed from the packed bed and laid adjacent to one another (Figure S.2.2.1Sb). This 
variation in cell number per carrier is to be expected in such a 'non-ideal' reactor, as 
explained in Section 5.3.1. 
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Figure 5.2.2.13 
Daily vector titres during controlled packed bed culture of FL YRD 18/LNC-hB7 cells. Error 
bars represent observed range, n=2. 
Packed bed culture conditions: closed perfusion, ImmobaSil-GTM carrIers, pH 7.2, 50% 
dissolved oxygen, cells at 37°C, bulk medium at 32°C. 
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Figure 5.2.2.14 
Immobilised cells in packed bed stained with MTT (5 mg/ml) on day 11. One hour at 37°C. 
Note non-uniform distribution of purple formazan on carriers throughout system. 
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Figure 5.2.2.15a 
Immobilised cells in packed bed stained with MTT (5 mg/ml) on day 11. Three hours at 
370C. Note non-uniform distribution of purple formazan on carriers throughout system. 
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Figure S.2.2.1Sb 
Carriers removed from packed bed (Figure 5.3.20a) after exposure to MTT (5 mg/ml) for 
three hours at 37°C. Variation in staining intensity is evident, indicating variation in cell 
number per carrier. 
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5.2.3 Cell Growth and Retroviral Vector Production in ImmobaSil Flasks 
Cell growth and vector production in ImmobaSil flasks was compared to that in standard T-
flasks. While virus titres in the ImmobaSil flasks were initially lower than in the standard 
flasks, from day 6 onwards the titres in the ImmobaSil flask were equal to or greater than 
those harvested from the standard flask (Figure 5.2.3.1). Virus titres in the ImmobaSil flasks 
increased through to day 13, whereas titres in the standard flasks were reduced after 5 days. 
Cell numbers harvested from the ImmobaSil flasks and standard T-flasks were 5 x 106 and 7 
x 106, respectively. 
In a second experiment, an attempt was made to re-use an ImmobaSil flask. Despite similar 
cell numbers after 4 days (compared to culture in a fresh ImmobaSil flask), the virus titres 
were significantly lower (Figure 5.2.3.2). 
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Figure 5.2.3.1 
Daily vector titres (CFU/ml) in ImmobaSil flask cultures of FLYRDI8/LNC-hB7 cells, 
compared to standard T-flask cultures. Error bars represent observed range, n=2. 
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Figure 5.2.3.2 
Vector titre (cfu/ml) after 4 days culture of FLYRD18/LNC-hB7 cells in fresh or re-used 
ImmobaSil flasks. Total cells harvested from each culture are indicated in brackets. Error 
bars represent observed range, n=2. 
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5.3 Discussion 
5.3.1 Packed Bed Characterisation 
Fluid Flow 
In order to characterise the fluid flow within a continuously perfused reactor, such as the 
packed bed system used in this chapter, the distribution of residence times of fluid elements 
passing through the vessel should be determined. Since different elements of fluid will take 
different routes through the packed bed, they will take different lengths of time to pass 
through the vessel and enter the effluent stream. The distribution of these times is called the 
exit age distribution, E(t), or the Residence Time Distribution (RTD). Since the Residence 
Time Distribution reveals the length of time various fluid elements remain within a reactor 
during circulation, the RTD is characteristic of the mixing that occurs within each reactor 
(Fogler, 1992; LevenspieI1972). 
A stimulus-response technique was chosen for determination of the RTD due to the 
simplicity of this method. Various tracers can be used for this method, such as salts, dyes or 
radioactive species. Phenol Red was chosen as it has a similar viscosity and density to water 
and hence will not disturb the normal flow patterns through the reactor. Furthermore, the 
concentration of Phenol Red in the effluent stream can be readily measured using absorbance 
measurements, with minimal costs. 
In an 'ideal' reactor, the tracer would pass through the vessel as a plug flow and exit as one 
undiluted bolus, giving a vertical line in the E(t) versus time plot (E curve). However, in 
reality, the tracer pulse is widened out to create a distribution curve. It obviously takes a 
finite time to inject the tracer, hence a small amount of diffusion will occur at the point of 
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entry. This results in a steep, but not vertical, peak in the concentration versus time curve (C 
curve), and hence in the E curve, as the tracer reaches the effluent stream (as seen in Figures 
5.2.1.1 and 5.2.1.3). The curve is often further widened due to various mixing and 
channelling of fluid elements (as described below). Hence after an initial steep peak, the 
tracer concentration decreases more gradually producing a 'tai1' region. 
Closed perfusion was used for most of the packed bed cultures described in this chapter, 
however, where the culture supematant was kept at a lower temperature to the cultured cells 
(supematant perfused onto ice), the cultures were performed under open perfusion. 
Therefore E curves were constructed under open and closed perfusion (Figures 5.2.1.2 and 
5.2.1.4 respectively) in order to characterise the fluid flow under both conditions. 
Comparison of these curves to those of Bratch (2000) using the same packed bed system 
under closed perfusion with Fibra-Cel™ carriers, allows an assessment of the effects of 
different carriers on fluid flow. Using the same fluid flow rates, similar curves were 
obtained. Both showed sharp peaks, with similar upward slopes. However, the downward 
slope in Figure 5.2.1.2 is more gentle than that of Bratch (2000), with a longer tail region, 
indicating a longer residence time of some fluid elements in the packed bed filled with 
ImmobaSil-GTM carriers. This could be attributed to the high porosity and different geometry 
of the ImmobaSil-GTM carriers compared to the Fibra-Ce1™ carriers. The ImmobaSil-GTM 
carriers are cylindrical (length 1mm; diameter 0.8mm), whereas the Fibra-CeFM carriers are 
flat discs (thickness < 1mm; diameter 5-6mm). Dye entering the pores of the ImmobaSil-
GTM carriers may take longer to diffuse out of each carrier than that entering the Fibra-CeFM 
carriers, hence the longer tail region in Figure 5.2.1.2. At the very end of the curve, the slow 
decline could be due to diffusional effects as opposed to fluid flow. 
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The E curves for closed and open perfusion in the packed bed, Figures 5.2.1.2 and 5.2.1.4 
respectively, like those of Bratch (2000), resemble that of a tubular reactor with dead zone 
channelling (Fogler, 1992). Typically in a packed bed reactor, an uneven flow distribution is 
observed. This is due to the uneven packing of carriers/particles (as illustrated in Figure 
5.3.1.1), causing 'channelling' where certain fluid elements will follow the route of least 
resistance to the exit stream whilst others flow around the carriers taking a longer route 
before exiting. Furthermore, wall effects come into play, where some fluid elements follow 
the shortest route along the wall of the vessel as opposed to passing through the packed 
carriers (see Figure 5.3.1.2). Both these effects contribute to the distribution of contact times 
of various fluid elements with the cell-seeded carriers. 
While the Residence Time Distribution of fluid in the packed bed system is far from 'ideal', 
any modifications to the packed bed could only slightly improve the distribution but never 
reach that of ideal plug flow. It must therefore be borne in mind that factors such as wall 
effects in a packed bed system may mean that certain elements of medium will not reach 
cells attached to the carriers within this region. Also, stagnant regions are likely to exist 
within the reactor, where cells may be deprived of nutrients and die. This could explain the 
decrease in retroviral vector titre occasionally observed after 3-5 days culture in the packed 
bed system (see Section 5.2.2). However, most of the medium passing through the packed 
bed should be sufficient to maintain other cells attached to carriers outside these stagnant 
regions. Hence after an early decrease, titres remain fairly constant in most packed bed 
cultures. 
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A wide RTD in a packed bed system can lead to the generation of a non-uniform culture of 
cells. Since certain elements of the medium will be in contact with the attached cells for 
different lengths of time, some elements will, for example, undergo relatively little glucose 
depletion while others (in the extreme) may have a high glucose depletion. The same is true 
for the deposition of metabolic by-products into the culture medium. Hence the pH and 
nutrient levels of various elements of medium may vary throughout the reactor, leading to 
non-uniform cell growth and virus production. Since the virus particles released by the cells 
are all pooled in the reservoir bottle, their final concentration is a mean of that from the high 
and low producing cells in the packed bed. Hence the resultant virus titre may not be 
optimal, but variation in production throughout the packed bed is not detected. 
A further consequence of a wide RTD is that virus particles released by the cells will reside 
in the vessel for different lengths of time. Where the culture vessel is maintained at a 
different temperature to that of the medium reservoir (for closed perfusion) or harvest 
reservoir (for open perfusion), the activity of particles in different parts/elements of the 
medium may differ (as loss of activity is temperature and time dependent). This is discussed 
in more detail in Section 5.3.2. 
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Figure 5.3.1.1 
Packed bed vessel filled with ImmobaSil-GTM carriers and culture medium. This photograph 
illustrates non-uniform packing of the carriers, responsible for so-called channelling of fluid 
elements. 
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Diagram to show various fluid movements through a packed bed with non-uniform 
distribution of carriers. 
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Oxygen Transfer 
Oxygen delivery is one of the key challenges in high density cell cultures. While the oxygen 
demand of such cultures is high, oxygen is only sparingly soluble in culture medium. In fact 
the oxygen concentration of culture medium saturated with air, at 37°C, is only 
approximately 0.2 mmol/L (Boraston et aI., 1984; Henzler and Kauling, 1993). Oxygen 
levels within the culture medium can be maintained through sparging, however, problems of 
cell lysis due to bubble bursting have frequently been reported (Kioukia et at, 1992). A 
number of groups have demonstrated the transfer of oxygen from the gas phase to liquid 
culture medium via silicone tubing (Fleischaker and Sinskey, 1981; Mano et aI, 1990). 
Emery et al. (1995) demonstrated equivalent oxygen transfer rates using immersed silicone 
tubing and pure oxygen, compared to sparging with air. This method of oxygen delivery 
avoids any agitation and bubble-bursting problems often associated with sparging. Pure 
oxygen should be used with care, as high oxygen levels within cultures has been shown to 
cause cell death through the production of superoxides and free radicals creating 'oxidant 
stress' (Ellis, 1991; Emery et at, 1995; Simpson et at, 1997). The medium within the 
packed bed system used throughout this chapter was aerated using 5% CO2 in air passed 
through immersed silicone tUbing. This allowed oxygenation of the medium as well as 
maintenance of the pH through the presence of 5% CO2 (which buffers any breakdown of 
sodium bicarbonate within the medium}. 
In this packed bed system, oxygen delivered to the cells must cross a number of barriers. 
These include the transfer of oxygen across the wall of the silicone tubing, the transfer of the 
oxygen from the gas phase to the liquid phase (dissolving in culture medium) and the 
delivery of the oxygenated medium to the attached cells. All of these factors will affect the 
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oxygen transfer coefficient of the system. Priessman et aI., (1997) demonstrated the 
penetration of oxygen only reached a maximum depth of 300llm in their cell-seeded carriers. 
This resistance to oxygen transfer through the carriers was reported to cause cell death in the 
centre of these carriers. The IrnmobaSil-GTM carriers used in the packed bed studies within 
this chapter should not show such inhibited oxygen transfer, since the manufacturers claim 
that the silicone material of these carriers is oxygen permeable throughout. 
The oxygen transfer coefficient, KT, is a useful parameter for characterising the oxygen 
transport from the gas phase, within the silicone tubing, to the liquid phase, in the bulk of the 
culture medium. In a packed bed filled with ImmobaSil-GTM carriers, KT was calculated as 
5.3 x 10-4 cm/sec. This value is almost 4-fold lower than that calculated by Bratch (2000), 
using the same packed bed under the same conditions but filled with Fibra-CeFM carriers. 
The lower KT found in the packed bed filled with ImmobaSil-GTM carriers may be attributed 
to the smaller pore size of these carriers andlor their tight packing within the packed bed. 
The geometry of the Fibra-Cel™ carriers (flat discs) does not encourage uniform tight 
packing within the vessel. Furthermore, only 6g of Fibra-CeFM discs were added to the 
packed bed in the studies by Bratch. This amount of Fibra-CeFM carriers does not 
completely fill the packed bed vessel (85ml capacity), hence the carriers were not tightly 
packed in these experiments. In the present study, IrnmobaSil-GTM carriers were tightly 
packed throughout the vessel, hence any oxygen passing across the wall of the silicone 
tubing and dissolving into the surrounding culture medium may diffuse into the pores of the 
surrounding carriers and hence take longer to diffuse out again. This would increase the time 
taken for oxygenated medium to reach the reservoir bottle, and hence increase the measured 
oxygen transfer coefficient of the system. The addition of packed carriers to the system is 
229 
also likely to affect the mixing within that vessel, which in turn could reduce the mass 
transfer rate. Indeed, Bratch (2000) demonstrated a significantly reduced oxygen transfer 
coefficient in the presence of carriers compared to that of a packed bed without carriers. 
More importantly, the ImmobaSil™ carriers, unlike Fibra-CeFM, are permeable to oxygen. 
This property may also affect the oxygen transfer within the system and may be the major 
factor causing reduced KT. 
More importantly, the ability of the packed bed system to deliver enough oxygen to the cells 
attached within the vessel should be assessed. It is essential that the oxygen uptake rate 
(OUR) of the attached cells does not exceed the oxygen transfer rate of the packed bed 
system. Furthermore, the dissolved oxygen level within the packed bed should not fall 
below the critical oxygen concentration (Stanbury et aI., 1995). The OUR of the 
FL YRD18/LNC-hB7 cell line attached to ImmobaSiFM carriers was previously measured 
(see Chapter 3). This data, along with the oxygen transfer coefficient in the packed bed, can 
be used to determine the total number of cells that can be supported by the reactor (Xv, total). 
In order to maintain cell growth and viability within the packed bed, the oxygen transfer rate 
should equal the oxygen uptake rate by the cells. Hence: 
AKT (C-CL) = Q02 Xv,total 
Where A is the total surface area of the silicone tubing (149.9cm2), Q0 2 is the specific 
oxygen uptake rate of the cells, C is the concentration of oxygen in air-saturated medium 
(0.2125 mmol/L) and CL is the required oxygen level in the packed bed. Since 20% 
dissolved oxygen is the lowest level of oxygen shown not to effect the growth and vector 
production ofFLYRD18/LNC-hB7 cells (see Chapter 4), the oxygen level w~thin the system 
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should not fall below this level. Therefore CL is the concentration of oxygen at 20% air 
saturation (i.e. 0.20C). Hence C-CL is 0.80C (i.e. 0.170 mmollL == 0.170 x 10-3 mmollcm3). 
The oxygen uptake rate (OUR) of FLYRD18/LNC-hB7 cells attached to ImmobaSil™ 
carriers is 1.55 x 10-15 mollcelllmin (== 2.58 x 10-14 mmollcell/sec), see Chapter 3. Therefore 
the total number of cells that can be supported within the packed bed (Xv,total), under the 
conditions described in this chapter, can be calculated as follows: 
Xv, total = AKT(0.80)C I Q02 
== 149.9 cm2 x 5.3 x 10-4 cm/sec x 0.170x 10-3 mm oIl cm3 
2.58 x 10-14 mmollcelllsec 
= 5.27 X 108 cells 
This value is higher than the number of cells actually inoculated in the packed bed cultures 
described in this chapter (typically 1.8 x 108). However, this value is not magnitudes higher 
than the number of inoculated cells and a 5-fold increase in cell number could well lead to 
oxygen limiting conditions within a closed batch culture. In the packed bed cultures 
described within this chapter, the medium in the reservoir bottle was changed for fresh every 
24 h, in order to harvest the retroviral vectors. Hence medium with a high dissolved oxygen 
level was introduced to the system daily. As a consequence of this, the dissolved oxygen 
levels within the packed bed system were observed not to fall below 60% during a typical 
10-day culture. However, it should be borne in mind that where the medium reservoir is not 
changed daily, the oxygen delivery to cells immobilised in the packed bed system could 
become a limiting factor for cell growth and virus production if the cell number increases. 
This can be overcome by continuous control of the dissolved oxygen concentration (as 
conducted in the last study of section 5.2). 
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In order to sustain greater cell numbers, the oxygen delivery within such a system can be 
increased by increasing the total surface area of the silicone tubing and/or using oxygen-
enriched air. The use of oxygen-enriched air can achieve dissolved oxygen levels of greater 
than 100%, however supra-optimal oxygen levels which may cause cell death should be 
avoided, as discussed earlier. 
5.3.2 Cell Growth and Retroviral Vector Production in Packed Bed Cultures 
The studies within this chapter demonstrate the feasibility of using a packed bed system for 
the long-term production oflarge quantities of retroviral vectors from the FL YRD 18/LNC-
hB7 cell line. ImmobaSil-GTM carriers appeared to perform well, compared to Fibra-CeFM 
carriers, with respect to the maintenance of cell viability and production of retroviral vectors. 
Other carrier types were not assessed. . 
Conditions within the packed bed can be optimised to increase vector titres. For example, 
decreasing the culture temperature from 37°C to 32°C lead to an increase in vector titre 
harvested from the packed bed (Figures 5.2.2.8 and 5.2.2.11). Combining this lower 
temperature with continuous control of the pH and oxygen levels further increased the vector 
titre as well as reducing the variation in daily vector titres (Figure 5.2.2.13). The reduced 
variation in vector titre was not expected as the vector containing stocks were replaced with 
fresh medium, in both the non-controlled and the controlled packed bed systems, on a daily 
basis. It is possible that the cells in the non-controlled cultures underwent periods of 
inhibited vector production before each medium change and their recovery may have varied 
each day. A further optimisation of the packed bed culture conditions involved the use of 
open perfusion of the culture medium, where the vector-containing supem.atant could be 
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collected in a separate bottle stored on ice. This system allowed a reduction in the vector 
decay rate. This significantly increased the maximum vector titre, compared to closed 
perfusion at 37°C (Figure 5.2.2.6). 
The above improvements in vector titre with each modification were not as great as 
expected. In monolayer cultures of FL YRDI8/LNC-hB7 cells, a decrease in culture 
temperature from 37°C to 32°C resulted in a greater increase in vector titre (Chapter 4) 
compared to that seen in the packed bed cultures. Furthermore, previous studies 
demonstrated an almost IO-fold increase in vector half-life when stored on ice, compared to 
storage at 37°C (Chapter 3). Hence the increase in titre during open perfusion onto ice, is 
not as great as would be expected. This is possibly as a result of the wide RTD of fluid 
elements in the packed vessel, as reported earlier. Fluid elements which have a short 
residence time will exit the packed bed more rapidly and enter the harvest bottle stored on 
ice, hence vector particles within these fluid elements will have a reduced decay rate. 
However, since there is a wide RTD, some fluid elements have a much longer residence time 
and hence remain in the packed bed vessel at 37°C for longer periods. Vector particles in 
these fluid elements will not have such a reduced decay rate. The expected increase in titre 
with recovery of supematants onto ice will therefore not be optimal. 
Furthermore, the non-uniformity of the packed bed means that not all cells are grown under 
optimum conditions. Stagnant regions may explain the early decrease in titre, observed in 
some of the 37°C cultures (Figures 5.2.2.4 and 5.2.2.5), as discussed in Section 5.3.1. 
However, this early decrease in vector titre was not observed in all packed bed cultures at 
37°C. This may be attributed to the fact that each vessel was filled with carners by hand 
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before sterilising, hence there will be variability in the packing of these carriers between 
experiments. Hence in some experiments the uniformity of carrier packing may be better 
than in others, causing a decrease or increase in channelling and stagnant regIons. 
Alternative geometry of the carriers may aid in more uniform packing of the vessel. 
Interestingly, both packed bed cultures conducted at 32°C yielded a progressively increasing 
daily vector titre. This is in contrast to the daily vector titres in packed bed cultures at 37°C 
which only increased for the first 1-2 days, then remained fairly constant, though sometimes 
after an initial decrease. The daily increase in vector titre in the 32°C packed bed cultures 
was accompanied by an increase in MTT conversion per carrier, indicating that the 
increasing titres were a result of increasing cell numbers. It is possible that in the 37°C 
cultures, the higher metabolic activity of the cells caused growth-limiting conditions at an 
earlier time point. Glucose levels were not found to be limiting in the 37°C cultures 
however, high concentrations of metabolic by-products, produced by the high cell numbers 
over 24 h, may have caused inhibition of cell growth and/or vector production. Furthermore, 
labile medium components, such as glutamine, may have a faster decay rate at 37°C 
compared to 32°C. Limiting conditions are likely to be reached at a later time point in the 
32°C packed bed cultures, where high cell numbers are reached later due to the reduced cell 
growth rates at this lower temperature. 
It can be concluded from the above studies that the packed bed system is a suitable candidate 
for the large-scale production of retroviral vectors, though some optimisation is required. 
For example, a reduction in the non-uniformity of the packed bed culture may be achieved 
through the use of carriers with a different geometry (to reduce channelling and stagnant 
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regions). Such modifications may allow the immobilised cells to be cultured under optimal 
conditions throughout the packed bed. The continuous control of parameters such as pH, 
temperature and dissolved oxygen levels is recommended for the optimisation of vector 
production throughout the culture period and reduction of vector titre variability. 
5.3.3 Cell Growth and Retroviral Vector Production in ImmobaSiI Flasks 
Vector titres in the ImmobaSil flasks were similar to those in standard T-flasks. 
Surprisingly, the number of cells counted in the ImmobaSil flasks was lower than that in the 
standard flasks, indicating increased vector productivity of the cells cultured on the 
ImmobaSil surface. However, it is possible that not all the cells were released after trypsin 
digestion in the ImmobaSil flasks. The ImmobaSil culture surface is highly porous and 
hence cells may migrate into the pores rendering them difficult to detach for counting. If all 
the cells were not removed by trypsin digestion the cell numbers in the ImmobaSil flasks 
will be higher than those counted. 
The vector titre in the ImmobaSil flasks continually increased through to day 13, whereas 
titres in the standard flasks were reduced after 5 days. Hence it appears that maximum titres 
in the ImmobaSil flasks are reached at a later time point than in standard flasks. This could 
be due to reduced cell growth rates on this alternative culture substratum, compared to 
standard tissue culture grade polystyrene. 
The progressive increase in vector titres in the ImmobaSil flasks suggests that cell numbers 
were increasing. The increased surface area in the ImmobaSil flasks may ultimately allow 
increased cell numbers per flask, however longer culture periods in these prototype flasks 
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would be necessary to determine whether this is indeed an advantage. If so, such flasks 
could be used for simple scale-up of retroviral vector production. 
Re-use of the ImmobaSil flask resulted in lower vector titres. A possible explanation for this 
is the attachment of vector particles to proteins deposited onto the ImmobaSil surface during 
the previous culture (though this was not tested). Data from this experiment suggests that 
these flasks should only be used as single-use disposable culture vessels for vector 
production. 
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Chapter 6: 
General Discussion and Conclusions 
The production of retroviral vectors for gene therapy applications faces a number of 
challenges. Of primary concern is the low titre of vector stocks produced by packaging cells 
in culture. Furthermore, the inherent instability of retroviral activity presents problems in 
optimising production processes. Retroviral vector production should aim to increase both 
titre and 'quality' (transduction efficiency). Quality can be improved by increasing vector 
stability and decreasing the concentration of inhibitors to infection, such as inactive vector 
particles and free envelope proteins (Forestell et aI., 1995) or proteoglycans released by the 
packaging cells (Le Doux et aI., 1998). Vector titres can be improved at both the genetic 
level and the cell culture level. While a number of groups have achieved higher vector titres 
through the construction of new and improved packaging cell systems, few reports exist on 
optimisation of the culture processes for vector production. 
In order to reduce production costs, the maximum titre achievable for each packaging cell 
system should be determined and maintained throughout production. In this thesis, an 
assessment of culture parameters that can influence vector titre was conducted. In addition, 
the use of an alternative production system, which is readily scalable, was investigated. 
These latter studies were conducted since the quantity of vector particles required for future 
clinical applications is likely to exceed those achievable using current production methods. 
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Culture Parameters 
While a number of factors had no measurable effect on vector production (e.g. dissolved 
oxygen concentration or addition of FGF, peptone, dexamethasone and sodium butyrate), 
studies within this thesis show that a number of parameters can significantly affect the vector 
titre achieved in cultures of FL YRD 18/LNC-hB7 cells. Cell proliferation rate was found to 
be closely linked to vector productivity (Chapter 3). For this reason, production cultures 
should be kept in a highly proliferative state in order to achieve maximum titres. Moreover, 
unlike a number of mammalian cells producing recombinant proteins, the arrest of 
FLYRD18/LNC-hB7 cells in any particular phase of the cell cycle affords no benefits in 
retroviral vector production. Cruz et aI., (2000) recently reported a correlation between cell 
proliferation and vector production, in P A317 retrovirus packaging cells, hence this finding 
may be true for a number ofretroviral packaging cell lines. 
A reduction in culture temperature was demonstrated to increase vector titres through a 
reduction in vector decay rates. This was only true within a small temperature range, since 
reduction of the culture temperature also leads to a decrease in vector production (due to 
lower cell proliferation/metabolic rates). Hence the optimum culture temperature is that 
which allows accumulation of vector particles in the culture medium (due to lower decay 
rates) whilst maintaining vector production at a sufficient rate. This may vary between 
different packaging cell systems due to their different production rates and vector half-lifes. 
Serum concentration was found to have a dose-dependent negative effect on vector titre. 
Low serum levels can therefore improve vector titres as well as reduce the protein 
concentration of vector preparations, though it would appear from the literature that the 
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effects of serum on vector production vary between different packaging systems. Since 
contaminating proteins such as those in serum should ideally be removed in the final 
product, the use of low serum concentrations during production can reduce the demands on 
down-stream processing. 
The pH of the culture medium was also observed to be a critical parameter in vector 
production (Chapter 4). Titres were significantly decreased when pH levels were higher or 
lower than the optimum level (PH 7.2). Continuous control of the pH throughout culture is 
therefore necessary in order to maintain optimal vector production. Surprisingly, this 
parameter has received little attention in the literature on retroviral vector production 
(possibly because typical culture methods such as roller bottles do not allow continuous pH 
control). The simplest method for continuous pH control involves monitoring the culture 
medium with a pH probe and the addition of a base, such as NaOH, when the pH drops 
below a critical level, or the addition of C02 gas when the pH rises (using a control unit). 
However, it has been reported that the addition of NaOH during prolonged culture can lead 
to dilution of the product and increased osmolarity of the culture medium (Harbour et aI., 
1989). Increased osmolarities can adversely effect the productivity of a number of cell lines. 
This should therefore be assessed for each packaging cell system. Due to the short half-life 
ofretroviral vectors, the culture supernatant of packaging cell cultures is usually harvested at 
frequent intervals (e.g. every 24h). The dilution of vector-containing supernatants due to 
NaOH addition may therefore not be significant over such a short period, but should be 
borne in mind. 
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Large-Scale Vector Production 
Few reports exist on the development of culture methods for the scale-up of retroviral vector 
production. Recently, Pan and Whitley (1999) investigated the use of a closed hollow fibre 
bioreactor and showed promising results. In this system, cells and released vectors are 
retained in the extra-capillary space, while medium is perfused through the capillaries. 
Nutrients are delivered to the cells via diffusion across the capillary walls. Such a system 
allows the concentration of the vector-containing supematant and titres were significantly 
increased compared to monolayer cultures. However, the total volume in the extra-capillary 
space of this system is relatively small, reducing the volumetric productivity. A further 
problem in such a hollow fibre system is the limited space for cell growth (anchorage-
dependent cells attach to the capillary walls). At high cell concentrations, Pan and Whitley 
reported that two thirds of the extra-capillary space were filled with cells after prolonged 
culture, leaving even less volume for supematant production. Large cell masses surrounding 
the capillaries can also reduce the ability of nutrients to diffuse across the capillary walls. 
Hence such a system may be limiting during intensive production from anchorage-dependent 
cells. 
Studies in Chapter 5 demonstrate the feasibility of using a novel packed bed system for the 
production of retroviral vectors. The vector titres produced in this perfused culture system 
were similar to those achieved in monolayer cultures. Large volumes of culture supematant 
can be harvested from the packed bed system at regular intervals (or continuously) and scale-
up of the system is relatively easy. Furthermore, the ability to maintain vector production 
over prolonged culture periods can reduce production costs by reducing the 'down-time' of 
each system between batches. Further optimisation of the packed bed system is, however, 
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necessary to reduce the residence time distribution (RTD). A reduced RTD could lead to 
improved titres, as each component of the culture supematant will be retained in the packed 
bed for the same length oftime and hence be exposed to the same optimum conditions. 
In Chapter 3, the dependence of vector half-life on temperature was clearly demonstrated. 
The increased vector half-life at low temperatures was exploited in a packed bed culture 
where open perfusion of the culture medium allowed the recovery of the vector-containing 
supematants onto ice, thereby increasing the stability of harvested vectors (Chapter 5). The 
use of such open perfusion cultures not only allows a reduction in vector decay rates, but 
also provides the potential for integration of the production process with primary down-
stream processing, such as vector isolation and purification (Braas et aI., 1996; Lyddiatt and 
O'Sullivan, 1998; Cruz et aI., 2000b) .. Continual harvesting of vector stocks may also be a 
more reliable method, since it has been recognised that during batch culture it is difficult to 
predict the optimal harvest time, when there is a 'peak' in titre (Shen et al., 1996). 
In such open perfusion cultures, reduced flow rates of the culture medium can increase the 
product concentration released by immobilised cells. However, if perfusion rates are too 
low, nutrient levels may become limiting and the concentration of metabolic by-products 
may become toxic (Griffiths et aI., 1992; Ozturk, 1996). A further consideration in perfused 
cell cultures for retroviral vector production is that a decrease in flow rate may lead to an 
increase in vector decay rate. This can occur where the vectors are retained in the culture 
vessel at a higher temperature for long periods before exiting into the recovery vessel 
(normally at a lower temperature). Low perfusion rates may therefore lead to a reduced 
active particle/total particle ratio, thereby reducing the quality of the vector preparation. The 
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quality of the vector stock may be further compromised by an increased concentration of 
inhibitors (released by the packaging cells) at lower flow rates. It is therefore necessary to 
adapt the perfusion rate of such culture systems according to the cell specific production 
rates and vector stability of each retroviral packaging cell system. In a recent paper by Cruz 
et aI., (2000a) a mathematical model was developed to determine the best retrovirus harvest 
. strategy in perfused cultures, in order to optimise the vector yield. It was claimed that this 
model could be used in any perfusion culture, provided the parameters of the cell system 
used are determined. 
The suitability of packed bed reactors for retroviral vector production has also been 
demonstrated in a recent paper by Kang et aI., (2000). This group compared vector 
production in monolayer, stirred microcarriers and packed bed cultures. Despite the rapid 
cell growth in the stirred microcarrier culture, the vector titre was lO-fold less than that 
obtained in monolayer cultures. Further studies on the effects of agitation indicated that this 
reduced titre was due to the effects of shear forces on the vector particles. This loss in vector 
particle activity due to agitation was also observed by Kenworthy (2000). The packed bed 
cultures conducted by Kang and co-workers yielded slightly lower vector titres than those 
from monolayer culture. However, a high cumulative titre and high volumetric productivity 
was demonstrated when using the packed bed system in continuous mode. 
Kang et al. initially compared vector production in packed bed cultures using three different 
carrier types for cell immobilisation (Siran™, MIF-5 and Fibra-CeFM). Fibra-CeFM gave the 
best results and was therefore chosen for use in further studies. Studies in Chapter 5 of this 
thesis employed the use of ImmobaSil-GTM carriers for packed bed culture o~ the packaging 
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cells. A study was conducted to compare these carriers to Fibra-CeFM and similar vector 
tires per cell were obtained using each carrier type (Figure 5.2.2.7). Hence ImmobaSil™ 
carriers are likely to perform well against other carrier types. 
The suitability of culture flasks with an ImmobaSiFM culture surface was also assessed in 
Chapter 5. These prototype flasks have an increased surface area for cell growth and hence 
may be suitable for the intermediate scale-up of vector production by anchorage-dependent 
cells (a scale between standard T-flasks and roller bottles/packed beds). Initial results were 
promising and demonstrated the use of these flasks as a simple disposable system for 
increased vector production. However, unlike the packed bed system, critical culture 
parameters such as pH cannot be continuously controlled in closed flasks. 
Clinical Requirements 
The studies in this thesis have demonstrated the importance of optimising culture conditions 
for improving vector titre. Obviously the titre requirements for clinical use will depend upon 
the application, where the number of cells which require transduction and the site of 
administration both vary. For example, a higher titre product may be necessary for 
successful systemic administration, where the vectors will become diluted and a high 
percentage may decay before reaching the target cells. On the other hand, site directed 
injections, such as those into solid tumours, may not require such high doses. Ex vivo gene 
delivery is unlikely to require such high titre vector stocks (in comparison with in vivo 
delivery), since successfully transduced cells can be 'selected' before transplantation back 
into the patient. However, production of vector stocks with the highest titre possible will 
inevitably reduce production costs. 
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Although outside the realms of this thesis, down-stream processing is also vital for clinical 
use of retroviral vector preparations. This includes concentration of the vector stock, 
purification (to remove contaminating proteins and inhibitors of transduction), preservation, 
storage and formulation. Common methods for concentration include ultrafiltration, and 
centrifugation. Alternative concentration methods under investigation include PEG 
(po1yethylene glycol) precipitation, two-phase extraction (using Dextran, PEG or PV A), 
membrane filtration, liquid chromatography and adsorption chromatography (Andreadis et 
aI., 1999; Lyddiatt and O'Sullivan, 1998; Braas et aI., 1996). While membrane filtration is a 
promising candidate, the membranes are prone to fouling and high shear forces may act on 
the envelope proteins of vector particles, leading to a decrease in activity (Kenworthy, 2000; 
Cruz et aI., 2000b). An underlying problem with most concentration methods is the co-
concentration of inhibitors to transduction, such as proteoglycans (Le Doux et aI., 1999). 
Hence additional steps such as enzyme digestion of inhibitors may be required to increase 
the transduction efficiency of concentrated vector stocks. 
Long term storage is also a problem for the inherently unstable vectors. The effectiveness of 
liquid nitrogen storage was demonstrated in Chapter 3, however, in large-scale this method 
of long-term storage becomes costly and impractical. Furthermore, significant losses in 
activity are incurred with the first freeze-thaw process. Lyophilisation is an alternative 
option, though significant activity loss is again a problem. Recently, ambient temperature 
vacuum dehydration has shown promising results (Andreadis et aI., 1999), but needs further 
work. 
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Clearly it is difficult to purify and store retroviral vector stocks without destroying some of 
their activity. Therefore, production processes should aim to produce vector stocks with 
high titres and minimal contaminating protein concentrations (to reduce the demands on 
down-stream processing). 
The production of vectors for clinical use requires not only stable products with high purity 
and high titre, but also safety is a key issue. Manufacturers need to ensure the final product 
is free of mycoplasma, endotoxins and other adventitious agents such as replication 
competent retrovirus (RCR). The production of RCRs is of major concern in the 
administration of retroviral vectors in humans. Stringent testing of vector stocks for the 
presence of RCRs is therefore essential. The importance of this issue was made clear at a 
forum sponsored by the FDA and NIH in 1996, where the development and evaluation of 
Phase I gene therapy vector products was discussed. A major topic for discussion at this 
meeting was the testing for RCRs during vector production and patient follow-up. The 
current requirement by the FDA was the testing of 5% of supernatant volumes and 1% of 
packaging cell cultures before products could be used in the clinic. However, as the size of 
production lots increased (to hundreds of litres), this testing became more logistically 
burdensome (and costly). Furthermore, significant quantities of product must be used for 
such testing, thus reducing the output. Steps to revise these requirements were therefore 
suggested. Statistical models to validate the testing strategies were presented which took 
into account both the volume oftest samples and the sensitivity of assays for the detection of 
RCRs. The FDA also proposed the provision of standardised stocks of RCRs to 
investigators, in order to allow 'calibration' of their assay sensitivity. 
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Whatever the methods employed for retroviral vector production, good control of the 
manufacturing processes are necessary to meet the current Good Manufacturing Practice 
(cGMP) requirements. cGMP requires safety (as outlined above), efficacy and potency of a 
product as well as consistency between batches. In typical monolayer culture methods it is 
difficult to control the culture parameters and the titre and quality of the vector stock can 
significantly vary from batch to batch. The packed bed system described in Chapter 5 may 
help to reach the goals of cGMP, as the culture parameters can be continuously controlled. 
Furthermore, such a system allows the implementation of a continuous perfusion culture, 
which is advantageous in· the production of inherently unstable biologicals, as they can be 
rapidly removed from the bioreactor (Kadouri and Spier, 1997). 
Summary 
The studies within this thesis have demonstrated the importance of temperature, pH, and 
serum concentration during retroviral vector production. In addition the proliferation of 
packaging cells was shown to be vital for the production of high titre vector stocks. Finally a 
packed bed system was proven to be a good candidate for the production of large quantities 
of active vectors. These findings should be considered during the development of 
appropriate procedures for the large-scale production and handling of retroviral vector stocks 
for human gene therapy applications. 
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